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        Melioidosis, caused by the environmental Gram negative bacillus Burkholderia 
pseudomallei, is an emerging infectious disease affecting both animals and humans. B. 
pseudomallei has the ability to enter the host cell and escape from the phagosome. Once in the 
cytoplasm, the pathogen proliferates and expresses a virulence-associated protein known as 
BimA which polymerises cellular actin at the pole of the bacterium to promote its movement 
inter- and intracellularly, a process known as actin-based motility. This actin-based motility is 
also used as a strategy to evade host immune responses and survive intracellularly.  
       In the first part of the thesis, we demonstrate that a B. pseudomallei ∆bimA mutant displays 
impaired intracellular survival compared to the isogenic parent strain in BALB/C bone-marrow 
derived macrophages (BMDMs), notably at later time points post-infection. Macrophages are 
the key innate immune cells that control B. pseudomallei in vivo and in vitro, and BALB/C 
mice provide an excellent model of acute human melioidosis. We also have determined that in 
BMDMs, the ∆bimA mutant is able to escape from the phagosome and enters the cytosol where 
it is unable to form actin tails. We used targeted, hypothesis-driven experiments to identify 
potential cell-autonomous innate mechanism/s of killing the mutant. First, we speculated that 
BimA mediates escape from autophagy. However our studies, including LC3-conversion 
assays, and bacterial co-localisation studies, failed to demonstrate a role for autophagy in 
clearance of the ∆bimA mutant from infected BMDMs. 
      In the second part of this thesis, we investigated the role of Toll-like Receptors (TLR) in 
recognition and elimination of B. pseudomallei. MyD88 (Myeloid differentiation primary-
response gene 88) and TRIF (TIR-domain-containing adaptor protein inducing IFNβ) are the 
main adaptor proteins involved in TLR signalling.  We utilised the gene silencing technique 
using short interfering RNAs (siRNAs) to knockdown MyD88 transcript, and in a separate 
experiment used MyD88- or TRIF-blocking peptides. In addition, we investigated the 
involvement of canonical and non-canonical inflammasome pathways in cell-autonomous 
immunity of the BMDMs. However, none of these pathways were shown to be involved in 
clearance of the ∆bimA mutant from infected BMDMs. 
      Finally we took an unbiased approach by microarray to characterise the global host 
transcriptome in BALB/C BMDMs upon B. pseudomallei infection, and to identify specific 
responses to the ∆bimA mutant. Analyses performed at the gene level revealed that several 
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interferon signalling-related pathways are activated in cells infected with either the WT or 
∆bimA mutant strains. A number of other pro-inflammatory mediators that are commonly seen 
in general inflammatory infections, such as IL-1α, IL-1β, IL-12β, and IL-6, were also 
upregulated. Interestingly, the cytoplasmic RNA sensors RIG-1 and MDA-5, thought primarily 
to be involved in the detection of RNA viruses, were also induced upon B. pseudomallei 
infection. Very few pathways were associated with a specific macrophage response to the 
∆bimA mutant, indicating that an as yet undescribed pathway may play a role in sensing and 
eliminating the ∆bimA mutant.  
      We conclude that actin-based motility mediates escape of B. pseudomallei from 





        Melioidosis, an emerging infectious disease that can affect both animals and humans, is 
caused by the bacterium Burkholderia pseudomallei. Melioidosis is endemic in tropical regions 
particularly in Southeast Asia and Northern Australia. Current diagnostic methods have 
limitations, no licensed vaccine is available and antibiotic therapy is often ineffective. 
        Macrophages are phagocytes that play a central role in the innate immune response to 
infection, including B. pseudomallei. After invading macrophages, B. pseudomallei escapes 
from the phagosome and enters the cytoplasm. Once in the cytoplasm, B. pseudomallei 
replicates and moves within and between the host cells via a mechanism known as actin-based 
motility. Actin-based motility is mediated by a bacterial protein called BimA which allows B. 
pseudomallei to avoid macrophage recognition and hence, to survive in the host cells. In this 
thesis we attempt to identify the immune surveillance pathways in macrophages that could be 
involved in detecting and killing the bacterium. We use a murine bone-marrow derived 
macrophage (BMDM) cell model system where we compare the ability of B. pseudomallei and 
a ∆bimA mutant strain which is unable to form actin tails to survive and replicate.   
      Autophagy is a process that deals with cellular stress, destroys unwanted proteins and 
organelles, and hence, maintains cellular homeostasis. Several studies have shown that 
autophagy also helps to eliminate intracellular pathogens, but some pathogens subvert this 
autophagic pathway to establish a persistent infection, including B. pseudomallei. Here we 
hypothesised that the BimA protein mediates the escape from autophagy, however, our findings 
did not agree with this hypothesis. We then investigated the role of Toll-like Receptors (TLR)-
signalling in recognition and elimination of B. pseudomallei. TLRs are one of the major innate 
immune sensors which recognise pathogen-associated molecular patterns (PAMPs) and 
initiates immune responses to resolve infections. Activated TLRs also link to the activation of 
the canonical and non-canonical inflammasomes. Inflammasomes are multiprotein oligomers 
which assemble upon activation to promote the maturation and secretion of inflammatory 
cytokines and induce the cell death. However, none of these pathways were involved in the 
clearance of the ∆bimA mutant from infected cells.  
      We also took an unbiased approach to characterise which cellular genes are switched on 
upon infection of cells with B. pseudomallei infection and to identify specific responses to the 
∆bimA mutant. Our analysis identified pro-inflammatory mediators, that are commonly 
v 
 
associated with general inflammatory infections, were upregulated in cells infected with either 
WT or ∆bimA mutant. Several Interferon Signalling-related pathways along with cytoplasmic 
RNA sensors, were also induced upon B. pseudomallei infection. Very few pathways were 
associated with a specific macrophage response to the ∆bimA mutant, indicating that an as yet 
undescribed pathway may play a role in sensing the ∆bimA mutant.  
      These studies allow us to conclude that actin-based motility mediates escape of B. 
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1 CHAPTER 1: INTRODUCTION  
1.1 Burkholderia pseudomallei and melioidosis  
1.1.1 History, background and epidemiology 
       
          Melioidosis was first described by the pathologist Alfred Whitmore in 1912 as a 
“glanders-like” disease from autopsies on deceased opium addicts he conducted in Rangoon, 
Burma (Whitmore & Krishnaswami, 1912). The term was derived from the Greek “melis” 
(distemper of asses) and “eidos” (resemblance) by Stanton & Fletcher (1932). Melioidosis is a 
disease caused by the motile Gram-negative bacterium Burkholderia pseudomallei.  B. 
pseudomallei is an environmental saprophyte commonly isolated from wet soil or surface water 
such as in rice paddy fields, in the endemic areas (reviewed in Inglis et al, 2001). Geographical 
factors namely high rainfall and temperature, anthrosol and acrisol soil types, soil with high 
salinity and a high proportion of gravel are strongly associated with the presence of B. 
pseudomallei (Limmathurotsakul et al, 2016). Recently, the global burden of human 
melioidosis was estimated to be approximately 165,000 cases per year worldwide with a high 
mortality rate of approximately 50%, from which 89,000 people will be expected to die. This 
estimation was generated using a formal modelling framework using the current map of human 
and animal melioidosis occurrences and also the environmental suitability for B. pseudomallei, 
predicted by a boosted regression tree (BRT) statistical model (Limmathurotsakul et al, 2016). 
The number of melioidosis cases is likely to be considerably underestimated as its clinical 
manifestations can mimic several other disorders and also due to inadequate laboratory 
facilities and poor reporting systems. The apparent emergence of melioidosis cases in new 
countries such as India, Southern China, Brazil and Malawi, is likely due to the upgrade of 
research facilities and microbiological laboratories. It has been suggested that melioidosis is 
severely underreported in 45 countries in which melioidosis is known to be endemic, and a 
further 24 countries are potentially endemic but have never reported the disease 
(Limmathurotsakul et al, 2016). Highest risk zones have been identified in Southeast and South 
Asia, tropical Australia, Western sub-Saharan Africa and South America. Besides,  risk zones 
are also observed in Central America, Southern Africa and the Middle East (Figure 1.1) 
(Limmathurotsakul et al, 2016). The high number of estimated cases and fatalities highlight 
the need for this disease to be given renewed attention by health workers, international health 
organisations and policy makers.  
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        The ability of B. pseudomallei to survive inside phagocytic cells for prolonged periods 
demonstrates that it is a facultative intracellular bacterium (Pruksachartvuthi, Aswapokee & 
Thankerngpol, 1990). Some early studies showed that inhalation is the main route of infection. 
For example, in 1941 many American servicemen (~225,000) in Vietnam were infected with 
B. pseudomallei, through inhalation of aerosolised infectious dust generated by helicopter 
blades (Howe, Sampath & Spotnitz, 1971). Interestingly, a small proportion of them were 
reported to have late-onset infections up to 62 years after leaving Southeast Asia which led to 
the name ‘Vietnamese Time Bomb’, and illustrates the prolonged latency and recrudescence 
of the disease (Mays & Ricketss, 1975; Ngauy et al, 2005).   
 
 
Figure 1.1 Predicted global distribution of melioidosis. The strength of evidence for melioidosis 
endemicity was assessed at national level, ranging from complete consensus on absence (green) and 
complete consensus on presence (red) (figure reprinted from Limmathurotsakul, D. et al (2016). 
Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature 
Microbiology, 1, 1–5. Copyright © 2016 with permission from Macmillan Publishers Ltd: Nature 





1.1.2 Routes of infection 
          
         Melioidosis has a strong correlation with occupational (18%) or recreational exposure 
(75%) to environmental B. pseudomallei in water and soil, with 81% of cases presenting during 
the monsoon season (Currie, Ward & Cheng, 2010; Currie & Jacups, 2003).  Higher rainfall is 
significantly associated with melioidosis sepsis and pneumonia, supporting the role of 
inhalation as a mode of acquisition with more severe pneumonic presentations (Currie et al, 
2010). By contrast, epidemiology in Northern Australia has supported the predominant mode 
of transmission in this region to be through percutaneous inoculation of B. pseudomallei after 
exposure to wet soil or contaminated water (Currie et al, 2000).  In addition, two recent clusters 
of melioidosis in Northern Australia have been linked to contaminated community water 
supplies, highlighting the possibility of ingestion as a route of transmission (Currie et al , 2001; 
Inglis et al, 2000). Human-to-human transmission of melioidosis has been reported previously, 
but such cases are exceedingly uncommon  (Abbink et al, 2001; Kunakorn, Jayanetra, & 
Tanphaichitra, 1991; McCormick et al, 1975). There is no evidence suggesting transmission 
occurs through biting insects in nature, despite Sulaiman et al (2000) reporting that B. 
pseudomallei can be isolated from synanthropic flies.  
 
1.1.3 Host risk factors, clinical presentations and treatment 
 
          In the majority of cases, the incubation period for melioidosis is between 1 and 21 days 
(with an average of 9 days) (Currie et al, 2000). The incubation period and clinical presentation 
depends on several factors including infecting dose, the bacterial strain, routes of transmission 
and importantly, host risk factors (reviewed in Currie, 2008). Melioidosis often affects 
individuals with one or more pre-existing conditions associated with an altered immune 
response, the most common being diabetes mellitus (which accounts for 50% of cases) 
followed by alcoholism, chronic lung disease and chronic renal disease. Other predisposing 
factors to melioidosis include malignancy, immunosuppression and thalassemia (Currie et al, 
2010). Cystic fibrosis patients should avoid travel to endemic regions as they are at substantial 
risk of infection with B. pseudomallei (Currie et al, 2010). Melioidosis septicaemia is the most 
severe clinical manifestation which is often associated with pneumonia, resulting in high 
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mortality rates of 49%. Other presentations range from skin lesions to abscess formation in 
internal organs (for example the liver, lungs or spleen) and also soft tissues that can progress 
to septic shock (Currie et al, 2010). 
         There is no licensed vaccine available for melioidosis at present, while the therapeutic 
options are very limited.  B. pseudomallei is highly resistant to wide groups of antibiotics, 
including penicillins, third-generation cephalosporins, rifamycins, aminoglycosides, 
quinolones and macrolides. Current post-exposure prophylaxis against melioidosis include 
ceftazidime, imipenem or meropenem with co-trimoxazole (reviewed in Dance, 2014; 
Sivalingam et al, 2008; Cheng & Currie, 2005). The antibiotic treatment falls into two distinct 
categories; phase 1 (acute infection) and phase 2 (eradication or maintenance therapy). The 
principal choice for the first acute-phase therapy includes a cephalosporin, usually Ceftazidime, 
or a carbapenem, usually Meropenem. Co-trimoxazole (trimethoprim/sulfamethoxazole) or co-
amoxiclav (amoxicillin/clavulanic acid) therapy is suitable for the eradication phase for a 
minimum of 12 weeks based on international consensus guidelines (reviewed in Dance, 2014). 
This antibiotic regimen has been shown to be effective to eradicate B. pseudomallei and reduce 
the chance of relapse (reviewed in Dance, 2014; Sarovich et al, 2014; Sivalingam et al, 2008). 
Non-antibiotic intervention using a statin has shown potential in treatment for phase 1, but this 
intervention is still under study and clinical efficacy for melioidosis has not yet been reported 
(Inglis, 2010). The severe course of infection, aerosol infectivity, intrinsic antibiotic resistance 
and lack of a vaccine has resulted in the listing of B. pseudomallei as a category B bioterrorism 
agent by the US Centres for Disease Control and Prevention (Patel et al, 2011). As such, 
continuous investigation on disease pathogenesis is crucial and may increase the likelihood of 
identifying new therapeutic targets for disease treatment. 
 
1.1.4 Taxonomy and related species  
 
        The genus Burkholderia contains >30 species, many of which are plant-associated 
inhabitants of the rhizosphere and plant pathogens. In exception, some members are pathogens 
of humans and animals namely B. pseudomallei, B. mallei and, in certain clinical conditions 
such as cystic fibrosis, Burkholderia cepacia (Coenye & Vandamme, 2003).  
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        Environmental isolates previously considered to be “B. pseudomallei- like” are now 
known as Burkholderia thailandensis. B. thailandensis can be differentiated from B. 
pseudomallei on the basis of their different abilities to assimilate arabinose and also based on 
a comprehensive 16S rDNA analysis. B. thailandensis, but not B. pseudomallei, can assimilate 
arabinose (ara+) (Godoy et al, 2003; Brett et al, 1998). Even though B. thailandensis and B. 
pseudomallei are closely related, B. thailandensis is relatively avirulent, at least in animal 
models of infection, requiring significantly higher doses of B. thailandensis than B. 
pseudomallei to cause disease or death in animal models (DeShazer, 2007; Brett et al, 1998).  
Although there have been reports of a few B. thailandensis infected patients in Thailand and in 
the United States, none were fatal (Glass et al, 2006; Lertpatanasuwan et al, 1999).  
        Burkholderia mallei is very closely related to B. pseudomallei and is the etiological agent 
of glanders in horses and other equines and, occasionally, can be transmitted to humans and 
other animals. It was originally demonstrated that B. pseudomallei and B. mallei are closely 
related genetically by DNA-DNA hybridisation experiments (Rogul et al, 1970). This 
similarity has been studied further by Godoy et al, 2003 using multilocus sequence typing 
(MLST). They found five isolates of B. mallei clustered within the B. pseudomallei strains, 
unambiguously classifying B. mallei as a clone of B. pseudomallei and not as a separate species. 
However, both were proven to be clearly distinct from B. thailandensis (Godoy et al, 2003). 
Glanders is now a very rare disease in Europe and North America and is largely an animal 
disease restricted to parts of Africa, Asia, the Middle East, and Central and South America. It 
has been reported that B. mallei was used during World War I by the German Army and may 
have been the first biological weapon of the 20th century (Srinivasan et al, 2001).  
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1.2  Pathogenesis and intracellular lifestyle of Burkholderia pseudomallei 
 
        As a facultative intracellular pathogen, B. pseudomallei has the ability to enter, survive, 
and replicate in both phagocytic and non-phagocytic cells (Jones et al, 1996). Indeed, this 
remarkable behaviour of B. pseudomallei to survive intracellularly may explain numerous 
features of melioidosis, namely, treatment difficulty, recrudescence and latency (Wiersinga et 
al, 2012). Numerous strategies have been employed by B. pseudomallei to survive in such a 
specialised niche as the intracellular environment. 
 
 
Figure 1.2 The intracellular lifestyle of Burkholderia pseudomallei. a) The Burkholderia secretion 
apparatus (bsa) system encodes proteins mediating host cell invasion, and also escape from the 
endocytic vacuole. (b) The bacterium is internalised into the endocytic vacuole or phagosome in the 
case of a phagocytic cell such as a macrophage. Once the bacterium escapes into the cytoplasm, B. 
pseudomallei proliferates. (c) B. pseudomallei can be propelled via BimA-dependent actin-based 
motility to protrude into the neighbouring cell and form a secondary vacuole in this new cell. 
Consequently, B. pseudomallei escapes from the secondary vacuole and enters the new cell cytoplasm 
and proliferates. (d) B. pseudomallei can induce cell fusion and form multinucleated giant cells (Figure 
reprinted from Wiersinga, W.J. et al (2006). Melioidosis: insights into the pathogenicity of 
Burkholderia pseudomallei. Nature Reviews Microbiology, 4, 272–282, Copyright © 2006 with 






1.2.1 Adhesion to host cells  
 
        Adhesion of the bacteria to the host cell is an essential early step in the pathogenesis of all 
intracellular bacteria, including B. pseudomallei. It has been demonstrated previously that the 
ability to adhere to the host cell is associated with the virulence of the bacteria. 
Kespichayawattana et al (2004) showed that B. pseudomallei has higher adherence capacity to 
human A549 lung epithelial cells than the avirulent B. thailandensis, resulting in more 
extensive cellular damage as represented by plaque formation. But, the molecular basis of this 
observation was not studied. Type IV fimbria (pili) and flagellum have been demonstrated 
previously as putative virulence factors required for cell adhesion of B. pseudomallei (Essex-
Lopresti et al, 2005; Inglis et al, 2003). Recently, two novel adhesins in B. pseudomallei were 
identified; BoaA and BoaB. Single boaA and boaB mutants showed a reduction in attachment 
to both A549 and Hep2 epithelial cell lines. A double boa/boaB mutant displayed a lack of 
synergism as the adherence level of the double mutant was similar to that of the single mutants, 
suggesting multiple adhesins are required for cell adhesion (Balder et al, 2010).   
 
1.2.2 Entry into host cells 
 
        The Type Three Secretion System (T3SS) is a central virulence factor in many Gram-
negative bacteria. The T3SS comprises a cell-surface located complex nanomachine that allows 
a set of bacterial protein translocators and effectors to be injected directly into eukaryotic target 
cells (Figure 1.3). B. pseudomallei has at least three T3SS gene clusters (Rainbow et al, 2002). 
Clusters 1 (T3SS1) and 2 (T3SS2) are related to the T3SS gene clusters encoding Hrp secretion 
systems of the plant pathogens Ralstonia (formerly Burkholderia), Solanacearum and 
Xanthomonas spp (Rainbow et al, 2002). Some studies demonstrated that these two gene 
clusters are involved in B. pseudomallei infection of tomato plants (Lee et al, 2010; Sun & 
Gan, 2010), but neither T3SS1 nor T3SS2 is needed for virulence in Syrian hamsters (Warawa 
& Woods, 2005). Cluster 3 (T3SS3) encodes the animal virulence-associated Bsa 
(Burkholderia secretion apparatus) T3SS which shares homology with the Inv/Mxi-Spa T3SS 
in Salmonella and Shigella (Stevens et al, 2002). Interestingly, T3SS2 and T3SS3 are present 
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in B. pseudomallei, B. mallei and B. thailandensis, but T3SS1 is unique to B. pseudomallei 
(Rainbow et al, 2002).  
        Several studies have demonstrated the importance of Bsa T3SS encoded proteins in 
various aspects of the intracellular lifestyle of B. pseudomallei, including invasion of host cells 
and escape from endocytic vacuoles (Figure 1.2). Invasion of B. pseudomallei into non-
phagocytic cells is facilitated by its secreted effector protein BopE. BopE, a homologue of 
SopE/SopE2 in Salmonella, acts as a guanine nucleotide exchange factor (GEF) for Rho 
GTPases that regulate the actin network (Cdc42 and Rac1) and subsequently, induces the 
cytoskeletal rearrangements that engulf bacteria, promoting invasion (Stevens et al, 2003). As 
BopE needs to be translocated into the host cytosol, BopE requires other Bsa proteins to act in 
concert to assist the translocation and hence, bacterial invasion. BipD, a translocator protein 
located at the tip of the needle (Figure 1.3), was shown to be important in cell invasion as a 
bipD mutant showed greater impairment in invading HeLa cells than a bopE mutant (Stevens 
et al, 2003). Additionally, Bsa structural proteins BsaQ and BsaZ, and the translocator protein 
BipD, are also essential for secretion of the BopE (Muangsombut et al, 2008; Stevens et al, 
2004). Interestingly, investigation of invasion of phagocytic cells, namely J774.2 murine 
macrophage-like cells, revealed that BopE was not required in invasion (Stevens et al, 2002), 
indicating that the T3SS may not be required for the invasion of phagocytic cells (Stevens et 
al, 2002). Moreover, the bopE mutant was not significantly attenuated in BALB/C mice 
following intraperitoneal or intranasal infection, suggesting BopE is not required for virulence 
and other effectors may be involved during both systemic and mucosal infection (Stevens et 
al, 2004). Conversely, the bipD mutant showed strong in vivo attenuation in the BALB/C 
mouse model of melioidosis and reduced bacterial colonisation of the liver and spleen at the 
early phase of infection (Stevens et al, 2004), however, immunisation with purified BipD 
protein failed to confer protection against challenge with wild type B. pseudomallei (Stevens 






Figure 1.3 Proposed structural model of the Burkholderia T3SS3 needle complex. Putative function 
of proteins and their position in the needle complex are based on information of homologous proteins 
found in other well-studied systems. Burkholderia T3SS3 consists of a basal body that spans across 
both the inner membrane (IM) and outer membrane (OM) and a hollow needle extending from the 
bacterial surface to form a translocation pore in the host cell membrane (figure reprinted from Sun, G. 
W., & Gan, Y.-H. (2010). Unraveling type III secretion systems in the highly versatile Burkholderia 
pseudomallei. Trends in Microbiology, 18(12), 561–568, Copyright © 2010, with permission from 
Elsevier).  
 
1.2.3 Escape from endocytic vesicles 
 
        Escape from endocytic vesicles is essential for the bacteria to subsequently survive 
intracellularly.  As early as 15 minutes following internalisation, B. pseudomallei lyses the 
endosomal membrane and escapes from the endocytic vacuole (Harley et al, 1998) in a Bsa 
T3SS-dependent manner (Stevens et al, 2002). bsaZ, similar to Salmonella spaS, is the last 
gene in the bsa gene cluster encoding a putative constituent of the T3SS apparatus (Stevens et 
al, 2002). bsaZ and bipD mutants are trapped in endocytic vesicles in J774.2 cells up to 6 hours 
post-infection (hpi) (Stevens et al, 2002).  In RAW264.7 cells, the majority of the bsaZ mutant 
showed delayed escape from endocytic vacuoles, becoming visible in the cytoplasm of infected 
cells at 18hpi (Burtnick et al, 2011). More specifically, the T3SS effector BopA has been 
shown to be required for efficient escape of B. pseudomallei from phagosomes (Gong et al, 
2011). In addition, the structural protein BsaQ is also involved in exiting endocytic vacuoles 
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(Muangsombut et al, 2008). Taken together these data suggest that the Bsa T3SS is not the 
only factor needed for phagosomal escape, but requires other bacterial-encoded proteins for 
this step in pathogenesis.  
 
1.2.4 Actin-based motility 
1.2.4.1  Actin-based motility in B. pseudomallei is mediated by BimA  
 
        Once in the host cell cytoplasm, the bacteria replicate and subvert the host cytoskeleton 
machinery to promote cell-to-cell spread, enabling pathogen dissemination while evading 
immune surveillance. Such actin-based motility is mediated by a bacterial factor known as 
BimA (Burkholderia intracellular motility A) which induces the formation of actin tails at one 
pole of the bacterial cell. Mutation of bimA abolished actin-based motility (ABM) of the 
pathogen in a macrophage-like J774.2 cell line, a phenotype that could be restored by inducible 
expression of the bimA gene on a pME6032 plasmid, showing the importance of the bimA gene 
in actin-based motility (Figure 1.4) (Stevens et al, 2005). Extensive investigations were then 
performed by our laboratory to determine if such actin-based motility contributes to the 
virulence of B. pseudomallei, as observed in other intracellular pathogens. As a result, bimA 
mutants exhibit attenuation in a murine model of melioidosis (Figure 1.5(C)) (unpublished 
data, G. Bancroft, LSHTM) and in a Galleria mellonella model system (unpublished data, J. 
Stevens and C. Vander Broek, The Roslin Institute). In addition, intracellular survival of a B. 
pseudomallei bimA mutant was found to be totally diminished in infected monolayers of A549 
lung epithelial carcinoma cells, a phenotype that could be restored when the bimA gene was 
provided in trans (Figure 1.5(A)) (unpublished data, J. Stevens, The Roslin Institute). 
Intracellular actin-based motility is believed to underlie the ability of B. pseudomallei to spread 
intercellularly and promote multinucleated giant cell (MNGC) formation. Plaque formation in 
the same cell line was found to require bimA, suggesting that actin-associated membrane 
protrusion facilitates cell-to-cell spreading (Figure 1.4(B)). These collectively increase the 







Figure 1.4 Actin-based motility of B. pseudomallei requires BimA in J774.2 murine macrophage-
like cells. The figure shows representative confocal micrographs of J774.2 cells infected with (a) WT 
Bp 10276, (b) Bp 10276 bimA::pDM4, and (c) Bp 10276 bimA::pDM4 pMEbimA. Mutation of bimA 
abolishes membrane protrusions in macrophage-like J774.2 cells. Bacteria were stained red, while 
filamentous actin was stained green with FITC-phalloidin. Scale bar = 5µM (Figure reprinted from 
Stevens, M. P. et al (2005). Identification of a bacterial factor required for actin-based motility of 
Burkholderia pseudomallei. Molecular Microbiology, 56(1), 40–53, Copyright © 2005 with permission 






Figure 1.5 BimA is required for intracellular survival, inter-cellular spread and virulence in mice. 
(A) Intracellular survival of B. pseudomallei 10276 (blue), a bimA mutant (red) and a bimA mutant 
transcomplemented with an IPTG-inducible vector expressing BimA (green), in A549 cells. The mean 
bacterial recoveries (CFU + SEM) from three independent experiments with triplicate measurements at 
2, 6, 19, and 24 hours post-infection (hpi) were shown. The number of intracellular bacteria of the WT 
remained almost unchanged up to 6 hpi, but had increased at 19 and 24 hpi. In contrast, the intracellular 
survival of bimA mutant was totally diminished up to 24 hpi, but the phenotype could be restored when 
the bimA gene was provided in trans.  (B) Ability of the same strains to spread from cell-to-cell and 
form plaques in A549 cell monolayers. Plaques were visualised by crystal violet staining of the 
monolayers. Plaques were formed by the cell monolayers infected with WT 10276 strain (blue) as well 
as the transcomplemented strain (green), indicating these strains were capable of spreading 
intercellularly. In contrast, intracellular bimA (red) mutant has a defect in cell-to-cell spreading as no 
plaque was observed by the infected cell monolayer.  (C) Comparison of the virulence of a bimA mutant 
to the WT and a TTSS mutant (bipD), in a murine intranasal model of melioidosis. 10 mice were 
inoculated for each strain at day 0 and the survival of mice were investigated for 40 days. Mice 
inoculated with WT 10276 strain at day 0 all died by day 4 post-inoculation, while mice inoculated with 
an isogenic bipD mutant were all survived  throughout the 40-days of experiment. For the mice 
inoculated with an isogenic bimA mutant, 6 out of 10 mice were survived until 40-days of experiment 





1.2.4.2 The mechanism of actin-based motility of Burkholderia pseudomallei is distinct 
from other intracellular pathogens  
 
        Actin-based motility (ABM) is common in members of several genera, including 
Burkholderia, Listeria, Shigella, Rickettsia and Mycobacterium (reviewed in Stevens et al 
2006). The majority of pathogens capable of actin-based motility do so by exploiting the 
cellular Arp2/3 complex and have developed several mechanisms to activate this complex. The 
conserved Arp2/3 complex consists of seven polypeptides and acts as a nucleating factor to 
facilitate de novo actin polymerisation in host cells. The Arp2/3 complex itself has weak 
biochemical activity and is activated by a nucleation promoting factor (NPF), in particular 
members of the Wiskott-Aldrich syndrome protein (WASP) family. This activation leads to 
conformational stabilisation and promotes actin monomer delivery for actin nucleation (Goley 
et al, 2004). The Listeria ActA protein mimics the action of N-WASP in activating the Arp2/3 
complex (Welch et al, 1997), while Shigella expresses the surface protein IcsA that recruits 
host cell WASP family proteins to the bacterial surface (Egile et al, 1999), facilitating the co-
localisation with Arp2/3 complex and hence, actin polymerisation. In contrast, BimA can 
stimulate actin polymerisation in vitro in a manner that is independent of the cellular Arp2/3 
complex, therefore the mechanism of B. pseudomallei ABM is different from those previously 
described for Listeria and Shigella (Benanti et al, 2015; Stevens et al, 2005). Moreover, over-
expression of a dominant negative domain of the cellular NPF Scar1, which inhibits actin tail 
formation by S. flexneri and L. monocytogenes, did not block actin tail formation by B. 
pseudomallei (Breitbach et al, 2003). Additionally, neither WASP nor the host elongation 
factor Ena/VASP protein are important as B. pseudomallei ABM was not impaired in knockout 
N-WASP-/- nor Ena/VASP-/- cells (Breitbach et al, 2003).  
        Recently, it has been revealed that B. pseudomallei establishes BimA-mediated ABM 
through a novel mechanism by mimicking the host Ena/VASP actin polymerases (Benanti et 
al, 2015). It has been demonstrated that BimA in B. pseudomallei and the closely related 
species B. mallei can oligomerise into trimers to initiate actin nucleation and elongation, similar 
in fashion for the requirement for tetramerisation and clustering for Ena/VASP actin 
polymerase activity. The actin monomer-binding motif WH2 (WASP homology domain 2) of 
BimA recruits actin subunits and brings them into close proximity so that actin nucleation can 
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occur.  BimA also demonstrates similar anti-capping activity of host Ena/VASP which removes 
the CapZ inhibition from barbed ends to enable actin elongation (Benanti et al, 2015). It has 
been described recently that the cellular cytoskeletal scaffold protein Ras GTPase-activating-
like protein IQGAP1 is recruited to the actin tails of B. pseudomallei (Jitprasutwit et al, 2016), 
a protein that has so far not been linked with ABM of any other intra-cytoplasmic microbe. 
IQGAP1 plays a functional role in regulating tail length and actin density of B. pseudomallei 
(Jitprasutwit et al, 2016). However, the interaction of B. pseudomallei BimA and IQGAP1 is 
believed to be indirect as confirmed by the yeast-two hybrid assay (Jitprasutwit et al, 2016). In 
addition to IQGAP1, the cellular protein α-actinin is also present in B. pseudomallei actin tails 
as observed by Breitbach et al (2003) by confocal microscopy, however the functional role in 
B. pseudomallei actin-tails has not been characterised. In fact, 30 cellular proteins have been 
identified to be recruited to BimA-expressing bacteria including actin, actin-depolymerising 
factor and capping protein under actin polymerising conditions in vitro (Jitprasutwit et al, 
2016). However, investigation of whether these proteins are essential for actin-tail formation 
in B. pseudomallei is warranted.  
1.2.4.3 Studies of BimA in different Burkholderia species 
 
           Studies on the BimA protein of B. pseudomallei were extended to its related species, B. 
mallei and B. thailandensis (Figure 1.6). B. mallei and B. thailandensis also exhibit actin tail 
membrane protrusion in infected cells, despite their BimA proteins showing no sequence 
identity to the BimA protein of B. pseudomallei (designated as BimAps) at the N-terminus 
(Stevens et al, 2005a). It has been shown that the BimA proteins from B. mallei and B. 
thailandensis can functionally compensate for the ABM defect of a Burkholderia pseudomallei 
bimA mutant. Hence, it was of interest to identify motifs or factors required for the subversion 
of actin dynamics in intracellular actin-based motility. Initially, B. pseudomallei BimA was 
identified by searching the translated B. pseudomallei genome for proline-rich Type V 
autosecreted proteins for similarity to the IcsA/VirG virulence-associated protein required for 
ABM in Shigella flexneri. BimA is a putative autosecreted protein which is homologous to the 
C-terminal region of the Yersinia enterocolitica adhesin YadA and Haemophilus influenzae 
Hia autotransporters (Stevens et al, 2005b). Later, the BimA proteins in B. mallei and B. 
thailandensis (designated as BimAma and BimAth respectively) were identified based on this 
conserved C-terminal region, corresponding to the putative membrane targeting and anchoring 




Figure 1.6 The putative domain organisation of BimAps, BimAma and BimAth. The domains are 
drawn to scale and the abbreviation and predicted signal sequence are shown in the table (Figure 
reprinted from Stevens, J.M. et al (2005a). Actin-binding proteins from Burkholderia mallei and 
Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a 
Burkholderia pseudomallei bimA mutant. Journal of Bacteriology, 187(22), 7857–7862. Copyright © 
2005 with permission from American Society Microbiology).  
 
        WH2 and proline-rich motifs (PRMs) are present in all three BimA proteins. In BimAps, 
the WH2 domains were found to be required for actin-binding, actin polymerisation and ABM 
(Benanti et al, 2015; Sitthidet et al, 2011). The CA domain is unique to BimAth, recruiting and 
activating the Arp2/3 complex for actin polymerisation, and is required for ABM in B. 
thailandensis. BimAps lacks this CA domain, consistent with the finding that B. pseudomallei 
polymerises actin in an Arp2/3-independent manner (Benanti et al, 2015; Sitthidet et al, 2011). 
A PRM is known to interact with profilin, a G-actin-binding protein that aids in funnelling 
monomeric actin to the tip of actin filaments for incorporation into growing filaments (Haglund 
et al, 2010; Holt, 2001).  In BimAps, a tandem repeat of 13 amino acids (NIPKVPPPMPGGGA) 
is adjacent to the PRM1 motif (also known as IP7) at the amino-terminus of the protein (Figure 
1.6) ( Stevens et al, 2005a). Both the PRM1 motif and 13 amino acid repeat are conserved in 
most B. pseudomallei strains, but are not essential for ABM of B. pseudomallei in vitro 
(Sitthidet et al, 2011; Sitthidet et al, 2010). Interestingly, BimAps that lacks the 13-aa direct 
repeat abrogated plaque formation (cell to cell spread) and intracellular survival, despite 
retaining the ability to undergo ABM. It has been speculated that the 13aa repeats may be 
responsible for recruiting bacterial or cellular factors that may mask BimA from recognition 
by the host autophagic pathway (Sitthidet et al, 2008). Putative consensus sites for cellular 
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casein kinase II phosphorylation are found adjacent to the WH2 domains. The number of 
PDASX repeats vary within sequenced B. pseudomallei strains (between 2 and 7 copies) 
(Sitthidet et al, 2008). These PDASX repeats are required for polymerisation of actin but not 
for actin binding. Interestingly, the rate of polymerisation increased in a step-wise manner as 
the number of repeats increased, indicating that the repeats stimulate actin polymerisation in 
vitro in an additive fashion (Sitthidet et al, 2011). The roles of the different BimAps motifs as 
studied by Sitthidet et al (2011) using the B. pseudomallei strain 10276 are summarised in table 
1.  
Table 1.1 Summary of the roles of different motifs in BimAps.. The functional roles of each motif are 
determined using the plasmid-borne bimA variants with in-frame deletions of specific motifs, followed 
by in vitro experiments on actin-based motility, intercellular spreading and the actin binding and 
polymerisation as studied by Sitthidet et al (2011).  
BimAps variant with 





Actin binding Pyrene-actin 
polymerisation 
∆13-aa Yes No Yes Yes 
∆PRM1 Yes Yes Yes Yes 
∆WH2 domains  No No No No 
∆PDASX repeats No No Yes No 
 
1.2.5 Multi-nucleated giant cell (MNGC) formation  
 
         Inter-cellular spreading mediated by BimA contributes to the phenomenon of cell fusion, 
inducing the formation of multi-nucleated giant cells (MNGC). This MNGC formation is not 
observed in other intracellular bacterial pathogens such as Salmonella enterica Typhimurium 
or Shigella flexneri (Kespichayawattana et al, 2000), but is common in viral infection such as 
human immunodeficiency virus (HIV), cytomegalovirus (CMV) and herpes simplex virus 
(HSV) (reviewed in Allwood et al, 2011). Cell fusion is thought to represent a strategy to 
facilitate cell-to-cell spreading, evasion of host-immune responses and persistence of B. 
pseudomallei within a host, which collectively increases the intracellular survival of B. 
pseudomallei in both phagocytes and non-phagocytes (Kespichayawattana et al, 2000; Harley 
et al, 1998). Moreover, MNGC formation has been observed in tissues from melioidosis 
patients (Wong et al, 1995), suggesting that MNGC formation is a part of pathogenesis.  
         In B. pseudomallei, MNGC formation has been associated with RpoS (RNA polymerase, 
sigma S) (Utaisincharoen et al, 2006), BipB (Suparak et al, 2005), and T6SS-1 (Burtnick et al, 
2011), however, the molecular mechanisms involved are poorly understood. Sigma factor 
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RpoS is the key transcriptional regulator in response to general stress and also during stationary 
phase. Utaisincharoean et al (2006) demonstrated that in comparison to the WT strain, a B. 
pseudomallei rpoS mutant is significantly impaired in its ability to induce MNGC formation in 
RAW264.7 cells, despite demonstrating no difference in intracellular survival and replication 
at a late time point of 18 hpi. Suparak et al (2005) demonstrated that a strain with mutation of 
the gene encoding the T3SS translocon protein bipB was deficient in forming MNGC in 
J774A.1 macrophage-like cells at 6 hpi but was restored by complementation with intact bipB 
on a plasmid. However, both the rpoS and bipB mutants were not tested for their ability to 
escape the endocytic compartment or for their ability to promote actin-based motility.   
        Besides T3SS, The Type VI secretion system (T6SS) is another contact-dependent protein 
translocation system commonly expressed by many Gram negative bacteria. B. pseudomallei 
possesses six evolutionarily distinct T6SSs and specifically, T6SS cluster 5 (T6SS-5) is strictly 
required for MNGC formation (Schwarz et al, 2010). Hcp (Haemolysin co-regulated protein) 
and VgrG (valine-glycine repeat protein) are hallmark proteins of T6SS activity. Hcp 
polymerises into tubules in a hexameric ring formation to translocate bacterial proteins across 
the membrane of the host cells, while VgrG forms a trimer at the tip of the T6SS apparatus for 
membrane puncturing, analogous to the structural counterparts of bacteriophage (Schwarz et 
al, 2014; Toesca et al, 2014). Studies by Burtnick et al (2011) showed that infection with the 
∆hcp1 mutant in RAW264.7 cells resulted in no MNGC formation, despite an increase in 
bacterial replication by 18 hpi and no difference in CFU counts when compared with the WT 
strain (Burtnick et al, 2011). On the other hand, mass spectrometry secretomic analysis by 
Schwarz et al (2014) identified VgrG-5 as a novel secreted protein whose export is dependent 
on T6SS-5 function. VgrG-5 is a specialised VgrG protein that harbours a C-terminal domain 
(CTD) conserved within B. pseudomallei, B. mallei and B. thailandensis (Schwarz et al, 2014). 
T6SS VgrG-5 is required for cell fusion and intercellular spread as a vgrG-5 mutant in B. 
pseudomallei failed to show MNGC in HEK293 (Toesca et al, 2014) and RAW264.7 cell lines 
(Schwarz et al, 2014), but is dispensable for endosomal escape and actin polymerisation 
(Toesca et al, 2014). Both studies documented that the VgrG-5 CTD specifically was 
responsible for T6SS-5-dependent MNGC formation (Schwarz et al, 2014; Toesca et al, 2014).  
The authors proposed that the force generated by the bacterial propulsion into the neighbouring 
cell facilitates bacteria-plasma membrane contact, bringing adjacent membranes into close 
apposition. The membrane contact may release some cue to deploy the T6SS-5, and the 
resulting energy drives the VgrG-5 CTD to be inserted across one or both cell surfaces, creating 
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a disordered “hemifusion zone” and subsequently membrane fusion. However, VgrG-5 CTD 
alone is unlikely to be sufficient for cell fusion and additional bacterial factors such as surface 
proteins and host factors such as adhesin may be required (Toesca et al, 2014).  In fact, 
inhibition of several macrophage surface proteins namely integrin-associated protein (CD47), 
E-selectin (CD62E), a fusion regulatory protein (CD98), and E-cadherin (CD324) with 
blocking monoclonal antibodies, were each able to suppress MNGC formation in a 
concentration-dependent manner, supporting the possible involvement of those host factors 
during B. pseudomallei-induced MNGC formation (Suparak et al, 2011). 
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1.3  Burkholderia pseudomallei and host immune responses  
1.3.1 Murine models of melioidosis  
 
        The laboratory mouse represents an excellent surrogate for the study of clinical 
melioidosis with respect to the disease presentation and immune response (Warawa et al, 
2010). Two inbred mouse strains, BALB/C and C57BL/6, have been extensively used to 
investigate the immunopathogenesis of several intracellular pathogens such as Listeria 
monocytogenes (Liu et al, 2000), Chlamydia muridarum (Jiang et al, 2010), Yersinia 
enterocolitica (Hancock et al, 1986) and Mycobacterium avium (Roque et al, 2007). In many 
of these mouse models, BALB/C mice are relatively susceptible compared to C57BL/6 mice. 
In melioidosis, several studies have shown that BALB/C mice are also highly susceptible to 
infection with B. pseudomallei, while C57BL/6 mice are considerably more resistant (Liu et 
al, 2002; Hoppe et al, 1999; Leakey et al, 1998). Intravenous administration of as few as 37 
CFU of B. pseudomallei in BALB/C mice resulted in substantial bacterial colonisation in liver 
and spleen, that progressively developed into bacteraemia within 48 hours, causing death of 
the animal within 72 to 96 hours (Leakey et al, 1998). However, bacteraemia is absent in 
infected C57BL/6 animals indicating that some innate resistance mechanisms may play 
important roles in controlling B. pseudomallei at early time points. However, considerable 
bacterial burden in the liver and spleen eventually leads to a fatal outcome in C57BL/6 mice 
and implies incomplete resistance (Leakey et al, 1998). Further studies indicate that acute 
melioidosis observed in BALB/C mice is characterised by hypersecretion of proinflammatory 
cytokines namely TNF-α, IL-1β and IL-6 (Ulett et al, 2000), resulting in an inappropriate cell 
response, multiple organ failure and failure to control the infection.  The relative resistance of 
C57BL/6 correlates with a more protective interferon-gamma (IFN-γ) mediated macrophage 
response (Breitbach et al, 2006), an effective NADPH oxidase (Breitbach et al, 2006), and a 
higher immunoglobulin IgG2a/IgG1 ratio (Hoppe et al, 1999). This differential susceptibility 
to infection classifies BALB/C and C57BL/6 mice as excellent models for the acute and 






1.3.2 Role of neutrophils and macrophages in melioidosis  
 
         Neutrophils and macrophages are key components of the innate immune response in the 
control of acute melioidosis (Breitbach et al, 2011; Barnes et al, 2008; Easton et al, 2007; 
Breitbach et al, 2006; Leakey et al, 1998). A role for macrophages in control of acute 
melioidosis in murine models has been established by in vivo depletion studies where the mice 
were administered clodronate-containing liposomes intravenously to eliminate macrophages in 
the spleen and liver, the organs known to accommodate B. pseudomallei (Breitbach et al, 2006). 
Macrophage-depleted mice were significantly more susceptible to disease and death indicating 
that macrophages are essential to control early B. pseudomallei infection in both BALB/C and 
C57BL/6 mice (Breitbach et al, 2006). In a study of a murine model of pulmonary B. 
pseudomallei infection,  neutrophils were shown to be rapidly recruited to the primary site of 
infection in the lung, showing a critical role in early resistance to invading bacteria and to 
prevent dissemination to distal organs (Easton et al, 2007). In the same studies, in vivo 
depletion of neutrophils using monoclonal antibody RB6 rendered mice exquisitely susceptible 
to experimental B. pseudomallei infection (Easton et al, 2007), which was accompanied with 
a decrease in early proinflammatory cytokines namely TNF-α, IL-6 and IFN-γ in the lungs 
(Easton et al, 2007). Riyapa et al. (2012) have demonstrated that neutrophils are capable of 
neutralising extracellular bacteria through the secretion of ‘neutrophil extracellular traps’.  
Recently, it has been demonstrated that autophagy in primary neutrophils clears intracellular 
B. pseudomallei through novel membraneous structures composed of partial phagosome-like 
single membranes and partial elongated membranes (Rinchai et al, 2015). 
        The importance of the host innate immune responses in melioidosis can also be evidenced 
from studies using a murine model of Type 2 Diabetes (diabetes mellitus) (Hodgson et al, 2013; 
Hodgson et al, 2011) as well as polymorphonuclear cells (PMNs) from diabetic subjects 
(Chanchamroen et al, 2009). Macrophages and neutrophils from diabetic patients have 
decreased chemotaxis, phagocytosis and antimicrobial mechanisms (Geerlings & Hoepelman, 
1999). This impaired innate immune response is assumed to underlie the diabetics’ 
susceptibility to infection with B. pseudomallei (Hodgson et al, 2011; Chanchamroen et al, 
2009), and also other bacteria such as Klebsiella pneumonia (Lin et al, 2013), Mycobacterium 
tuberculosis (reviewed in Dooley & Chaisson, 2009) and Staphylococcus aureus (reviewed in 
Breen & Karchmer, 1995).  A defective innate immune response allows the pathogen to resist 
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killing within immune cells which then could lead to persistence of the bacteria and 
dissemination of infection, followed by progression to sepsis. Hodgson et al (2011) 
demonstrate that macrophages from diabetic mice have a significantly impaired ability to 
phagocytose and kill B. pseudomallei in vitro. Similarly, PMNs from diabetics subjects also 
exhibited reduced phagocytosis of B. pseudomallei (Chanchamroen et al, 2009).  The 
bactericidal activity was also reduced in infected macrophages from diabetic mice as they 
secreted significantly lower nitric oxide (NO) compared to infected macrophages from non-
diabetic mice (Hodgson et al, 2011). While in diabetic patient PMNs, the oxidative killing 
seemed to be decreased compared to healthy volunteer PMNs in response to B. pseudomallei 
(Chanchamroen et al, 2009).   
        In vivo, two different diabetic mouse models are used to mimic human Type 2 Diabetes 
and melioidosis comorbidity namely the monogenic db/db model that has a genetic mutation 
in leptin signalling and secondly, the polygenic diet-induced HFD (high-fat-diet-fed) mouse 
models (Hodgson et al, 2013; Hodgson et al, 2011). Subcutaneous infection of monogenic and 
polygenic diabetic mice with B. pseudomallei resulted in 100% and 40% mortality rate 
respectively, while the infected non-diabetic mice survived during the 10-day experimental 
period (Hodgson et al, 2013; Hodgson et al, 2011). This increased mortality of diabetic mice 
was accompanied by earlier dissemination of B. pseudomallei to several organs as early as 24 
hpi  (Hodgson et al, 2013; Hodgson et al, 2011).  These findings together show that the 
impaired host innate functions in diabetics could contribute to an increased susceptibility to 





1.4  Host cell-autonomous immunity in response to microbial infection  
 
         In response to microbial infection, cell-autonomous immunity is activated as a first line 
of defence to eliminate an invasive infectious agent. The host cell surveys the presence of 
microbial PAMPs (Pathogen Associated Microbial Patterns) or DAMPs (danger-associated 
molecular patterns) in the extracellular, vacuolar and cytoplasmic compartments using 
germline-encoded specialised sensor proteins known as pattern-recognition receptors (PRRs). 
Activation of these PRRs is dependent on the ligands and signals detected, and triggers 
downstream innate immune signalling networks to eliminate the pathogen. Classification of 
PRRs include Toll-like receptors (TLRs), retinoic acid-inducible gene 1 (RIG-I)-like receptors 
(RLRs), nucleotide-binding and oligomerisation domain (NOD)- and leucine-rich repeat 
containing proteins (NLRs), absent in melanoma (AIM2)-like receptors (ALRs), C-type lectin 
receptors (CLRs) and sequestome 1-like receptors (SLRs) (Figure 1.7). Some of these PRRs 
are not exclusively expressed by immune cells like macrophages and dendritic cells, but are 
also expressed in other cell populations such as endothelial and epithelial cells (Irving et al, 
2014; reviewed in Bäckhed & Hornef, 2003), which allow these cells to engage in immune-
surveillance and host defence.   
         CLRs and TLRs belong to the family of membrane anchored PRRs that are either located 
on the cell surface or within phagosomal/endosomal compartments. CLRs, which consist of 
Dectin-1 and Dectin-2, recognise complex carbohydrate structures such as the cell wall of fungi. 
These CLRs signal through adapter kinase Syk and CARD9 via nuclear factor κB (NF-κB) 
transcription factor to express inflammatory cytokines (Saijo et al, 2010; Taylor et al, 2007). 
Some TLRs detect bacterial components such as lipopolysaccharide (LPS), bacterial flagellin, 
lipoteichoic acid of the Gram-positive bacteria cell wall and many others, while some TLRs 
namely TLR3, TLR7 and TLR9 detect ‘non-self’ nucleic acids.  Upon ligand binding, an 
individual TLR triggers distinctive downstream signalling depending on the recruitment of the 
adaptor proteins MyD88 or TRIF (Figure 1.7).  MyD88 is employed by all TLRs except TLR3 
and certain TLR4, while TRIF is an exclusive adaptor used by TLR3 as well as the TLR4-
induced MyD88-independent pathway (reviewed by Kawai and Akira, 2010). There are other 
adaptor proteins that either serve as bridging adaptors (MyD88-adaptor-like (MAL) and TRIF-
related adaptor molecule (TRAM)) or as a TLR-negative regulator (sterile α- and armadillo-
motif containing protein (SARM)). MAL bridges TLR2 and TLR4 to recruit MyD88, and 
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TRAM is exclusively used by TLR4 to bridge TRIF to allow for IFN regulatory factor (IRF) 3 
activation (reviewed in Kawai & Akira, 2011). SARM inhibits the TRIF signalling pathway, 
functioning as a negative regulator of TRIF (Peng et al, 2010). Ligand binding and TLR 
activation triggers the transcription of Type I interferon (IFN) and various inflammatory 
cytokines and chemokines through the transcription factors nuclear factor κB (NF-κB), 
activation protein-1 (AP1) and IRF  (reviewed in Schattgen & Fitzgerald, 2011) (Figure 1.7). 
Transcription of these immune molecules are crucial for cell-intrinsic control of bacterial 
pathogens as well as activation of adaptive immunity (reviewed in von Moltke et al, 2013).    
        Sensing of PAMPs or DAMPs in the cytosol is mediated by the family of NOD receptors 
(NOD1 and NOD2), NOD-like receptors (NLRs), RNA-sensing RLRs (RIG-1 and MDA-5) 
and other nucleic acid receptors. NOD receptors (NOD1 and NOD2) recognise bacterial cell 
wall fragments such as peptidoglycan containing muramyl dipeptide (MDP). Upon ligand 
binding, cytosolic NOD receptors activate NF-κB for induction of inflammatory cytokine 
production (Figure 1.7) (Ogura et al, 2001). Cytosolic ‘non-self’ RNA can be recognised by 
the cytosolic sensor RIG-1 or MDA-5, which then associates with the adaptor protein MAVS 
(mitochondrial anti-viral signalling, also known as IPS-1) to induce expression of Type I IFNs 
and inflammatory cytokines via IRF3 and NF-κB signalling pathways respectively (Figure 1.8). 
Activation of IRF3 requires upstream signalling through TBK1 (Tank-binding Kinase) to 
induce transcription of Type I IFN. Besides MAVS, STING (stimulator of interferon genes) is 
another essential adaptor protein that functions upstream of TBK1 and IRF3 to induce Type I 
IFN (Figure 1.8). In addition to STING, ZBP-1 (Z-DNA binding protein 1, also known as 
DNA-dependent activator of IRFs (DAI)) is another DNA-sensor which leads to the production 
of Type I IFN. Several other DNA sensors can induce the production of inflammatory cytokines 
and Type I IFNs in a STING-dependent and independent manner. 
        In addition to cytosolic NOD-receptors and RLRs, activation of cytosolic NLR (NLRP3, 
NLRP1 and NLRC4) and some ALR (AIM2) can lead to the assembly of oligomeric 
multiprotein complexes known as inflammasomes upon recognition of ‘non-self’ nucleic acids 
or upon recognition of certain danger signals.  Inflammasomes provide signalling platforms to 
catalytically activate pro-caspase 1 into its active subunit caspase 1. This cleaved caspase-1 
promotes the maturation and release of biologically active pro-inflammatory IL-1β and IL-18 
(reviewed in von Moltke et al, 2013; Nikolov et al, 1992). Also, inflammasome-induced 
activation of caspase-1 induces pyroptotic cell death, an inflammatory programmed cell death 
to prevent the establishment and dissemination of intracellular pathogens (Miao et al, 2010). 
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Pyroptosis is distinct from the programmed cell death known as apoptosis, which is dependent 
on activation of caspase-3 and caspase-7 and is non-inflammatory (Miao et al, 2010). 
Inflammatory pyroptosis can also be mediated in a non-canonical manner through activation 
of murine caspase-11, which is known as caspase 4/5 in humans. Downstream signalling of 
this non-canonical activation pathway results in the maturation of pro-inflammatory 
interleukin-1 alpha (IL-1α), which is distinct from the scenarios following activation of the 
canonical inflammasome pathway (Groß et al, 2012).  
        SLRs such as p62 (also known as sequestome 1) and nuclear dot protein 52 (NDP52) 
promote host defence by selectively targeting ubiquitinated substrates or cytoplasmic bacteria 
such as Listeria, Shigella and Mycobacterium tuberculosis for destruction by the autophagy 
pathway (reviewed in Vojo and Kliewer, 2012). All in all, closely interlinked networks between 
multiple PRRs facilitate bacterial recognition, however, an appropriate scaling of these PRRs 




Figure 1.7 Recognition of PAMPs and DAMPs by TLR and NLR signalling pathways.  Toll-like receptors (TLRs) are located on the surface membrane 
and also within endosomal compartments. Some TLRs are non-nucleic sensors detecting several bacterial components while some TLRs namely TLR3, 
TLR7, TLR8 and TLR9 recognise only the presence of certain nucleic acid. Activation of the TLR signalling pathway induces transcription of inflammatory 
cytokines and Type I IFN through transcription factor NF-κB, AP1 or IRF. NOD receptors recognise peptidoglycan components and signal via API and 
NF-κB. Inflammasome activation is achieved by different NLRs characterised by caspase-1-mediated proteolytic cleavage of matured IL- 1β and IL-18. 
NLRP3 inflammasome can also be activated in a non-canonical way by cytosolic LPS, mediated by an inflammatory caspase-11. Source of diagram: 








Figure 1.8 Cytosolic nucleic acid sensors. RIG-1 and MDA5 sense ‘non-self’ RNA, recruits an 
adaptor IPS-1 (MAVS) for induction of Type I IFNs and inflammatory cytokines via IRFs and NF-κB 
signalling pathways respectively. Several DNA sensors can induce the production of inflammatory 
cytokines and Type I IFNs in a STING-dependent and independent manner. (Figure reprinted from 
Mahla, R.S. et al (2013) Sweeten PAMPs: Role of sugar complexed PAMPs in innate immunity and 
vaccine biology. Frontiers in Immunology, 4(SEP), 1–16, Copyright © 2013 with permission under 
Creative Commons Attribution License (CC BY)).  
 
1.4.1 Toll-Like receptor signalling pathways in melioidosis  
 
        TLRs occupy a prominent position in the innate immune system by virtue of their ability 
to recognise various bacterial components. Engagement of TLRs with their ligands leads to the 
production of many inflammatory cytokines, chemokines and effector molecules which 
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together orchestrate the inflammatory response.  In septicaemic melioidosis, there is an 
increase in mRNA encoding TLR1, TLR2, TLR3, TLR4, TLR5, TLR8, TLR10, CD14 and 
MD-2 in leukocytes (Wiersinga et al, 2007). Expression of TLR2 and TLR4 along with CD14 
and TLR1 were shown to be upregulated on the surface of circulating monocytes and 
granulocytes, indicating the importance of TLR2 and TLR4 in response to the presence of B. 
pseudomallei.  In melioidosis research, TLR2, TLR4 and TLR5 were given much attention to 
study the innate immune response both in vivo and in vitro. Gram-negative lipopolysaccharide 
(LPS) comprises of a core polysaccharide, O-antigen and lipid A (endotoxin) which is the 
canonical bacterial ligand for TLR4. Lipid A is the endotoxic centre of an LPS molecule where 
this region interacts with TLR4 in association with MD-2 and CD14 to induce a pro-
inflammatory signal.  Charuchaimontri et al (1999) found high levels of serum antibodies to 
LPS are associated with improved survival in severe melioidosis, suggesting the importance of 
B. pseudomallei LPS for an appropriate response. Furthermore, administration of monoclonal 
or polyclonal antibodies (mAb) to B. pseudomallei LPS proved to be protective upon aerosol 
challenge in murine melioidosis (Nelson et al, 2004). In fact, in humans, polymorphisms in the 
gene encoding TLR4 are associated with susceptibility to melioidosis (West et al, 2012).  
However, B. pseudomallei LPS is reported to be less immunostimulatory compared to 
pathogenic enterobacterial LPS (Matsuura et al, 1996). The differences in such immunological 
activities can be further explained by the unique three-dimensional shape of the lipid A moiety 
of B. pseudomallei LPS which has  different disaccharide backbone, different fatty acyl-chains 
as well as the presence of modified phosphate group (Novem et al, 2009). In the RAW264.7 
macrophage-like cell line,  B. pseudomallei LPS exhibits slower and weaker kinetics of 
macrophage-activating activity compared to E. coli LPS, in which the delayed onset of 
cytokines production may serve as a way to evade host defence (Utaisincharoen et al, 2000). 
In addition, human and murine macrophages stimulated with B. pseudomallei LPS secrete less 
inflammatory cytokines TNFα, IL-6 and IL-10 when compared to cells stimulated with LPS 
from avirulent  B. thailandensis (Novem et al, 2009). In a separate study, B. pseudomallei LPS 
has been demonstrated to possess weaker pyrogenic activity in rodents than enterobacterial 
LPS but stronger mitogenic activity in murine splenocytes (Matsuura et al, 1996).  In vivo, 
TLR4 knock out has no obvious effect on mouse survival upon B. pseudomallei infection 
(Wiersinga et al, 2007).   
        TLR2 is a promiscuous receptor which heterodimerises with either TLR1 or TLR6 upon 
recognition of a bacterial cell wall component; lipotechoic acid, peptidoglycans or lipoproteins 
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(reviewed in Kawai and Akira, 2010). Though TLR2 is predominantly regarded as a receptor 
for Gram-positive bacteria, the unique LPS structure derived from B. pseudomallei has been 
shown to signal via TLR2 (Feterl et al, 2008; Wiersinga et al, 2007). Activation of TLR2 been 
reported in response to LPS from a range of  other Gram-negative bacteria such as Legionella 
pneumophila (Katz et al, 2006), Porphyromonas gingivalis (Darveau et al, 2004) and 
Helicobacter pylori  (Smith et al, 2003). In vitro study using HEK294 cells transfected 
transiently with murine or human TLRs demonstrated that both TLR2 and TLR4 are activated 
in the presence of B. pseudomallei, illustrated by an increased level of NF-κB signalling 
(Weehuizen et al, 2015). Wiersinga et al (2007) showed similar observations where TLR2 and 
TLR4 were found to contribute to cellular responsiveness to B. pseudomallei in vitro.  
        In contrast with in vitro studies showing the importance of both TLR2 and TLR4 in 
response to B. pseudomallei, West and colleagues (2008) characterised B. pseudomallei LPS 
as solely a TLR4 ligand , and macrophage cytokines TNFα and IL-10 production were shown 
to be dependent on TLR4 alone. These findings are contrary to the in vivo studies of Wiersinga 
et al (2007) which described that only the TLR2 receptor recognised B. pseudomallei LPS. 
Significantly less cytokine levels of TNFα, IL-6 and IL-10 were observed in TLR2 knockout 
mice compared to WT mice. Nevertheless, the TLR2 signalling induced upon recognition of B. 
pseudomallei LPS resulted in an uncontrolled stimulation that impaired the protective immune 
response against the pathogen (Wiersinga et al, 2007). TLR2 knockout mice were found to be 
less susceptible to lethal infection with less bacterial growth, diminished dissemination and 
reduced distant organ injury (Wiersinga et al, 2007). This is in accordance with the genome-
wide expression study where the overwhelming induction of TLR2 was observed to counteract 
B. pseudomallei (Chin et al, 2010). Though undoubtedly TLR signalling responses play a 
crucial role in eliminating invading pathogens, uncontrolled stimulation that exceeds the 
threshold of immune homoeostasis may cause excessive inflammation, as in the case of sepsis. 
       In addition to the role of TLR2 and TLR4 as innate mechanisms in the pathogenesis of 
melioidosis, TLR5 that detects bacterial flagellin has also been shown to be activated in 
response to B. pseudomallei. In infected CHO cells in vitro, B. pseudomallei induces a TLR5-
dependent innate immune response through NF-κB signalling (West et al, 2013). In fact, 
polymorphisms in TLR5 are associated with survival from melioidosis (West et al, 2013). A 
hypofunctional TLR5 variant that is insensitive to flagellin has been postulated to generate an 
impaired inflammatory response during melioidosis infection, and therefore reduced sepsis-
induced organ failure and lower mortality (West et al, 2013). In vivo studies using TLR5 
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knockout mice showed significantly more susceptibility to B. pseudomallei by intranasal 
challenge (West et al, 2014), a phenotype that contrasts with that observed in TLR2 and TLR4 
knockout mice (Wiersinga et al, 2007).  
        The key roles of TLR2, TLR4 and TLR5 in the pathogenesis of melioidosis are 
underscored by the finding that mice deficient of the main adaptor protein MyD88, but not 
TRIF, show a strong lethality upon intranasal infection with B. pseudomallei (Wiersinga et al, 
2008). MyD88, which is the key adaptor for all TLRs except TLR3 and certain TLR4s, was 
shown to give protection through recruitment and activation of neutrophils at the site of primary 
infection in vivo (Wiersinga et al, 2008). This is in accordance with in vitro studies in RAW 
macrophage-like cells where B. pseudomallei induced expression of genes downstream of the 
MyD88-dependent pathway only, and not through the TRIF-dependent signalling pathway 
(Tangsudjai et al, 2010). Conversely, an LPS mutant was able to stimulate both MyD88-
dependent and -independent pathways. It was shown that only the MyD88-dependent pathway 
is needed to control the WT infection, but, the survival of the LPS mutant was suppressed by 
MyD88-independent activation (Tangsudjai et al, 2010). Additionally, an LPS mutant of B. 
pseudomallei is able to activate IFN-β production in macrophage-like cell lines leading to the 
expression of iNOS for nitric oxide-mediated killing, a pathway that is not stimulated by the 
WT strain (Arjcharoen et al, 2007). These findings suggest that the LPS mutant strain may 
induce a different TLR signalling pathway from the WT strain.  The failure to activate the 
MyD88-independent pathway may facilitate B. pseudomallei survival within macrophages 
(Tangsudjai et al, 2010).  
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1.4.2 Canonical inflammasome pathways in counteracting Burkholderia 
pseudomallei 
 
          Inflammasomes, of which several different types have been identified, are multiprotein 
complexes containing PRRs belonging to the Nod-like receptor family (NLR family; NLRP1, 
NLRP3, NLRC4) or the PYHIN family (such as AIM2), together with ASC adaptor and the 
protease caspase-1. Different inflammasomes are triggered by different microbial components 
or endogenous ‘danger signals’. Upon activation, the procaspase-1 will be auto-cleaved into its 
active form of p10 and p20 caspase-1. Active caspase-1 mediates the maturation of the pro-
inflammatory cytokines pro-IL-1β and pro-IL-18 into their respective biologically active IL-
1β and IL-18 (von Moltke et al, 2013; Schattgen and Fitzgerald, 2011). Additionally, the 
inflammasome can regulate the innate immune pathway through the induction of programmed 
cell death known as pyroptosis, which destroys the intracellular niche and prevents the 
subsequent dissemination of the pathogen.  
        Caspase-1 activation is triggered in macrophages by many intracellular pathogens 
including Salmonella (Jarvelainen et al, 2003), Shigella (Suzuki et al, 2007), and Listeria 
(Warren et al, 2008), causing rapid cell death. Similarly, an in vitro experiment by Sun et al 
(2005) demonstrated that B. pseudomallei is also capable of inducing pyroptotic caspase-1-
dependent cell death in the human THP-1 monocytic-like cell line, along with the secretion of 
IL-1β. In other in vitro studies,  Caspase1-/- macrophages infected with B. pseudomallei showed 
slower cell cytotoxicity as demonstrated by Breitbach et al (2009). This suggests that prolonged 
cell death in the absence of caspase-1 benefits the pathogen by allowing it to survive and 
replicate in a cell displaying reduced bactericidal capacity. An in vivo experiment showed that 
caspase-1 mediates resistance towards intranasal challenge of B. pseudomallei, where caspase-
1 knockout mice reached 100% mortality as early as 3 days post-infection, with significantly 
higher bacterial load in spleen, liver and lung when compared to WT mice (Aachoui et al, 2013; 
Breitbach et al, 2009). Likewise, caspase-1 also protects from the closely related, but far less 
virulent B. thailandensis as Casp-1-/- mice succumbed to B. thailandensis infection, whereas 
the WT mice survived (Aachoui et al, 2013). Consistent with these findings, in vitro 
experiments showed that bone marrow-derived macrophages (BMDMs) which lack caspase-
1/11 contained higher bacterial loads compared to WT macrophages at 3 hpi, the difference 
became more pronounced at 6hpi (Bast et al, 2014). Collectively, the canonical caspase-1-
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dependent inflammasome pathway seems to play an important role in controlling B. 
pseudomallei at the early phase of infection, which is crucial for host survival.   
        In terms of which inflammasome receptors are involved in the recognition of B. 
pseudomallei, Ceballos-Olvera and co-workers revealed that B. pseudomallei can induce the 
activation of caspase-1 inflammasome via both NLRP3 and NLRC4 (Ceballos-Olvera et al, 
2011). NLRP3 triggers caspase-1 activation in response to host-derived ‘danger signals’ 
(DAMPs), multiple pathogens including bacteria, virus and fungi, and also to several non-
infectious crystals.  These crystals are also termed as particulate matter which can be 
endogenous such as monosodium urate (MSU) crystals, cholesterol crystals and amyloid β 
structures, or exogenous as for examples, silica crystals, asbestosis fibers and aluminium salts. 
These crystals can cause chronic diseases like gout disease, Alzheimer’s disease, 
atherosclerosis and silicosis (reviewed by Kazazian, 2014).  Perturbation of cell membrane 
integrity such as phagosomal or vacuolar rupture is also a common event which is triggered by 
NLRP3 activation. NLRC4 specifically responds to Type III secretion system (T3SS) inner 
rod/needle components and also the cytoplasmically delivered bacterial flagellin, in which the 
specificity is determined by its interaction with the NAIP molecules NAIP2 or NAIP5, 
respectively.  In a murine model of melioidosis, both Nlrc4-/- and Nlrp3-/- inflammasome-
deficient mice were dramatically susceptible to aerosolised B. pseudomallei infection 
compared to WT mice, showing the importance of inflammasomes in controlling B. 
pseudomallei.  NLRC4 was shown to mainly regulate pyroptosis, whereas NLRP3 was required 
for the production of IL-1β and IL-18 (Ceballos-Olvera et al, 2011). Nlrc4-/- BMDMs, but not 
Nlrp3-/- BMDMs, exhibited substantially reduced pyroptosis when infected with B. 
pseudomallei when compared to macrophages from WT animals. Consistent with the role of 
pyroptosis in restricting the intracellular bacterial growth, substantially higher numbers of 
bacteria were recovered from inflammasome-deficient Nlrc4-/- BMDMs compared to the WT 
and Nlrp3-/- BMDMs (Ceballos-Olvera et al, 2011). This result is paralleled with the in vivo 
studies where infected Nlrc4-/- mice carried considerably higher bacterial load in the spleen, 
liver and lungs at 24hpi and 48hpi than WT and Nlrp3-/- mice (Ceballos-Olvera et al, 2011).  
        The studies described above were then extended to investigate the role of inflammasome-
mediated cytokines IL-1β and IL-18 during murine melioidosis. IL-18-/- mice were extremely 
vulnerable to B. pseudomallei even at a low dose of infection (Ceballos-Olvera et al, 2011). 
This finding is parallel to the in vivo experiment by Wiersinga et al (2007) where upon 
intranasal challenge with a lethal dose of B. pseudomallei, IL-18-/- mice displayed enhanced 
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bacterial growth in the lungs and liver as compared to the WT mice as early as 24 hours post-
infection. This protective role of IL-18 was then shown to be associated with the induction of 
IFN-γ production (Ceballos-Olvera et al, 2011; Wiersinga et al, 2007). However, unexpectedly 
mice deficient in interleukin-1 receptor (Il-1r-/-) displayed better resistance to lung infection 
compared to WT mice, with reduced neutrophil influx into the lungs, lower bacterial burden, 
and less severe lung pathology (Ceballos-Olvera et al, 2011). The IL-1β cytokine was found to 
be deleterious by causing excessive neutrophil recruitment, leading to excessive inflammation 
and subsequently tissue damage (Ceballos-Olvera et al, 2011). The detrimental effect of IL-1β 
was further confirmed when the administration of recombinant IL-1β significantly increased 
the bacterial burden, inflammation and mortality, while administration of IL-1 receptor 
antagonist IL-1ra protected WT mice from mortality (Ceballos-Olvera et al, 2011). It has been 
argued that neutrophils might be permissive for B. pseudomallei growth and the continuous 
production of IL-1β excessively increased the influx of neutrophils which benefits the bacteria 
for dissemination (Ceballos-Olvera et al, 2011). Therefore, the host innate immune response 
must be tailored accordingly to each pathogen to elicit the correct inflammatory response, 
otherwise it may lead to excessive inflammation that results in severe morbidity and mortality.
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1.4.3 The non-canonical inflammasome, an indispensable defence against 
Burkholderia pseudomallei  
 
         Pyroptotic cell death can also occur through activation of the non-canonical 
inflammasome. This non-canonical inflammasome pathway is mediated by murine caspase-11 
(known as caspase-4/5 in humans). The non-canonical inflammasome pathway requires 
priming by TLR4 in a TRIF-dependent manner and with an IFNβ-responsive factor. TLR4 
recognises cytosolic LPS in a TRIF-dependent manner, leading to upregulation of Type I IFN 
expression, commonly IFN-β. The released Type I IFN is recognised by Type1 IFN receptor, 
activates the STAT (Signal transducer and activator of transcription) interferon signalling 
pathway and leads to expression of more procaspase-11 protein. Whether pro-caspase-11 
expression itself is sufficient for caspase-11 auto-activation (Rathinam et al, 2012) or requires 
additional yet unknown bacterial signals for activation (Broz et al, 2012), still remains a 
controversy. Upon activation, procaspase-11 is cleaved into its active form of p20 and p10, or 
partially cleaved into p30, similar to the mechanism of caspase-1 activation.  Caspase-11 
activation also leads to release of pro-inflammatory cytokine IL-1α and high mobility group 
protein B1 (HMGB1) in a caspase 1-independent manner. Caspase-11 also promotes assembly 
of the NLRP3 inflammasome and IL-1β secretion in a caspase-1 dependent manner (Maltez 
and Miao, 2016; Man and Kanneganti, 2015). 
        This pyroptotic cell death pathway via caspase-11 contributes to a novel cell autonomous 
response that is reserved exclusively to detect cytosolic, but not vacuolar, bacteria. It has been 
demonstrated previously that the specific sifA mutant of Salmonella that aberrantly enters the 
cytosol, triggers caspase-11 to enhance clearance of Salmonella Typhimurium, independently 
from all known canonical inflammasomes NLRP3, NLRC4 and ASC. On the other hand, the 
WT Salmonella Typhimurium that remains within the vacuole can effectively escape from 
Caspase-11 pyroptotic killing (Aachoui et al, 2013). In response to naturally cytosolic B. 
pseudomallei, inflammasome activation is key for protection of the host, as Casp1-/-Casp11-/- 
mice succumb more readily to infection in vivo (Kayagaki et al, 2011). This finding is 
consistent with the evidence from Aachoui et al (2013) where Casp11-/- knockout mice 
exhibited greater mortality in vivo when infected with B. pseudomallei, indicating that a novel 




1.4.4 Interferon response to Burkholderia pseudomallei and other intracellular 
pathogens  
 
        Interferons (IFNs) are secreted cytokines that orchestrate diverse immune responses to 
viruses and other intracellular microbes. Type I interferon family members include a single 
IFNβ protein, as well as numerous IFNα and other family members namely IFN-ε, IFN-κ, IFN-
ω, IFN-δ, IFN-ι and IFN-ξ (reviewed in Platanias, 2005).  All Type I IFNs signal via a common 
heterodimeric cell surface receptor (IFNAR), comprised of IFNAR1 and IFNAR2 which are 
associated with tyrosine kinase 2 (TYK2) and Janus Activated Kinase 1 (JAK1), respectively 
(Figure 1.9).  Type II IFN mainly consists of IFNγ, and the IFNγ receptor (IFNGR) consists of 
heterodimeric IFNGR1 and IFNGR2 subunits which are associated with JAK1 and JAK2, 
respectively (Figure 1.9). Activation of JAK leads to the phosphorylation of STATs which 
rapidly translocate to the nucleus and initiate gene transcription. Both Type I and II IFNs can 
induce the formation of STAT1-STAT1 homodimers which then enter the nucleus and bind to 
a GAS (IFNγ-activated site) element, a specific motif in the promoters of various Interferon-
Stimulating Genes (ISGs) and initiates transcription. However, only the Type I IFN signalling 
pathway results in the formation of STAT1-STAT2 heterodimers, which forms a heterotrimeric 
transcription complex with IRF9 known as ISGF3 (interferon-stimulated gene factor 3). This 
ISG3 complex is then transported to the nucleus and recognises IFN-stimulated response 
elements (ISREs) in DNA, which is distinct from GAS elements, to initiate transcription of 
another set of ISGs (reviewed in Platanias, 2005). 
       Although typically considered to be the most important antiviral immune response, it is 
increasingly evident that stimulation of Type I IFNs correlates with host susceptibility to 
infections with several bacterial pathogens such as Listeria monocytogenes (O’Connell et al, 
2004), Mycobacterium tuberculosis (Novikov et al, 2011) and Francisella tularensis (Henry 
et al, 2007). This bacterial induction of Type I IFNs can occur via TLR-dependent or TLR-
independent pathways using cytosolic sensors (reviewed in Perry et al, 2005). TLR3 and TLR4 
sense dsRNA and lipopolysaccharide (LPS) respectively, and stimulate Type I IFN in a TRIF-
dependent manner. While other nucleic acid recognising TLRs namely TLR7, TLR8 and TLR9 
can induce Type I IFNs in a MYD88-dependent pathway. Several studies reported that they 
are restricted to cell types such as plasmacytoid dendritic cells (pDCs) and conventional 





Figure 1.9 Type I and II interferon receptors and their respective signalling pathways. Type I 
IFNs utilise heterodimeric cell surface receptors (IFNAR) which consist of IFNAR1 and IFNAR2 
chains to signal through a canonical JAK/STAT cascade involving JAK1, Tyk2, STAT1 and STAT2 
proteins. A similar mechanism is used by Type II IFN (IFNγ) but requires different receptor subunits 
and proteins during activation. Type II IFN receptors (IFNGR) consist of IFNGR1 and IFNGR2, where 
upon binding with IFNγ they activate the canonical JAK/STAT pathway involving JAK1, JAK2 and 
STAT1 proteins. Different STAT complexes are formed in response to different types of interferons 
resulting in distinct gene-expression programmes. STAT1 and STAT2 complexes together with IFN-
regulatory factor 9 bind to IFN-stimulated response element (ISRE) sequences to activate classical 
antiviral genes. In contrast, downstream signalling cascade of STAT1 homodimers bind to gamma-
activated sequences (GASs) to induce pro-inflammatory genes (figure reprinted from  Platanias, L.C. 
(2005). Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Reviews Immunology, 





        Type I IFN can also be induced in a TLR-independent cytosolic pathogen receptor manner.  
Cytosolic RNA is detected by RNA helicase Retinoic-acid inducible gene-1 (RIG-1), or RIG-
1-like receptors (RLR) such as MDA-5 (melanoma differentiation antigen 5). RIG-1 and MDA-
5 recognise RNA via a DExD/H box-containing RNA helicase domain. Upon ligand 
recognition, RIG-1 and MDA-5 are recruited to mitochondria to bind with the adaptor protein 
MAVS to activate IRF3 as well as NF-κB transcription factors (Figure 1.8), subsequently 
inducing transcription of Type I IFNs and inflammatory cytokines respectively. Activation of 
IRF3 requires upstream signalling through TBK1. RLRs which are thought primarily to detect 
RNA viruses, have also been recently shown to detect RNA from intracellular bacteria such as 
Listeria monocytogenes (Hagmann et al, 2013), Legionella pneumophila (Monroe et al, 2009) 
and Shigella flexneri (Dixit & Kagan, 2013; Jehl et al, 2012). In addition to RNA sensors, Type 
I IFN also can be induced by cytosolic DNA-sensing pathway such as DNA sensor ZBP-1 
which is activated in response to human cytomegalovirus (DeFilippis et al, 2010). However, 
ZBP-1 may not be a unique DNA sensor and its ability to stimulate IFNβ production may be 
redundant with other DNA sensors (Monroe et al, 2009;  Lippmann et al, 2008). Besides 
MAVS, STING (stimulator of interferon genes) is another essential adaptor protein that 
functions upstream of TBK1 and IRF3 to induce Type I IFN (Figure 1.8). STING recognises 
the second messenger cyclic-diguanylate monophosphate (cGAMP) that is generated by 
nucleotidyltransferase cyclic GMP-AMP synthase (cGAS) in response to recognition of 
foreign DNA. STING also recognises cGAMP that is secreted directly from cytosolic bacteria 
(reviewed in Burdette and Vance, 2013). Bacterial pathogens such as Listeria monocytogenes 
(Ishikawa et al, 2009) and Chlamydia trachomatis (Barker et al, 2013) require STING for Type 
I induction in vitro. Interestingly, STING has been shown to be associated with autophagy 
during microbial infection. This novel STING-dependent autophagy-like response has been 
observed for the intracellular bacteria Mycobacterium tuberculosis (Watson et al, 2012) and 
also α-herpesvirus (Rasmussen et al, 2011).  
       B. pseudomallei by itself fails to stimulate IFNβ production in infected RAW264.7 cells 
(Utaisincharoen et al, 2003), resulting in better survival inside the host cell. It was reported that 
the inability to stimulate IFNβ also leads to a reduced expression of transcription factor IRF-1 
and nitric oxide synthase (iNOS) for antimicrobial nitric oxide (NO) production 
(Utaisincharoen et al, 2003). In the presence of exogenous IFNβ, B. pseudomallei-infected 
macrophages express high levels of both IRF-1 and iNOS, and subsequently suppress the 
intracellular survival of B. pseudomallei, indicating the role of IFNβ as an antimicrobial by 
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upregulating NO production (Utaisincharoen et al, 2003). Which sensor is required for the 
production Type I IFN in response to B. pseudomallei is not well studied.  Tangsudjai et al 
(2010) reported that B. pseudomallei is incapable of activating TRIF-dependent signalling for 
Type I IFN expression. Failure to induce IFNβ stimulation by B. pseudomallei itself may be 
related to the low activation of TLR4 due to the unique LPS structure of B. pseudomallei which 
is a poor macrophage activator (Utaisincharoen et al, 2000). In addition to this finding, in vivo 
global transcription profiling by microarray identified several highly induced Type I interferon 
related genes such as members of the oligoadenylate synthetase (OAS) family and Signal 
Transducer and Activator of Transcription (STAT1 and STAT2) in B. pseudomallei-infected 
mice (Chin et al, 2010). However, involvement of other cytosolic sensors such as RIG-1, 
MDA-5, ZBP-1 and others in relation to melioidosis have not been described so far.  
        Exposure of cells to Type I IFN during viral infection elicits an antiviral state that inhibits 
viral replication, but in bacterial infections, Type I IFN does not always participate in the host 
immune resistance against infection. Type I IFN has been regarded as the main cytokines which 
suppresses intracellular survival of Legionella pneumophila in infected murine macrophages, 
which is directly associated with the polarisation of macrophages toward the classically 
activated M1 phenotype, but independent from STAT1- and STAT2- mediated pathways 
(Plumlee et al, 2009). Similarly, Type I production in response to group B Streptococci 
increased the production of proinflammatory cytokines and hence, resistance to infection 
(Mancuso et al, 2007). Often, however, the production of Type I IFN causes susceptibility 
towards other bacterial infections. Indeed, Type I IFN receptor-knockout mice (IFNAR-/-) 
exhibit substantially increased resistance to infection with Francisella tularensis (Henry et al, 
2010; Henry et al, 2007) and Listeria monocytogenes than WT mice (Stockinger et al, 2009).  
        Type II IFNγ is generally a more potent activator of phagocytic cells and is essential for 
host resistance to Listeria monocytogenes (Rayamajhi et al, 2010) and other intracellular 
pathogens.  It has been shown that IFNγ is essential for resistance to B. pseudomallei. In one 
in vivo study, administration of neutralising monoclonal antibody (mAb) against IFNγ rendered 
the mice significantly more susceptible to death. Higher mortality observed in mAb-treated 
mice was due to significantly increased bacterial burden in liver and spleen compared to the 
control mice (Santanirand et al, 1999). In clinical samples, patients presenting with lethal 
melioidosis express high levels of IFNγ which correlates with mortality (Lauw et al, 1999;  
Brown et al, 1991). In addition, one of the IFNγ-inducing cytokines known as IL-12p40 was 
found to be significantly higher in melioidosis patients (Lauw et al, 1999). However, IFNγ 
38 
 
mediated resistance to B. pseudomallei is not complete and does not provide protective 
sterilising immunity as observed with resistance to Listeria monocytogenes (Utaisincharoen et 
al, 2004). Besides, Ekchariyawat et al (2005) documented that suppression of IFNγ responses 
in infected macrophages is possibly due to B. pseudomallei-induced expression of Suppressor 
of cytokine signalling 3 (SOCS3) and Cytokine-Inducible Src Homology 2-containing protein 
(CIS). Activation of these proteins inhibits phosphorylation of Y701-STAT and consequently, 






1.4.5 Autophagy as a host innate mechanism against Burkholderia pseudomallei   
1.4.5.1 The molecular autophagic pathway   
        
          Essential in the context of cellular homeostasis, autophagy involves the elimination of 
non-functional organelles and misfolded protein aggregates in response to various 
environmental and cellular stresses. The cellular autophagic activity is presumed to occur at 
low basal levels and can be rapidly regulated in response to various stimuli such as nutrient 
starvation, high-temperature, hypoxia and energy depletion. Autophagy suppression is often 
associated with certain diseases, including cancers, infectious diseases, aging and 
neurodegenerative disorders (reviewed in Levine & Kroemer, 2008). Recently, autophagy has 
been implicated as a part of the innate immune response by targeting intracellular pathogens 
residing in the cytoplasm or within vacuolar compartments to the host autophagic machinery 
for clearance. Intracellular Streptococcus pyogenes (Nakagawa et al, 2004) and 
Mycobacterium tuberculosis (Gutierrez et al, 2004) have been shown to be cleared by 
autophagy. Conversely, some pathogens such as Listeria monocytogenes (Yoshikawa et al, 
2009; Py et al, 2007) and Shigella (Ogawa et al, 2005) actively subvert the autophagic process 
and survive within host cells. Such selective degradation of intracellular pathogens has resulted 
in a new class of innate immunity receptors known as SLR (sequestome-like receptor/p62) or 
LIR (LC3-interacting region)(reviewed in Wileman, 2013).   
        Autophagy is initiated by formation of an isolated membrane phagophore (vesicle 
nucleation), which then elongates into a double-membrane vesicle known as an autophagosome 
(vesicle elongation). This process is then followed by fusion with lysosomes to form 
autolysosomes and subsequently, degradation of the autophagosome contents by a series of 
lysosomal proteases. The autophagosome can also fuse with an endosome before fusion with 
the lysosome, to form a structure known as an amphisome. Amino acids and other small 
molecules can be recycled and delivered to the cytoplasm for reuse (Figure 1.10) (reviewed in 
Jo et al, 2013). 
        Autophagosome formation involves different enzymatic pathways (Figure 1.10). This 
begins with a serine/threonine protein kinase complex that responds to upstream inhibitory 
signals like TOR kinase (Target Of Rapamycin kinase). TOR kinase senses amino acids levels 
in cells and in the presence of abundant nutrients, this major inhibitor shuts off autophagy. 
However, when amino acid levels fall during starvation, the TOR kinase becomes inactive and 
40 
 
autophagy is switched on (reviewed in Levine & Kroemer, 2008). The pharmacological inducer 
rapamycin mimics autophagy starvation by inhibiting the negative regulatory signal of TOR 
kinase, hence inducing autophagy. The second part of the pathway is vesicle nucleation which 
requires a class III phosphatidylinositol 3-kinase (PI3K) enzymatic complex. In yeast, PI3K 
Vps34 activation depends on its binding partners Beclin1/Atg6 (AuTophaGy 6), Atg14 and 
Vps15 to generate a PI3P complex. This complex  localises other autophagy proteins to the 
forming autophagosomes as well as phosphorylates lipids at autophagosome sites (Kihara et al, 
2001). Many membrane sources can generate autophagosomes including ER (Endoplasmic 
Reticulum), mitochondria and Golgi apparatus. Some regulatory molecules such as AMPK (5’-
AMP-activated protein kinase) which responds to low energy (low ATP (adenosine 
triphosphate)) can enhance autophagy at this step. Conversely, the drugs 3-MA and 
wortmannin can inhibit PI3K activity and suppress cell autophagy. The third element of the 
pathway is known as vesicle expansion. During the expansion process, LC3-I (microtubule-
associated light chain 3) (a mammalian homologue of yeast Atg8) is conjugated to the highly 
lipophilic phosphatidylethanolamine (PE) moiety to generate LC3-II. LC3-II is then integrated 
into the lipid membranes of the autophagosome (Nakatogawa et al, 2009). This lipidation 
requires the Atg12-Atg5-Atg16 complex in which upon expansion, the autophagosomes are 
eventually released into the cytosol. Only LC3-II protein is known to be recruited to the 
autophagosome, hence it serves as a widely used marker for autophagosomes. LC3-II 
molecules are located both in the inner and outer membranes of autophagosomes, in which the 
outer one is cleaved by Atg4 to form LC3-I and recycled back into the cytoplasm, while the 






Figure 1.10 Molecular pathway of autophagy: Autophagy formation begins with vesicle nucleation 
(formation of the membrane/phagophore), which then elongates into a double-membrane 
autophagosome. An autophagosome fuses with a lysosome and to form an autolysosome. Enzymes that 
are present in the lysosome such as proteases and hydrolases degrade the content of autolysosome as 
well as lysis of the autophagosome inner membrane. Some of the degraded materials are recycled into 
the cytoplasm. Each step is regulated by different signalling pathways and Atg proteins (figure reprinted  
from Green, D. R. & Levine, B. (2014). To be or not to be? How selective autophagy and cell death 




1.4.5.2  Autophagy and Burkholderia pseudomallei   
 
        Antibacterial autophagy (xenophagy) is an autonomous immune response that can target 
intracellular pathogens that are residing both in the vacuolar and cytoplasmic compartments. 
Some bacteria such as Mycobacterium tuberculosis actively modify their endosome 
compartments to prevent lysosomal fusion, however they are eventually taken up into 
autophagosomes before being degraded by autophagy (Gutierrez et al, 2004). Bacteria such as 
Streptococcus pyogenes  can exit from endosomes and enter the cytoplasm, but then the 
cytoplasmic Streptococcus can be captured by autophagosomes which fuse with lysosomes for 
degradation (Nakagawa et al, 2004). In other pathogens, autophagy is used for the bacterium’s 
own benefit to survive and replicate, and their survival is decreased in host cells treated with 
autophagy inhibitors. For examples, Mycobacterium marinum generates double-membrane 
vacuoles independently of Atg5 and LC3, hence avoiding classical autophagy before entering 
the cytoplasm for replication (Collins et al, 2009). Coxiella burnetti is resistant to lysosomal 
degradation, but yet activates autophagy to fuse lysosomes and formation of a parasitophorous 
vacuole for replication (Gutierrez et al, 2004). Some cytosolic pathogens such as Shigella 
(Dupont et al, 2009) and Listeria (Yoshikawa et al, 2009), avoid recognition by the autophagy 
machinery.   
        In mammalian cell lines such as RAW264.7 and murine embryonic fibroblast (MEF), LC3 
molecules have been shown to be recruited directly to B. pseudomallei localised in a single-
membrane phagosome, a process termed as LC3-associated phagocytosis (LAP) (Gong et al, 
2011; Cullinane et al, 2008). This LAP formation is distinct from the double-membrane 
canonical autophagosomes as LC3 molecules are recruited directly to the phagosome 
containing the pathogen rather than the phagophore or autophagosomes. LAP is used as a 
pathway to enhance pathogen degradation within phagosomes. LAP structures can fuse with 
lysosomes for phagosomal maturation, or alternatively deliver phagosomal cargo to PRRs, and 
also facilitate antigen presentation to MHC class II molecules (reviewed in Romao & Munz, 
2014).  The colocalisation of LC3 with phagosomal B. pseudomallei has been shown to be 
further increased in infected RAW264.7 cells when autophagy was pharmacologically induced 
using rapamycin, accompanied by a significant reduction in intracellular bacteria (Gong et al, 
2011; Cullinane et al, 2008). These together implicate the importance of LAP-mediated 
autophagy in controlling phagosomal B. pseudomallei at early time points of infection.  
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Similarly, recruitment of LC3 molecules to phagosomal B. pseudomallei has also been 
observed ex vivo in primary human neutrophils, but through a novel elongated single-
membrane structure that partially fuses with an autophagosome-like or a phagophore-like 
structure (Rinchai et al, 2015). In the same studies, inhibiting autophagy by treating neutrophils 
with 3MA, and also the lysosomal hydrolase inhibitors E64d and pepstatin A, enhanced the 
intracellular survival of B. pseudomallei in a time-dependent manner. However, it is worth 
noting that in infected primary human neutrophils, very few B. pseudomallei escape from the 
phagosomes and reach the cytoplasm, suggesting that autophagy is likely the second line of 
defence against cytoplasmic B. pseudomallei (Rinchai et al, 2015). Furthermore, those 
cytoplasmic B. pseudomallei  did not form actin-tails unlike those observed in infected 
immortalised cell lines such as HeLa (Stevens et al, 2005b), A549 (Sitthidet et al, 2011), J744.2 
(Sitthidet et al, 2011; Stevens et al, 2005b) and RAW264.3 (Burtnick et al, 2008). Therefore, 
the different cell-types used for these studies could account for the difference in the effect of 
the host autophagic machinery. Nevertheless, in those cells where B. pseudomallei is capable 
of escape from the phagosomes in a Bsa T3SS-dependent manner (Stevens et al, 2002), LAP 
targeting of B. pseudomallei becomes relatively ineffective. Cytoplasmic B. pseudomallei is 
rarely sequestered in a double-membrane canonical autophagosome as observed by 
transmission electron microscopy (TEM) (Rinchai et al, 2015; Gong et al, 2011), suggesting 
that B. pseudomallei actively evades the autophagy innate immune response. Such autophagy 
evasion could be mediated by bacterial actin-based motility as shown for intracellular Listeria 
monocytogenes and Shigella flexneri.  
 
1.4.5.3  Actin-based motility allows Listeria monocytogenes and Shigella flexneri to 
evade autophagy  
        
        The intracellular pathogens S. flexneri (Ogawa et al, 2005) and L. monocytogenes 
(Yoshikawa et al, 2009; Py et al, 2007) have been shown to evade host autophagy through 
actin-based motility, but with distinct molecular mechanisms. S. flexneri evades autophagic 
recognition in the presence of the T3SS effector protein IcsB (Ogawa et al, 2005), while host 
protein recruitment to the actin-tail of L. monocytogenes camouflages the bacterium from being 
recognised by autophagy (Yoshikawa et al, 2009; Py et al, 2007). S. flexneri expresses IcsA on 
its surface to mediate actin polymerisation and appears to activate autophagy. IcsA has been 
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shown to interact with the autophagic protein, Atg5, which targets cytoplasmic Shigella for 
autophagy. However, virulent Shigella isolates expressing IcsB do not activate autophagy as 
the IcsB protein competes for the binding of Atg5 to IcsA, thus shielding Shigella against 
autophagic recognition (Ogawa et al, 2005). In B. pseudomallei, BimA is unlikely to be a 
functional counterpart of S. flexneri IcsA in evading autophagy as the BimA protein lacks the 
114 amino acid region of IcsA that is targeted by Atg5 (Gong et al, 2011). B. pseudomallei BopA 
has been predicted to be a homologue of Shigella IcsB and a B. pseudomallei mutant lacking 
bopA has an increased colocalisation with LC3 molecules (Gong et al, 2011). However, it 
appears unlikely that BopA assists in autophagy evasion in a manner analogous to IcsB. Instead, 
the bopA mutant has a reduced ability to escape from the phagosome and is targeted to 
autophagy in an LAP-dependent manner, but not cytoplasmic engulfment by autophagosomes 
(Gong et al, 2011; Cullinane et al, 2008). It has been suggested that the presence of the Rho 
GTPase inactivation domain at the BopA carboxyl terminus disrupts the phagosome membrane, 
assisting the sequestered bacteria to escape into the host cytosol (Gong et al, 2011). Alternatively, 
the BopA cholesterol binding domain leads to the accumulation of cholesterol on the 
phagosome membrane, which could prevent lysosomal recognition and hence, disrupts 
autophagy (Gong et al, 2011; Kayath et al, 2010).  
        When L. monocytogenes enters the cytoplasm, the bacterium expresses ActA which is 
required for actin-tail formation. It has been shown that ActA has binding sites for the host 
proteins Arp2/3 and Ena/VASP (Yoshikawa et al, 2009). Yoshikawa et al (2009) demonstrated 
that recruitment of Arp2/3 and Ena/VASP to the actin-tails on the bacterial surface camouflages 
the bacteria from autophagic recognition. On the other hand, actA mutants have been shown to 
be first ubiquitinated, which is followed by recruitment of LC3 and the adaptor protein p62, 
before finally entering the autophagic pathway (Yoshikawa et al, 2009). B. pseudomallei has 
been shown to form actin-tails independently from the host proteins Arp2/3 and Ena/VASP. In 
fact, B. pseudomallei BimA itself mimics Ena/VASP during actin polymerisation (Benanti et 
al, 2015). However, some host proteins that are postulated to be involved during the process 
of forming actin-tails such as IQGAP1 (Jitprasutwit et al, 2016) could disguise B. pseudomallei 
from host autophagy recognition. Whether B. pseudomallei employs a similar strategy to 
subvert host autophagy has yet to be determined. 
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1.5 Central hypothesis and objectives of thesis  
 
        Macrophages are important host immune cells in innate defence against B. pseudomallei, 
yet the pathogen has evolved multiple strategies to manipulate such cells to survive and 
replicate within the host. We hypothesise that B. pseudomallei utilises actin-based motility, 
which is mediated by the bacterial BimA protein, as a strategy to escape from macrophage 
innate defence pathways. Therefore, the broad aim of this thesis is to elucidate the macrophage 
response to infection with B. pseudomallei, and to discover the innate mechanisms that are 
avoided by B. pseudomallei in a BimA-dependent manner. Understanding the basis of such 
evasion could provide novel insights into potential host-directed therapies against this 
emerging pathogen. Primary BALB/C bone-marrow derived macrophages (BMDMs) have 
been utilised throughout this PhD project to address the following specific objectives:  
1. To isolate and characterise the phenotype of BALB/C BMDMs (Chapter 3) 
2. To compare the intracellular survival of B. pseudomallei with the isogenic ΔbimA 
mutant in BALB/C BMDMs (Chapter 3)  
3. To investigate if B. pseudomallei evades autophagy in a BimA-dependent manner 
(Chapter 3)  
4. To investigate the contribution of MyD88- and TRIF-dependent signalling in 
controlling the intracellular fate of B. pseudomallei and the ΔbimA mutant (Chapter 4)  
5. To demonstrate whether cytosolic canonical- or non-canonical inflammasomes are 
activated in response to intracellular B. pseudomallei or the ΔbimA mutant in BALB/C 
BMDMs (Chapter 4) 
6. To use Affymetrix gene expression profiling to characterise the global macrophage 
transcriptomic response to infection with B. pseudomallei, as well as to identify any 




2 CHAPTER 2: MATERIALS AND METHODS  
 
2.1 Preparation of murine bone marrow cells  
        12-week old BALB/C mice were obtained from Envigo Laboratory, UK. Briefly, tibias 
and femurs were aseptically removed with the whole bone intact, and dissected free of adhering 
tissues, in a class II Microbiological Safety Cabinet. The bones were then placed in 70% 
ethanol for a minute, washed in complete RPMI medium and kept in PBS (phosphate-buffered 
saline) solution. The complete RPMI medium (Sigma-Aldrich) was supplemented with 10% 
(vol/vol) heat-inactivated foetal calf serum (FCS) (Gibco Life Technologies) and 100U/ml 
penicillin, 100µg/ml streptomycin and 29.2mg/ml L-glutamine (Pen-Strep-Glu from Gibco 
Life Technologies). The bone ends were removed with a scalpel and bone marrow cells were 
flushed out using a syringe filled with complete RPMI medium into a sterile polypropylene 
Falcon tube. The medium containing the cells was suspended up and down to gently dissociate 
the cells. Fresh bone marrow cells were counted using a haemocytometer, and centrifuged at 
~150 x g for 10 minutes. The pellet was then resuspended in recovery-cell culture freezing 
medium (Thermo Fisher Scientific) at a density of 6 x 106 cells per ml. 1ml aliquots of this 
suspension were dispensed into cryogenic storage vials. The vials were placed into a ‘Mr Frosty’ 
and stored at -80°C until needed.  
2.2 Differentiation of bone marrow-derived macrophages (BMDMs)  
        To thaw the cells, cryovials were quickly transferred to a 37°C water bath until the 
suspension was completely thawed. For a 10cm-square petri dish, four vials were diluted into 
17ml of complete medium containing 10ng/ml recombinant murine granulocyte-macrophage 
colony stimulating factor (GM-CSF) (Gibco Life Technologies), to give a density of 2.4 x 107 
cells per plate. The cells were incubated at 37oC in a 5% CO2 atmosphere. On day 4, 10ml of 
fresh complete RPMI medium containing 10ng/ml GM-CSF was added per plate and cultivated 
for an additional 3 days. On day 7, the supernatants were discarded and the attached cells were 
washed with 10ml of sterile PBS. BMDMs were harvested gently using a rubber scraper. The 
cell suspension was then collected and centrifuged at ~150 x g for 10 minutes. The supernatant 
was then discarded and the pellet was resuspended in 10ml of complete RPMI medium 
containing 10ng/ml GM-CSF. The cells were counted using the haemocytometer before 
seeding into tissue culture plates for experiments. For 96 well plates, the BMDMs were seeded 
at a density of 1 x 105 cells per well, while BMDMs were seeded at a density of 5 x 105 cells 
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per well for 24 well-plates. 96-well plates were used for assaying intracellular survival of 
bacteria at different time points while other experiments were conducted in 24-well plates.  
BMDMs were incubated for 2 days before any further experimental procedure.  
2.3 Phenotypic characterisation of BMDM cells by Flow Cytometry  
        BMDMs were harvested in FACS buffer [PBS with 2% FCS (Gibco Life Technologies)] 
using a cell scraper. The cells were pelleted by centrifugation at 450 x g for 5 minutes and 
supernatant was discarded. The pellet was then resuspended in FACS buffer and the number 
of cells were adjusted to 1 x 106 cells per 100µl. 100 µl aliquots were dispensed into 
microcentrifuge tubes for staining. Each aliquot was pelleted again at 450 x g for 5 minutes and 
supernatant was discarded. The pellet was resuspended in 100µl FACS buffer containing the 
Phycoerythrin (PE)-conjugated antibody for staining. Two antibodies were used to stain 
separate cell samples. The isotype control antibody (PE Rat IgG2a, κ Isotype Control from BD 
BioSciences, UK) and PE anti-mouse F4/80 antibody (BioLegend, UK) were both used at a 
final concentration of 0.5µg/ml. Unstained cells were used as a negative control. This staining 
step was carried out for 30 minutes at 4oC, in the dark. Then, 500µl of ice-cold FACS buffer 
was added to stop the reaction. The cells were washed twice in 400µl of FACS buffer before 
being analysed using a FACS Calibur (BD Biosciences). The data was then analysed by FlowJo 
software.  
2.4 Phagocytosis assay  
        BMDM cells were seeded on a coverslip in a 24-well plate in complete RPMI medium 
containing 10ng/ml GM-CSF. The medium was then removed and replaced with 350µl fresh 
medium containing approximately 2.5 x 107 fluorescein-conjugated Zymosan A 
(Saccharomyces cerevisiae) BioParticles (Molecular Probes). The Zymosan A BioParticles 
were not added to the control well. The cells were incubated for an hour at 37˚C to allow 
particle uptake. Phagocytosis was stopped by adding 550µl ice-cold PBS and BMDMs were 
washed with cold-PBS four times. The cells were then fixed with freshly prepared 4% (wt/vol) 
paraformaldehyde in PBS, and incubated for 30 minutes at room temperature. After fixing, 
cells were permeabilised with 0.5% (vol/vol) Triton X-100 in PBS for 15 minutes and non-
specific binding sites were blocked with 0.5% (wt/vol) BSA in PBS (PBS/BSA) for 30 minutes. 
F-actin was stained using phalloidin conjugated to Alexa-Fluor 568 (Molecular Probes) at a 
concentration of 5U/ml diluted in PBS/BSA and incubated for 15 minutes in the dark at room 
temperature. Nuclei were counter-stained with DAPI (Molecular Probes) at a concentration of 
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0.17µg/ml. Coverslips were then mounted with ProLong Gold Antifade reagent (Life 
Technologies). Images were captured using a Zeiss LSM70 confocal laser scanning microscope 
and analysed with Image J software.     
2.5 Bacterial strains  
        Burkholderia pseudomallei strain 10276 was isolated from a human melioidosis patient 
from Bangladesh (Maegraith & Leithead, 1964) and obtained from Ty Pitt, Health Protection 
Agency, Colindale, United Kingdom. A null mutant of this strain with a targeted deletion of 
bpss1492 (∆bimA) was generated by Charles Vander Broek in our laboratory (Jitprasutwit et 
al, 2016). Plasmid pME6032-bimA containing the intact bimA gene from B. pseudomallei strain 
10276 has been described previously (Stevens et al, 2005a; Stevens et al, 2005b). The plasmid 
pME3062-bimA was transformed into the ∆bimA mutant strain and fully restored actin-based 
motility to 10276 ∆bimA. Strain 10276 bsaZ::pDM4 lacks a functional Bsa Type III secretion 
system and has been described previously (Stevens et al, 2003; Stevens et al, 2002). Wild-type 
and ΔbimA mutant bacterial strains were amplified in Luria-Bertani broth (LB) without 
antibiotics, while bsaZ::pDM4 mutant required 15μg/ml chloramphenicol. The ∆bimA strain 
complemented with pME6032-bimA plasmid required 15μg/ml tetracycline. All cultures were 
incubated at 37oC with shaking for 12 to 20 hours. 
2.6 Cell infection studies  
        Bacterial strains were cultured to stationary phase in Luria-Bertani broth at 37 oC , with 
shaking at 200 rpm overnight, and adjusted to the same OD600 of 0.5 (for strain details and 
antibiotic selection refer to part 2.5 Bacterial Strains). To make the infection media, the 
bacterial suspension was diluted 1:500 in DMEM (Sigma-Aldrich) containing 10% (vol/vol) 
heat-inactivated FCS (Gibco Life Technologies) without antibiotics to give approximately 1 x 
106 bacteria per ml. The BMDM cells were then inoculated with the infection media at an MOI 
of 2 (bacteria per cell) and the bacteria were pelleted onto the surface of the cells at 60 x g. The 
actual number of bacteria added was enumerated by retrospective plating of serial dilutions of 
each culture on LA plates. After 30 minutes of infection, cells were washed with PBS and 
overlaid with medium containing an inhibitory level of 250 µg/ml kanamycin to suppress the 
growth of residual extracellular bacteria (Stevens et al, 2005a). For the ΔbimA mutant strain 
complemented with the plasmid pME-bimA, 0.25mM isopropyl-βisopropyl-β-D-
thiogalactoside (IPTG) was always included in the medium to induce the expression of the 
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bimA gene. In a small number of experiments, rapamycin (or solvent DMSO) was used at 4µM 
to induce autophagy.  
At the indicated time point of infection, infected BMDMs were rinsed with PBS twice and 
lysed with 0.1% Triton X-100 in PBS for about 5 minutes at room temperature. Lysates were 
then diluted serially 10-fold with PBS and aliquots plated onto LA (Luria-Agar) plates which 
were incubated at 37 oC for 48 hours. The number of viable intracellular bacteria were counted 
and expressed as colony forming units (CFU) per well of a 96-well plate. 
2.7 Kanamycin and chloroquine protection assay  
       BMDMs were seeded at 1 x 105 per well in a 96-well plate. Briefly, BMDM cells were 
infected at an MOI of 2 with bacterial strains. After 30 minutes of infection at 37°C in a 5% 
CO2 atmosphere, the cells were washed and overlaid with medium containing 250 µg/ml 
kanamycin. The infection then proceeded for another 3 hours at 37°C in a 5% CO2 atmosphere, 
before adding chloroquine at a concentration of 50 μg/ml. The cells were incubated for an 
additional 1.5 hours to allow killing of any bacteria that were trapped inside vacuoles by the 
action of the chloroquine. The cells were washed twice with PBS and lysed in 0.1% Triton X-
100 in PBS. The lysates were serially diluted 10-fold with PBS and aliquots plated on LA agar 
plates to count the CFU after 48 hours incubation at 37°C. 
2.8 Cell cytotoxicity assay  
        Cell cytotoxicity was determined using lactate dehydrogenase (LDH) assays purchased 
from Promega known as CytoTox 96 Non-Radioactive Cytotoxicity Assay, according to the 
manufacturer’s instructions. Briefly, a 50μl aliquot of culture supernatant was transferred into 
a well of a 96-well plate. 50μl of CytoTox 96 Reagent was then added to each well and 
incubated for 30 minutes at room temperature. Control wells lacking any cells served as the 
negative control to determine culture medium background, whilst a Maximum LDH release 
Control was achieved by adding 1X Lysis solution to a confluent monolayer of cells 45 minutes 
before adding the CytoTox 96® Reagent. Lastly, 50μl of Stop solution was added and the 
absorbance was measured at 490nm. The percentage of cytotoxicity was calculated as follows: 
100 X (A490 experimental-A490 background)/(A490 maximum-A490 background). The assay was 
performed on samples obtained from three independent experiments, each containing three 
technical replicates and the data reported as the mean + SEM.  
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2.9 Immunostaining and confocal microscopy  
        BMDMs were seeded at 5 x 105 per well in a 24-well plate on coverslips. Briefly, BMDM 
cells were infected at an MOI of 2 with bacterial strains. At the indicated time point of infection, 
the medium was removed and the cells were washed with PBS twice before fixing with 4% 
paraformaldehyde, or methanol, for 30 minutes at room temperature or overnight at 4 oC. After 
fixing, cells were permeabilised with 0.5% (vol/vol) Triton X-100 in PBS for 15 minutes and 
non-specific binding sites were blocked with 0.5% (wt/vol) bovine serum albumin (BSA) in 
PBS (PBS/BSA) for 30 minutes at room temperature. The primary antibody at the dilution 
indicated in Table 2.1 was added onto the coverslip in PBS/BSA for one hour at 37°C. The 
coverslips were then washed with PBS before adding the relevant secondary anti-species 
antibody conjugated with either Alexa Fluor 568 or 488 (Molecular Probes) at 10µg/ml in 
PBS/BSA for another hour at 37°C in the dark. On certain occasions, F-actin was stained with 
phalloidin diluted in PBS/BSA at room temperature for 15 minutes (Table 2.2) after washing 
the coverslips with PBS. Where necessary to counter-stain nuclei, the coverslips were then 
washed again in PBS and dipped in distilled water containing DAPI (4’, 6-Diamidino-2-
Phenylindole, Dihydrochloride) (Sigma-Aldrich) at a concentration of 500nM.  Finally, the 
coverslips were rinsed with distilled water and mounted with ProLong Gold Antifade reagent 
(Life Technologies). The slides were stored in the dark at 4 oC. Images were captured using a 
Zeiss LSM70 confocal laser scanning microscope and analysed with Image J software.     
Table 2.1 Primary antibodies used in immunofluorescence 




on used  
Supplier  Product 
code  
B. pseudomallei LPS  Mouse 
monoclonal  
B. pseudomallei  2µg/ml Camlab, Cambridge, 
UK 
 
B. pseudomallei LPS Rabbit 
polyclonal  
B. pseudomallei  1:200 Ty Pitt, Health 
Protection Agency, 
London   
 











Human, Rat  
































Supplier  Product code  




5U/ml Molecular Probes  A12379 













2.10 Protein gels and western blots 
        For preparation of BMDM cell lysates, the medium in each well was removed at the 
indicated time point, and cells washed with PBS twice. 50µl of BugBuster MasterMix 
(Novagen) was added directly to the cells (for cells plated in a 24-well plate). 10µl of 6x 
Laemmli buffer (300mM Tris pH8.8, 12% SDS, 0.6% Bromophenol blue and 20% glycerol) 
was added to each of the lysates, heated at 90 oC for 10 minutes. This step of heating the samples 
was required to inactivate the bacteria and allow the samples to be removed from the 
Containment Level 3 laboratory for further procedures.   
        The lysates were first resolved by SDS-PAGE gel (Sodium dodecyl sulphate (SDS) 
polyacrylamide gel electrophoresis (PAGE)). Samples were separated either on ready-made 
any kDa Mini-Protean TGX Precast Gels (BioRad) or on self-prepared 15% polyacrylamide 
gels. The gels were electrophoresed in 1X Tris-Glycine-SDS PAGE (FlowGen BioScience) 
running buffer for 50 minutes at 160V or until the loading dye front reached the bottom of the 
gel.  
        The proteins were transferred from the gel matrix onto a nitrocellulose membrane 
(BioRad) using a Trans-Blot Turbo Transfer System for 30 minutes at 25V. Both filter papers 
and membrane were pre-wetted and equilibrated in 1X transfer buffer containing 20% v/v 
EtOH (BioRad) for about 5 minutes. After the protein transfer was completed, the blot was 
then blocked in PBS containing 5% (wt/vol) Blotto milk protein for 30 minutes at room 
temperature on a rocking platform. The blot was washed three times (15 minutes each) with 
PBS-T (PBS containing 0.1% (vol/vol) Tween 20) before being incubated with primary 
antibody diluted in PBS-T (Table 2.3) at 4 oC overnight on a rocking platform. This was 
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followed by washing three times with PBS-T (first 15 minutes and then 2 x 5 minutes) and then 
incubated with secondary IRDye (Cell Signalling Technology) anti-mouse, anti-rabbit or anti-
goat IgG antibody (1:10,000) diluted in PBS-T for 45 minutes, at room temperature on a 
rocking platform. After washing a further 4 times (5 minutes each), the bound antibodies were 
detected using a LI-COR Odyssey Infrared Imaging System (LI-COR BioSciences), according 
to the manufacturer’s instructions. The images were processed using Image Studio Lite 4.0 
software (LI-COR BioSciences). 
Table 2.3 List of primary antibodies for Western Blot 
Detected 
antigen  
Antibody  Species reactivity  Dilution/ 
concentration 
used  
Supplier  Product Code  
















Caspase-1  Rabbit 
polyclonal  
Mouse, Pig, Rat, 
Worm 







Mouse, Rat 1.0μg/ml Bioss Inc  bs-6858R 
 
2.11 ELISA (Enzyme-linked immunosorbent assays) 
        To detect qualitatively the amount of secreted cytokines TNF-α, IL-1α and IL-1β in cell 
supernatants, commercially available ELISA Ready-SET-Go! sets from eBioscience (UK) 
were used, essentially as described in the manufacturer’s protocol. Cell culture supernatants 
from the infected cells were filtered through a 0.22μM Millipore filter prior to analysis. This is 
an important step to ensure the supernatants were free from bacterial contamination before 
removing from the Containment Level 3 Laboratory for processing.  
        Briefly, high-binding 96-well ELISA plates (Corning Costar) were coated with 100μL per 
well of the capture antibody (IL-1α, TNFα, IL-1β) in Coating Buffer, overnight at 4°C. The 
wells were washed three times with 200μl/well Wash Buffer (1X PBS, 0.05% Tween-20) with 
an interval of 1 minute soaking in between the washes. Next, 200μl of blocking solution (1X 
Assay Diluent as provided in the kit) was added per well and incubated at room temperature 
for 1 hour. The cytokine standards were serially diluted 2-fold in 1X Assay Diluent to make 
the standard curve ranging from 4-500 pg/ml. 100μl of each dilution or supernatant was added 
to the coated plate and incubated overnight at 4°C. The plate was washed 5 times with Wash 
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Buffer before adding 100μl of detection antibody (as provided in the kit) into each well. After 
incubation at room temperature for 1 hour, the plate was washed 5 times with Wash Buffer. 
Next, 100μl of 1X avidin-horseradish peroxidase HRP in Assay diluent was added to each well 
and incubated for 30 minutes at room temperature. This was followed by washing with Wash 
Buffer 7 times to remove any unbound enzyme, before adding 100μl/well of Substrate Solution 
(TMB solution) for the next 15 minutes at room temperature. Lastly, the reaction was stopped 
by adding 50μl of stop solution (2N H2SO4). The cytokine levels were assessed by taking OD450 
measurements using a microplate spectrophotometer, and quantified based on the standard 
curve drawn from the standards described above. The assay was performed on samples 
obtained from three independent experiments, each containing three technical replicates and 
the data reported as the mean + SEM (standard error of mean). 
2.12 Proteome Profiler Mouse Cytokine Array  
2.12.1 Sample preparation and protein concentration measurement  
        BMDMs were infected with B. pseudomallei WT or ∆bimA strain as described in section 
2.6 for 8 hpi and 16 hpi. For the positive control, BMDMs were stimulated with 500ng/ml E. 
coli LPS for 8 hours. Uninfected BMDMs at respective time points served as a baseline for 
measuring cytokine and chemokine concentration fold-change. Cell lysates were obtained by 
lysing the cells using 500µl of 1% Triton X-100 in PBS per well of a 24-well plate for 5 
minutes. The lysates were then filtered through a 0.22µm membrane filter (Millipore). Some 
of the filtrate were plated onto an LA plate for sterility testing to ensure no intact bacteria were 
present in the samples. This step was required before bringing the sample out of the 
containment level 3 laboratory.  
        Total protein concentration of lysates were then determined using a Pierce BCA 
(bicinchoninic acid) Protein Assay Kit (Thermo Fisher Scientific) according to the 
manufacturer’s instructions. Briefly, BCA working reagent was prepared by mixing 50 parts 
of BCA reagent A with 1 part of BCA reagent B. Proteins standards were prepared from Bovine 
Serum Albumin (BSA) (Sigma) at different concentrations 25, 125, 250, 500, 750, 1000, 1500 
and 2000µg/ml. 25µl of each standard or sample was added into each microplate well in 
duplicate. 200µl of working reagent was then added into each well and mixed on a plate shaker 
for 30 seconds, followed by incubation at 37°C for 30 minutes. Finally, the absorbance was 
measured at 562nm. The protein concentrations were determined based on the BSA standard 
curve.      
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2.12.2 Proteome Profile Mouse Cytokine Array  
        Cytokine and chemokine profiling in BMDM cell lysates was performed using a Proteome 
Profiler Mouse Cytokine Array Kit, Panel A (R&D Systems) according to the manufacturer’s 
instructions. Firstly, the array membranes were placed carefully in a separate well of a Multi-
Dish containing 2.0ml of Array Buffer 6 to block any non-specific binding. The membranes 
were placed with the number on the membranes facing upwards. The membranes were 
incubated for an hour on a rocking platform, at room temperature. While the membranes were 
blocking, samples were prepared by mixing 1ml of each sample containing 100µg of protein 
lysate with 0.5ml of Array Buffer 4. Next, 15µl of reconstituted Detection Antibody cocktail 
was added to each prepared sample, mixed and incubated at room temperature for an hour. 
When the incubation period elapsed, Array Buffer 6 was aspirated from the wells and the 
sample:antibody mixtures were then added into each well. The membranes were incubated 
overnight at 4°C on a rocking platform. The next day, each membrane was washed three times 
with 20ml of 1x Wash Buffer on a rocking platform for 10 minutes each. After washing, each 
membrane was carefully removed from its wash container and the lower edge blotted onto 
absorbent paper to drain excess buffer from the membrane. Afterwards, each membrane was 
placed back into the well containing 2ml of IRDye 800CW Streptavidin (LI-COR Biosciences) 
that was diluted 1:2000 in Array Buffer 6. The membranes were then incubated for 30 minutes 
at room temperature on a rocking platform. After incubation, each membrane was washed as 
described previously. Finally, each membrane was blotted onto absorbent paper to drain excess 
buffer before scanning using a LI-COR Odyssey Infrared Imaging System (LI-COR 
BioSciences). The images were processed using Image Studio Lite 4.0 software (LI-COR 
BioSciences). 
2.13 Griess assay  
        Nitric oxide (NO) is synthesised by iNOS (inducible nitric oxide synthase), and is an 
important antimicrobial mediator and physiological messenger in many biological systems. 
NO2- (nitrite) is one of the primary, stable breakdown products of NO, hence measuring the 
nitrite concentration by Griess assay gives an indication of NO production in the sample. For 
this assay 100μl of cell supernatant was aliquoted into each well of a clear, flat-bottomed 96-
well plate, followed by 50μl of Griess assay R1 and R2 reagent (Cayman Chemical). The 
reaction was incubated for 10 minutes at room temperature before values were obtained at 
OD540 using a microplate spectrophotometer. A nitrite standard curve was produced by serially 
diluting 2-fold sodium nitrite, ranging from 100μM to 1.56μM. The nitrite concentration in 
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each sample was then quantified in comparison to the reference curve of sodium nitrite 
standards. The assay was performed on samples obtained from three independent experiments, 
each containing three technical replicates and the data reported as the mean + SEM.  
2.14 Methods for evaluation of siRNA-mediated gene silencing  
2.14.1  siRNA transfection  
        For MyD88 gene silencing in BALB/C BMDMs, Pre-designed Silencer siRNA duplexes 
specific for mouse MyD88 (RefSeq Accession No. NM_010851.2) were obtained from 
Ambion (Thermo Fisher Scientific) (5’-GGAUAUACUGAAGGAGCUG-3’). MISSION 
Universal Negative siRNA control (Sigma-Aldrich), which does not share homology with any 
known mammalian gene, was included at the same concentration in each experiment as a non-
target siRNA control.  
        MyD88 siRNA transfection into BALB/C BMDMs was performed using Lipofectamine 
RNAiMAX reagent (InvitrogenTM, Life Technologies), following the manufacturer’s 
recommendations. Briefly, 6µl RNAiMAX was mixed with 6µl of 20µM siRNA in 200µl of 
Opti-MEM I reduced serum medium (Invitrogen), and incubated at room temperature for 20 
minutes. Meanwhile, the medium was removed from each well containing BMDMs and 
replaced with fresh RPMI medium (supplemented with 20% FCS, 50µM β-mercaptoethanol 
and 5mM L-glutamine). BMDMs were seeded at 1 x 105 cells per well of a 96-well plate for 
assessing intracellular bacterial survival. Cells were seeded in wells of a 12-well plate at a 
density of 7.5 x 105 cells per well to harvest RNA for subsequent gene analysis.  The 
RNAiMAX-siRNA mixture was added dropwise to give a final concentration of 75nM siRNA 
per well, and incubated at 37°C. After 24 hours, the medium was replaced with fresh 
supplemented RPMI medium, and incubated for another 24 hours at 37°C in a 5% CO2 
atmosphere, before infection as described in section 2.6, or RNA isolation as described in 
2.14.2. 
2.14.2 Total RNA isolation and reverse-transcriptase PCR (RT-PCR)  
        Total cellular RNA was isolated from 1 x 106 cells using a ReliaPrep RNA Cell Miniprep 
kit (Promega), according to the manufacturer’s recommendations. Briefly, 200µl of lysis buffer 
(BL) containing 0.1% 1-thioglycerol (TG) was added to each well. The sample was pipetted 
repeatedly to lyse the cells and transferred to a new tube. The lysate was centrifuged at 300 x 
g for 5 minutes. Addition of TG to the BL helps to inactivate the ribonucleases present in cell 
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lysate. The cell lysate was then washed with ice-cold PBS and centrifuged again at 300 x g for 
5 minutes. Next, 250µl of BL + TG was added to the washed cell lysate, mixed with 85µl of 
isopropanol and vortexed for 5 seconds. The lysate was then transferred to a ReliaPrep 
Minicolumn and centrifuged at 13, 000 x g for 30 seconds. Nucleic acids in the lysates adsorb 
rapidly to the column in this step.   The column was then washed with 500µl of RNA Wash 
solution containing 60% ethanol, centrifuged again at 13,000 x g for 30 seconds. The 
contaminating genomic DNA was then removed by adding 30µl of freshly prepared DNase I 
incubation mix (80% Yellow Core Buffer, 9mM MnCl2 and 10% DNase I enzyme) directly to 
the membrane of the column and incubated for 15 minutes before washing with 200µl of 
Column Wash solution. The column was then washed twice with RNA Wash solution to further 
purify the bound RNA from contaminating salts, proteins and cellular components. Finally, 
30µl of nuclease-free water was added to the membrane and centrifuged at 13,000 x g for 60 
seconds to elute the total RNA. The total RNA was stored at -20°C until used in downstream 
experiments.  
         RNA samples were subjected to one-step RT-PCR using 10ng of RNA using the Access 
RT-PCR System (Promega), according to the manufacturer’s recommendations. This kit uses 
a two-enzyme system in which the first enzyme AMV Reverse Transcriptase (AMV RT) from 
Avian Myeloblastosis Virus synthesises first-strand complementary DNA (cDNA) from the 
RNA. This is followed by second-strand cDNA synthesis and DNA amplification by the second 
enzyme Tfl DNA polymerase from Thermus flavus. Briefly, the reaction mixture contained 
10ng of sample RNA, 1X AMV/Tfl Reaction Buffer, 0.2mM dNTP mix, 1µM forward primer, 
1µM reverse primer, 1mM MgSO4, 0.1u AMV Reverse Transcriptase and 0.1U of Tfl DNA 
polymerase. The RT-PCR reaction consisted of incubation at 45°C for 45 minutes and 94°C 
for 2 minutes for the first cDNA synthesis step, followed by 40 cycles of 94°C for 30 seconds, 
60°C for 1 minute and 68°C for 2 minutes for second strand synthesis and PCR amplification. 
Finally, a final extension step was carried out at 68°C for 7 minutes. 30µl of the amplified 
reaction was electrophoresed on a 2.5% TAE agarose gel (UltraPure Agarose from Thermo 
Fisher Scientific) and DNA was visualised by adding 1X Invitrogen SYBR Safe DNA Gel 




Table 2.4 Primers for RT-PCR 
Target Primer sequence   
MyD88 Forward:5’ CCCACTCGCAGTTTGTTGGATGCCTGG 3’ 
Reverse: 5’ GGTGGTGATGCCTCCCAGTTCCTTTGT 3’ 
β-actin  Forward: 5’ GGATGACGATATCGCTGCGCTGGT 3’  
Reverse: 5’ TCTTTTCACGGTTGGCCTTAGGGTTC 3’  
 
2.15 TLR-blocking peptide treatment  
        TRIF-blocking peptide (Pepinh-TRIF) and the negative control peptide (Pepinh-Control) 
(InvivoGen) were prepared as 1mM stock solutions by dissolving peptides in endotoxin-free 
water and used at final concentrations of 20µM. The MyD88-dependent pathway was blocked 
with the MyD88 Homodimerisation Inhibitor Peptide NBP2-29328, which was purchased from 
Novus Biologicals.  Stock solutions of NBP2-29328 and the negative control inhibitor were 
prepared to 5mM by dissolving in PBS and were used at final concentrations of 100µM.  
BMDM cells were pre-treated with TRIF- or MyD88- blocking peptides (or the corresponding 
negative control inhibitors), for 4 hours or 24hours respectively, at 37°C before stimulation 
with exogenous ligand or carrying out the bacterial infection experiment. To determine the 
effectiveness of the TRIF -blocking peptide, BMDMs were stimulated with 25µg/ml of polyI:C 
(polyinosinic-polyctidylic acid) (InvivoGen) for 6 hours before isolating the cellular RNA 
(refer to section 2.16) and carrying out quantitative RT-PCR (qPCR) for expression of the 
Interferon-β (IFN-β) gene. While to determine the effectiveness of the MyD88-blocking 
peptide, 4µg/ml of Pam3CSK4 (Bio-Techne) were used to stimulate BMDMs for 24 hours, 
followed by RNA isolation (refer to section 2.16) and qPCR for expression of the Interleukin-
1β (IL-1β) and Interleukin-6 (IL-6) genes.  
2.16 Total RNA extraction using the RNeasy Plus Micro Kit (Qiagen) 
        Prior to experiments involving TLR-blocking peptides and microarray, total RNA was 
extracted using the RNeasy Plus Micro Kit (Qiagen) according to the manufacturer’s 
instructions. Approximately 5 x 105 cells were lysed using 350µl of RLT lysis buffer containing 
β-mercaptoethanol, followed by homogenisation using a QIAshredder (Qiagen) spin column. 
The lysates were recovered by centrifuging the spin columns for 2 minutes. All centrifugation 
steps were performed at 13, 000 x g at room temperature.  The flow-through lysates were then 
transferred to gDNA Eliminator spin columns to eliminate gDNA contamination, and lysates 
recovered by centrifugation at 30 seconds.  Next, 350µl of 70% ethanol was added to the flow-
through, mixed and transferred to the RNeasy spin column which was centrifuged for 15 
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seconds. Addition of ethanol at this step provides the appropriate conditions for RNA to bind 
to the column. The column was then washed with 700µl of buffer RW1 and centrifuged for 15 
seconds. The column was then rinsed with 500µl of buffer RPE and centrifuged for 15 seconds. 
The final wash involved the addition of 500µl of 80% ethanol, which was removed by 
centrifugation for 2 minutes. The column membrane was then dried by centrifugation for 5 
minutes. Lastly, the RNA was eluted by adding 14µl of RNase-free water directly to the centre 
of the spin column membrane followed by centrifugation for 1 minute. The RNA concentration 
was quantified using a Nanodrop ND-100 (NanoDrop Technologies). 
2.17 Reverse Transcription of RNA into cDNA  
        Total RNA was reverse transcribed using random oligo (dT)15 primer (Promega) with 
Promega GoScript Reverse Transcriptase (Promega GoScript Reverse Transcription System).  
Firstly, 100ng of RNA was combined with 0.5μg of Oligo (dT)15 primer and the 
primer/template mix was thermally denatured at 70°C for 5 minutes and immediately chilled 
on ice. The template-primer mixture was then added to the reaction mix containing 2.5mM 
MgCl2, 1X RT buffer, 1mM dNTP and reverse transcriptase (RT) enzyme on ice. For the 
negative control reactions, RNAse free water was added instead of the RT-enzyme. The 
reactions were then incubated first at 25°C for 5 minutes for annealing, followed by extension 
at 42°C for 50 minutes and enzyme inactivation at 70°C for 15 minutes. The cDNA products 
were then stored at -80°C.   
        To determine if the RNA samples contained genomic DNA contaminants, PCR was 
carried out by amplifying β-actin in both the samples with and without the RT-enzyme. The 
forward and reverse primer sequence for β-actin were 5’-
GGATGACGATATCGCTGCGCTGGT-3’ and 5’-
TCTTTTCACGGTTGGCCTTAGGGTTC-3’ respectively. β-actin primers were designed 
spanning an exon-exon boundary, thus avoiding the detection of the target gene from residual 
genomic DNA in the initial RNA sample. 0.4U of Phusion high-fidelity polymerase (Thermo 
Scientific) was used for gene amplification with 1x Phusion buffer, 0.3µl DMSO, 0.2mM 
dNTPs, 1µM of primers and 2.5ng diluted cDNA product. The reaction conditions used were 
98°C for 2 minutes, followed by 25 three step cycles (98°C for 10 seconds, 68°C for 20 
seconds, and 72°C for 30 seconds) and a final extension of 72°C for 10 minutes. PCR products 
were visualised using agarose gel electrophoresis. Gel electrophoresis was performed using 
2.5% TAE agarose gels (UltraPure Agarose from Thermo Fisher Scientific) and DNA was 
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visualised by adding 1X Invitrogen SYBR Safe DNA Gel Stain. The electrophoresis was 
performed at 80-90V for 45-60 minutes. Amplification of β-actin from cDNA gives a band 
product at approximately 350bp while amplification from genomic DNA gives a band about 
420bp which indicates gDNA contamination in the RNA samples. 
2.18 Design of the real-time PCR (qPCR) primers  
        The primers were carefully designed and analysed using Beacon Designer software 
(PREMIER Biosoft International) to identify if the primer set (forward and reverse primer of 
the target) could form any secondary DNA structure, namely a primer dimer (self-dimer, or 
cross-dimer) or hairpin structure. The software predicts the Gibbs free enthalpy (represented 
as ΔG) required to fully break a secondary DNA structure. Hence, the more negative value it 
is, the more energy required to separate the DNA structure. All the primer sets were designed 
with an energy value below -4.0 kcal/mol, which ensures that primers do not form stable dimers 
or hairpin structures.  The primers were designed to span exon-exon boundaries (table 2.5), 
thus avoiding the detection of target genes from residual genomic DNA in the initial RNA 
sample. The primers were also checked with the NCBI BLAST database to ensure that they 
did not anneal to any non-specific DNA targets. Nine different concentrations of reverse and 
forward primers were tested (two-by-two combinations of 100, 200 or 300nM) to obtain the 
optimum concentration for each pair that gave the lowest threshold cycle (Ct) but maximum 
amplification (with minimum non-specific amplification). All the primers were ordered from 
Sigma-Aldrich. Below are the criteria that were taken into account when designing the primers:  
1) GC content: 40-60%  
2) Tm value: 60°C - 75°C 
3) Product size: 100-250 base pairs  
4) Primer length: 24-28 base pairs  
5) Self-dimer, cross-dimer and hairpin energy value: ≤-4.0kcal/mol
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Table 2.5 Primers for qPCR 
Target  Primer sequences  
FNBP1L / TOCA-1  Forward: 5’ CAAACAGCAGTTGAACCTTCGTACG 3’  
Reverse: 5’ CGTACGAAGGTTCAACTGCTGTTTG 3’ 
IL-12β Forward: 5’ CATAGGCTCTGGAAAGACCCTGACCATC3’  
Reverse: 5’ AGTAATTTGGTGCTTCACACTTCA 3’ 
IL-1β Forward: 5’ TTTGACCTGGGCTGTCCTGATGAGAGC 3’  
Reverse: 5’ ATTCTGTCCATTGAGGTGGAGAGCTTT 3’  
IL-6  Forward: 5’ TTCCATCCAGTTGCCTTCTTGGGACTA 3’  
Reverse: 5’ ATCCAGTTTGGTAGCATCCATCATTTC 3’  
TNF  Forward: 5’ AGCACAGAAAGCATGATCCGCGACGTG 3’  
Reverse: 5’ TGTGAGGGTCTGGGCCATAGAACTGAT 3’  
NOS2  Forward: 5’ AGAATCCCTGGACAAGCTGCATGT 3’  
Reverse: 5’ AAGGAGCCATAATACTGGTTGATG 3’  
IL-1α Forward: 5’ TGATGCAAGCTATGGCTCACTTCATGAG 3’  
Reverse: 5’ GGTCATTTAACCAAGTGGTGCTGAGAT 3’  
CD40  Forward: 5’ CAAGGGCTTCGGGTTAAGAAGGAGGG 3’ 
Reverse: 5’ TTGTCCAGGGATAACACTTTTCGAAAA 3’  
ISG15  Forward: 5’ TAGTGGTACAGAACTGCAGCGAGCCTC 3’ 
Reverse: 5’ CTCAGGCGCAAATGCTTGATCACTGTG 3’ 
IFIH1/MDA-5  Forward: 5’ CCAGAAGTTGTCAAATCTTACGATGTTATT 3’ 
Reverse: 5’ CTTGAGGTCATTGTTTCTCAGCTTCTG 3’  
FAS  Forward: 5’ CTTGAGCCGTGCACAGCAACCAGCAA 3’ 
Reverse: 5’ ACTGGAGGTTCTAGATTCAGGGTCATCC 3’ 
IFN-β Forward: 5’ GGAATGAGACTATTGTTGTACGTCTCCTGG 3’ 
Reverse: 5’ GTCTTCGAATGATGAGAAAGTTCCTGA 3’  
  
        Primer sets for the amplification of six different reference genes were purchased from 
PrimerDesign Ltd (Mouse geNormPLUS 6 gene kit) for use in qPCR. The reference genes 
provided in this kit were:  
1. Mus musculus adaptor-related protein complex 3, delta 1 subunit (Ap3d1), mRNA 
2. Mus musculus casein kinase 2, alpha prime polypeptide (Csnk2a2), mRNA 
3. Mus musculus PAK1 interacting protein 1 (Pak1ip1), mRNA 
4. Mus musculus 18S rRNA gene 
5. Mus musculus actin, beta, cytoplasmic (ACTB), mRNA 
6. Mus musculus glyceraldehyde-3-phosphate dehydrogenase (GAPDH), mRNA   
2.19 Quantitative Real-Time PCR (qPCR)  
        Approximately 120ng of cDNA for each sample was mixed with Agilent Brilliant III 
Ultra-fast SYBR Green qPCR Master Mix (Agilent Technologies) containing SYBR Green I 
fluorescent dye, Taq DNA polymerase, Mg2+ and dNTPs, together with the optimal 
concentration of forward and reverse primers. An inert ROX reference dye (30nM) was 
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included to normalise the fluorescent signal between reactions. This normalisation was 
performed automatically by the MxPro software (Agilent Technologies), and was represented 
as dRn in the amplification plot. The thermal cycling was performed using the following 
temperature profile: Cycle 1 for 3 minutes at 95°C and 50 cycles of 10 seconds at 95°C 
followed by 22 seconds at 60°C. A dissociation curve was included in every PCR run; 95°C 
1min, 60°C 30sec and 95°C 15 sec. A ‘no template’ control was also included as a negative 
control. The real-time PCR reactions were performed using a Stratagene Mx3000P qPCR 
System (Agilent Technologies). 
2.20 Standard PCR to generate PCR products for standard curves  
        Standard PCR was used to generate PCR products for standard curves in qPCR reactions. 
PCR reactions contained 0.4U of Phusion high-fidelity polymerase (Thermo Scientific), 1X 
Phusion buffer, 0.3µl DMSO, 0.2mM dNTPs, 1µM of primers and 3ng diluted cDNA product. 
The reaction conditions used were 98oC for 2 minutes, followed by 35 cycles of three steps 
reaction (98oC for 10 seconds, 68oC for 20 seconds, and 72°C for 30 seconds) and final 
extension of 72oC for 10 minutes. The PCR products were diluted to give a range of 10-1 to 10-
6 ng of PCR product for standard curve, quantified using a Nanodrop ND-100 (NanoDrop 
Technologies). 
2.21 qPCR analysis software 
        qPCR data were analysed using MxPro QPCR software (Agilent Technologies). The 
validation of reference genes were assessed using the geNorm algorithm implemented in 
qBase+ software (BioGazelle). 
2.22 Affymetrix microarray technology  
2.22.1 Generation of RNA samples, labelling, hybridisation and scanning  
        BMDM cells in wells of a 24-well plate were infected at an MOI of 2 for 8 and 12 hours 
post infection. Total RNA was carefully extracted from uninfected BMDM cells, BMDM cells 
infected with WT 10276 strain and BMDM cells infected with the ∆bimA mutant strain using 
an RNeasy Plus Micro Kit as described above. Three biological replicates were performed for 
each sample at each time point, giving a total of 18 samples. The RNA integrity was verified 
using an Agilent 2100 Bioanalyser (Agilent Technologies) and the concentration was 
quantified using a Nanodrop ND-100 (NanoDrop Technologies). All the samples used for 
microarray passed the QC with an RIN >7, and ratios of OD 260/230 and OD 260/280 >1.7.        
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        Samples were sent to Source BioScience GeneService (Nottingham, UK) for the 
downstream processes of biotin-labelling, hybridisation and scanning. Biotin-labelled cDNA 
was prepared from each sample using the GeneChip Whole Transcript Sense Target Labelling 
Assay (Affymetrix) and hybridised to Affymetrix GeneChip Mouse Gene 2.0 ST Arrays 
according to the manufacturer’s instructions. Arrays were washed and stained using the 
GeneChip Hybridisation, Wash, and Stain Kit in a Fluidics Station 450 and scanned with a 
GeneChip Scanner 3000 according to the manufacturer’s instructions. An output file known as 
a Cell Intensity File (*.CEL), containing intensity values for each probe cell on the array 
(probe-level data), was obtained from Source BioScience and analysed as described below. 
2.22.2 General software used for Microarray analysis  
        The raw CEL files were imported into the Affymetrix Expression Console Software for 
data pre-processing and normalisation. The raw CEL files were background-adjusted, 
normalised and log2-transformed using the GC-RMA (robust-Multiarray average) algorithm. 
The intensity signal was standardised across arrays via the quantile normalisation algorithm. 
The quality control (QC) assessment of the arrays were performed using the same software. 
The normalised data were grouped on the basis of experimental conditions (uninfected or 
BMDM cells infected with different bacterial strains, and infection time points) using 
Affymetrix Transcriptome Analysis Console (TAC) Software. Pairwise comparison was then 
applied to find the differentially expressed transcripts of the infected BMDMs (with either WT 
strain or ΔbimA strain) versus uninfected BMDMs, at respective time points of infection. The 
comparison was carried out based on error-weighted one-way unpaired Analysis of Variances 
(ANOVA), and genes with *p ≤ 0.05 and fold change of ≥1.5 were defined as significantly 
differentially expressed.     
        Venny 2.0 tool (http://bioinfogp.cnb.csic.es/tools/venny/) was then used to create Venn 
Diagrams to identify common subsets of genes that were differentially expressed in cells 
infected with both WT and ΔbimA bacteria. This group of overlapping genes represents the 
common host response of BMDMs towards B. pseudomallei. The software was also used to 
identify genes that were differentially expressed in ΔbimA infected cells compared to WT. Gene 
lists were evaluated using Ingenuity Pathway Analysis (IPA) 
(https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis/). The IPA 
analysis categorised the list of DEGs into functions, interactions and pathways that reflect the 
underlying biological processes uniquely involved in the experiment. 
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2.23 General Statistical Analysis of Data  
        To determine significance, the student’s t-test was used to compare samples using 







3 CHAPTER 3: ASSESSING THE ROLE OF AUTOPHAGY IN THE MACROPHAGE 
RESPONSE TO INTRACELLULAR BURKHOLDERIA PSEUDOMALLEI  
 
3.1 INTRODUCTION  
         
          Macrophages and neutrophils are the key innate immune cells that control B. 
pseudomallei in vivo and in vitro (Breitbach et al, 2011; Barnes et al, 2008; Easton et al, 2007; 
Breitbach et al, 2006; Leakey et al, 1998). The essential role of macrophages has been revealed 
by in vivo studies where macrophage-depletion led to increased mortality in both BALB/C and 
C57BL/6 mice when challenged with B. pseudomallei (Barnes et al, 2008; Breitbach et al, 
2006). Macrophages from melioidosis patients demonstrate reduced phagosome-lysosome 
fusion and the subsequent metabolic oxidative burst compared with healthy individuals, 
allowing bacterial proliferation in macrophages (Puthucheary & Nathan, 2006). Furthermore, 
an ineffective cellular innate immune response shown in diabetic mice (Hodgson et al, 2013; 
Hodgson et al, 2011) as well as human polymorphonuclear neutrophils (PMN) from diabetic 
patients (Chanchamroen et al, 2009) contribute to an increased susceptibility to melioidosis, 
and corresponds with their central role as a first line of host defence against bacterial infections.  
        The laboratory mouse represents a useful surrogate for the study of clinical melioidosis 
with respect to the disease presentation and immune response (Warawa et al, 2010). The 
establishment of a murine model demonstrating differential susceptibility towards B. 
pseudomallei infection allows us to examine the host innate mechanisms involved in control 
of this bacterium. Two inbred mouse strains, BALB/C and C57BL/6, have been extensively 
used to investigate the immunopathogenesis of B. pseudomallei. Several studies have shown 
that BALB/C mice are  susceptible to infection with B. pseudomallei, while C57BL/6 mice are 
considerably more resistant (Breitbach et al, 2011; Barnes et al, 2008; Easton et al, 2007; 
Breitbach et al, 2006; Liu et al, 2002; Hoppe et al, 1999; Leakey et al, 1998). This differential 
susceptibility to infection classifies BALB/C and C57BL/6 mice as good models for the acute 
and chronic forms of human melioidosis respectively.     
        The higher susceptibility of BALB/C mice to infection with B. pseudomallei is mirrored 
in in vitro studies using bone-marrow derived macrophages (BMDMs). Breitbach et al (2006) 
showed that C57BL/6 BMDMs have lower numbers of B. pseudomallei compared to BMDMs 
differentiated from the susceptible BALB/C strain. The difference in macrophage killing 
65 
 
activity between C57BL/6 and BALB/C derived macrophages can be explained by the 
proteomic and transcriptomic analysis documented by Depke et al (2014). In comparison to 
BALB/C BMDMs, C57BL/6 BMDMs have more abundant respiratory complexes to generate 
more ROS (reactive oxygen species) and also more lysosomal membrane proteins and 
lysosomal enzymes, hence, have a more effective antimicrobial activity. In addition, 
components that protect cells from oxidative stress such as peroxiredoxin and mitochondrial 
superoxide dismutase are also more abundant in C57BL/6 BMDMs as compared to BALB/C 
BMDMs (Depke et al, 2014).  This suggests that the differences observed in vitro using 
BMDMs from BALB/C and C57BL/6 mice might correlate with differences in susceptibility 
in vivo to several infections including B. pseudomallei.  
        The majority of human melioidosis cases present  as acute disease (Currie et al, 2000). As 
described above, the BALB/C strain represents a mouse model for acute human melioidosis. 
As the broad aims for the thesis are to investigate the macrophage innate mechanisms in 
controlling intracellular bacterial survival, we decided to use BMDMs from BALB/C mice as 
an appropriate in vitro cell system.   
        As a facultative intracellular pathogen, B. pseudomallei has the ability to enter, survive, 
and replicate in both phagocytic and non-phagocytic cells (Jones et al, 1996), deploying a Type 
III secretion system (Bsa) to promote its entry into host cells (Stevens et al, 2003). Bsa also 
influences endosome lysis and escape into the cytosol (Stevens et al, 2002; Harley et al, 1998). 
Within the cytosol, B. pseudomallei replicates and subverts the host cytoskeleton machinery to 
nucleate actin at one pole, forming F-actin enriched tails that propel the organism within and 
between host cells in a BimA (Burkholderia intracellular motility protein A) -dependent 
manner (Stevens et al, 2005b). As with other pathogens, B. pseudomallei uses actin-based 
motility to disseminate between cells while evading immune surveillance. Following actin-
based motility, and uniquely among bacteria, B. pseudomallei is able to induce fusion of 
adjacent cells forming multinucleated giant cells (MNGC) (Kespichayawattana et al, 2004) as 
observed in tissues from melioidosis patients (Wong et al, 1995).  
        The work described in this thesis aims to investigate the general response of macrophages 
to intracellular B. pseudomallei, and also to elucidate the role of BimA in aiding the bacterium 
to evade macrophage innate detection and elimination mechanisms. To address this second 
scientific question, a bacterial mutant lacking the bimA gene (∆bimA) was included in the study 
as a comparison to the WT strain. In this chapter we hypothesised that autophagy plays a role 
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in the clearance of the ∆bimA mutant in infected BMDMs. The specific aims of the work 
described in this chapter are:  
1. To generate and phenotype BALB/C BMDMs  
2. To identify the time course of infection where the mutant ∆bimA strain shows an 
impaired intracellular survival compared to the WT strain  
3. To demonstrate that the WT strain, but not the mutant ∆bimA strain, is able to form 
actin tails in BMDMs  
4. To determine if the mutant ∆bimA strain has a defect in bacterial uptake or phagosomal 
escape in comparison to the WT strain  





3.2.1 Phenotypic characterisation of BALB/C BMDMs  
 
Many previous studies on the intracellular life of B. pseudomallei have utilised 
immortalised cell lines as model systems. However, it is clear that in some instances certain 
phenotypes described in these models are not relevant in a primary cell. An example is the 
finding by Rinchai et al (2015) that B. pseudomallei does not escape the phagosome of infected 
primary neutrophils and does not display actin-based motility. Selective pressure imposed by 
continual subculture of immortalised macrophage-like cells such as RAW cells usually results 
in the loss of genes that are not essential for cell division and replication, but are key for 
macrophage immune functions (Kaur & Dufour, 2012; Chamberlain et al, 2009). For example, 
Chamberlain et al (2009) demonstrated that in response to lipopolysaccharide (LPS), murine 
BMDMs produce significantly more inflammatory cytokines TNF-α, IL-6, IL-12 and MCP-1 
compared to RAW264.7 cells. In addition, phenotypes of BMDMs and RAW264.7 cells often 
differ. For example, the immortalised RAW264.7 cell line express higher levels of CD14 than 
primary BMDMs (Berghaus et al, 2010; Chamberlain et al, 2009), but the macrophage marker 
F4/80 is significantly more highly expressed in primary BMDMs compared to RAW264.7 cells 
(Chamberlain et al, 2009). Studies on the intracellular life of B. pseudomallei should therefore 
be conducted in the most relevant cell system available. Studies by other laboratories have 
shown that BMDMs represent a more biologically relevant in vitro model for studies on the 
intracellular survival of B. pseudomallei (Breitbach et al, 2011; Breitbach et al, 2006). Hence, 
BALB/C bone-marrow derived macrophages (BMDMs) were used as an infection model 
system in the experiments described in this thesis.  
        This chapter begins with the description on the generation and phenotyping of BMDMs 
isolated from BALB/C mice. Briefly, the femur and tibia were dissected from the hind legs of 
BALB/C mice to obtain the bone-marrow cells. These were differentiated in vitro in RPMI 
media for 7-9 days in the presence of the growth factor GM-CSF (granulocyte macrophage-
colony stimulating factor) as described in Section 2.1. The purity and the phagocytic activity 
of the BMDMs were then determined by FACS assay and assessment of uptake of Zymosan 
BioParticles respectively. 
        Fluorescence activated cell sorting (FACS) of live cells was utilised to phenotype the 
differentiated BMDMs by staining with specific antibody to detect the F4/80 antigen. F4/80 is 
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regarded as one of the most specific cell-surface markers for mature murine macrophages 
(Austyn & Gordon, 1981). To harvest the cells, BMDMs were scraped gently from the 10cm-
square petri dish after rinsing with phosphate buffered saline (PBS).  Of 2.5 x 107 bone marrow 
cells seeded per plate on day 0, approximately 20% (4.8 x 106) of the total cells matured into 
BMDMs and were harvested on day 7. The BMDMs were then stained separately with 
Phycoerythrin (PE)-conjugated F4/80 antibody and PE-conjugated isotype control as described 
in Section 2.3. Unstained cells were used as a negative control. Data was acquired and analysed 
using a FACS Calibur (BD Biosciences) and FlowJo software respectively.  Histograms of 
isotype control, F4/80-specific stained cells as well as the unstained control, were overlaid after 
applying gating around the macrophage population. The percentage of F4/80-stained positive 
cells was determined using the software and a representative histogram is shown in Figure 3.1. 
From three independent experiments, the differentiated cells expressed high levels of F4/80 
antigen with a percentage average of 83.5 % + 2.2% (SEM).  
        The phagocytic activity of BMDMs was determined by assessing the ability of cells to 
engulf fluorescein-conjugated Zymosan BioParticles. Zymosan BioParticles were added to the 
BMDMs plated on a coverslip at a ratio of 50 beads per cell, and incubated for one hour at 
37oC to allow uptake. BMDMs were then fixed in 4% PFA in PBS before staining with 
phalloidin conjugated to Alexa-Fluor 568 (green) and DAPI. Images were captured using a 
Zeiss LSM70 confocal laser scanning microscope and analysed with Image J software. It is 
clear from the representative confocal images, that BALB/C BMDMs displayed high 







Figure 3.1 Phenotypic characterisation of BALB/C BMDMs by FACS. Cells were stained for the 
presence of macrophage marker F4/80 (red) and also the isotype antibody control (blue) as decribed in 
Materials and Methods 2.3. Unstained cells (orange) were also included as a negative control. (A) 
Population of BMDMs was first gated based on the forward (FSC; x-axis) and side scatter (SSC; y-
axis) properties to remove cellular debris and dead cells, as shown in the light-scatter density plot (A). 
Each dot represents the individual cell that has passed through the laser. This gated population (BMDM) 
was then selected for the analysis of expression marker F4/80 as shown in (B). (B) Single parameter 
histograms display number of events (cell counts) (y-axis) versus fluorescence intensity (x-axis). 
Overlay of isotype control and unstained cells population together with the cells stained with F4/80 










Figure 3.2 BALB/C BMDMs display high phagocytic activity. BALB/C BMDMs were grown on 
coverslips at a density of 5 x 105 cells. BMDMs were then incubated with fluorescently-labelled 
Zymosan BioParticles (green) (right image) at a ratio of 50 beads per cell for an hour before fixing and 
staining as demonstrated in Materials and Methods 2.4. No Zymosan BioParticles were added into the 
control well (left). The cell nuclei and the actin cytoskeleton were stained with DAPI (blue) and 
phalloidin (red) respectively. The images were captured using a Zeiss LSM70 confocal laser scanning 




        In this in vitro system, BMDMs were differentiated under the influence of GM-CSF as a 
growth factor. Another growth factor commonly used in the in vitro culture of BMDMs is M-
CSF (macrophage-colony stimulating factor). CSFs are a heterogenous group of glycoproteins 
which promote the proliferation and differentiation of haematopoietic progenitor cells (Kruse 
et al, 1989). It has been reported that differentiating BMDMs under the influence of different 
CSFs polarise the macrophages into different sub-populations; M1 and M2 macrophages. M1 
macrophages are polarised in the presence of GM-CSF while M2 macrophages are polarised 
in the presence of M-CSF (Martinez & Gordon, 2014; Verreck et al, 2004). The M1 
macrophage is the ‘classically-activated’ anti-microbial macrophage, generated in response to 
interferon-gamma (IFN-γ) or lipopolysaccharide (LPS), or both, and also tumour necrosis 
factor (TNF-α). This population produces reactive oxygen and nitrogen species, secretes 
proinflammatory cytokines such as interleukin (IL)-23 and promotes type 1 immunity which 
is required for optimal host defence against intracellular pathogens (Martinez & Gordon, 2014; 
Barnett & Brundage, 2010). Conversely the M2 macrophage is the ‘alternatively activated’ 
macrophage, also known as the ‘wound-healing’ macrophage. This population is stimulated by 
IL-4, IL-13 (Th2 cytokines) and does not produce nitric oxide. This alternative activation leads 
to an anti-inflammatory phenotype, hallmarked by IL-10 as the signature cytokine (Verreck et 
al, 2004). M2 macrophages promote type 2 immunity responses such as dampening 
inflammation, tissue remodelling, wound healing but also tumour promotion (Martinez & 
Gordon, 2014). With this understanding, differentiating BM cells in the presence of GM-CSF 
is appropriate to produce M1 macrophages for the investigation of the intracellular survival of 
B. pseudomallei in phagocytes. This is consistent with the work by Ivo Steinmetz and 
colleagues on B. pseudomallei infection of BMDMs of susceptible BALB/C mice, which utilise 
GM-CSF as a growth factor in the differentiation process from bone marrow cells into BMDMs 
(Depke et al, 2014; Breitbach et al, 2011; Breitbach et al, 2006).  Besides, based on our 
experiences on in vitro culturing BMDMs cells, differentiating BALB/C BMDMs in the 
presence of M-CSF was not successful, and the proportion of differentiated BMDMs cells was 
too small for subsequent experimentation. Difficulty in proliferating BALB/C BMDM cells in 
response to M-CSF has been reported by Kruse et al (1989) previously, who conclude that 
BALB/C mice can be regarded as a low responder to this growth factor. 
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3.2.2 Intracellular survival of B. pseudomallei WT, ∆bimA mutant and the trans-
complemented ∆bimA mutant strain in BALB/C BMDMs  
        The second part of this chapter compares the intracellular survival of B. pseudomallei WT 
and ∆bimA mutant strains in the BALB/C BMDM infection model. Intracellular survival was 
assessed in a kanamycin protection assay where samples were taken over a time course (at 2, 
8, 16 and 24 hours post infection: hpi) to identify the optimal time points showing a significant 
clearance of the ∆bimA mutant compared with the WT strain. BMDMs were infected at a 
multiplicity of infection (MOI) of 2 bacteria per cell for 30 minutes before being overlaid with 
medium containing an inhibitory level of kanamycin (250µg/ml) to kill any extracellular 
bacteria (Stevens et al, 2003; Stevens et al, 2002). At the indicated time point post-infection, 
the infected cell monolayers were subsequently lysed with 0.1% Triton X-100 in PBS, serially 
diluted and plated on Luria-Bertani (LB) agar. Bacterial colony forming unit (CFU) were 
recorded after 2 days incubation at 37oC. This assay also included a trans-complemented 
∆bimA mutant strain harbouring the inducible plasmid pME6032 containing the full length 
bimA gene from strain 10276 (simplified as ΔbimA+pME-bimA). This was used to investigate 
if the bimA gene provided in trans could restore the intracellular survival and complement the 
actin-based motility defect of the ∆bimA mutant in BMDMs. In this trans-complemented 
mutant strain, Isopropyl β-D-1-thiogalactopyranoside (IPTG) was present at all times during 
the assay to induce the expression of the bimA gene from the tac promoter in the pME6032 
vector (Heeb et al, 2002), which stably replicates in B. pseudomallei (Stevens et al, 2005b). In 
addition, the infected cells were immunostained and imaged by confocal microscopy to identify 
if actin tail formation could be observed in BMDMs infected with the WT strain and the 
complement strain, as demonstrated previously in the macrophage-like cell line J774.1 






Figure 3.3 Intracellular survival of WT B. pseudomallei (blue), ∆bimA mutant (orange) and the 
trans-complemented strain (grey) in BALB/C BMDMs. The chart represents mean bacterial 
recoveries (cfu + standard error) from four independent experiments, each with triplicate technical 
measurements. This assay was performed on BMDMs plated in a 96-well plate format which containing 
1 x 105 cells per well. Kanamycin-resistant bacteria were recovered at 2 hpi, 8 hpi, 16 hpi and 24 hpi 
after infection of BALB/C BMDMs as described in Materials and Methods 2.6. Statistical significance 




       The graph in Figure 3.3 demonstrates similar levels of net intracellular survival of both WT 
B. pseudomallei 10276 and the ∆bimA mutant at 2 hpi and 8 hpi in BALB/C BMDMs. 
However, there was a dramatic decrease in the net intracellular survival of the ∆bimA mutant 
at 16 hpi compared to the WT strain. Almost no ∆bimA mutants were recovered at 16 and 24 
hpi (Figure 3.3). Reduced numbers of bacteria at later time points could result from cytotoxicity 
of the strains, which in turn would cause lysis of the infected cell, exposure of the intracellular 
bacteria to the kanamycin in the media and subsequent killing. The cellular cytotoxicity was 
assessed using a commercial Lactate-dehydrogenase(LDH)-release assay. LDH is a stable 
cytosolic enzyme that is released upon cell lysis into the surrounding medium. This enzyme 
converts its substrate lactate into pyruvate which results in the conversion of the tetrazolium 
salt iodonitrotetrazolium violet (INT) into a red formazan product, which can be measured at 
490nm using a spectrophotometer. The absorbance of the sample is proportional to the amount 
of LDH released and hence, the number of lysed cells. The data displayed in Figure 3.4 
indicates that the cytotoxicity measured in all samples was not significantly different compared 
to the uninfected control cells (<15%).  
       The infected BMDMs on the coverslip were then stained with anti-B. pseudomallei 
antibody and phalloidin to detect actin filaments.  Analysis of confocal images revealed that 
numerous intracellular WT B. pseudomallei formed actin tails at 8 hpi, and some had formed 
membrane protrusions at the cells periphery, consistent with previous observations in the 
immortalised cell lines HeLa (Stevens et al, 2005b), A549 (Sitthidet et al, 2011), J744.2 
(Sitthidet et al, 2011; Stevens et al, 2005b) and RAW264.3 (Burtnick et al, 2008). As expected, 
no actin tails were observed in cells infected with the ∆bimA mutant (Figure 3.5). Furthermore, 
the defect in actin-based motility of the ∆bimA mutant was partially restored by inducible 
expression of the native bimA allele in pME6032 at 24 hpi, but not at 16hpi, consistent with a 
role for the BimA protein in actin-based motility (Figure 3.3). The partial restoration of actin-
based motility is likely due to imperfect bimA expression on the inducible plasmid. This is a 
common issue with complementation of genetic defects in trans. Confocal microscopy 
demonstrated that the trans-complemented strain formed actin-tails of a similar morphology to 








Figure 3.4 Cytotoxicity level of uninfected (light green), infected BMDMs with WT (blue) and 
∆bimA mutant (orange). Bacterial cytotoxicity was determined from three independent experiments 
with triplicate measurements using a commercial LDH-release assay as described in Materials and 
Methods 2.8. Cytotoxicity was calculated by first subtracting the average absorbance values of the 
triplicates with the culture medium background control. These corrected values were then divided by 
the absorbance of maximum LDH release, followed by multiplication of 100% to give percentage of 
cytotoxicity. The maximum LDH release control was obtained by lysing the cells with Lysis solution 











Figure 3.5 Representative z-stack confocal images of BMDMs infected with B. pseudomallei WT, 
∆bimA mutant or the trans-complemented ∆bimA mutant strain under IPTG induction. BMDMs 
were seeded on coverslips and infected with bacterial strains at an MOI of 2 for 8 hpi before fixing and 
staining for confocal microscopy. Bacteria were stained red with mouse anti-B. pseudomallei LPS and 
anti-mouse Ig-Alexa 568. Filamentous actin was stained green with Alexa Fluor 488 Phalloidin. White 





3.2.3 The ∆bimA mutant strain displays no difference in bacterial uptake nor 
phagosomal escape compared to the WT strain  
 
        Before investigating the macrophage innate mechanisms involved in killing the 
intracellular ∆bimA mutant, it was important first to determine if the defect observed in 
intracellular survival of the ∆bimA mutant in BALB/C BMDMs was a result of differences in 
bacterial uptake or escape from the phagosome between the strains. Bacterial uptake or 
invasion of B. pseudomallei is normally assessed at 2 hpi using the kanamycin-protection assay. 
Figure 3.3 confirms that the ∆bimA mutant does not have any defect in uptake by BALB/C 
BMDMs, as the intracellular bacterial number at 2 hpi is comparable between the WT and 
∆bimA mutant strains.  
        In J77.4 murine macrophage-like cells, both WT strain 10276 and an insertion mutant 
(bimA::pDM4) were shown to escape into the cytosol, gaining access to this replicative niche 
at 3 hours post-infection (Stevens et al, 2005b). However these data were not analysed 
quantitatively. Here the ability of the ∆bimA mutant to escape the phagosome was determined 
using a chloroquine-protection assay as described by Marathe et al (2012) and Fernandez-Prada 
et al (2000). Chloroquine is a lysomotropic agent that enters the cell membrane at weak base 
state and becomes protonated within the acidic environment of the phagosome. Consequently, 
chloroquine becomes concentrated within the phagosomes and selectively kills the intracellular 
bacteria localised in the phagosomes, discriminating between the intracellular bacteria that are 
free in the cytoplasm which are not exposed to chloroquine. To assess the efficiency of the 
strains to escape the phagocytic compartment, infected BMDMs were either treated with 
kanamycin alone, or with both kanamycin and chloroquine. Kanamycin is used to kill 
extracellular bacteria, hence, CFU recovered from the infected cells lysed after kanamycin 
treatment without chloroquine represents the total number of intracellular bacteria that are 
localised in the phagosomes as well as within the cytoplasm. On the other hand, in the presence 
of both kanamycin and chloroquine treatment, the CFU recovered from the lysed macrophages 
represent only the cytoplasmic population of B. pseudomallei, since those within the 
phagosomes will have been killed by the chloroquine (Marathe et al, 2012; Fernandez-Prada 
et al, 2000). BMDMs were infected with WT, ∆bimA mutant or bsaZ::pDM4 (bsaZ) mutant 
strain at an MOI of 2 for 30 minutes. The bsaZ mutant strain is a Type III secretion system 
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(T3SS) mutant which has been described previously to be defective in phagosomal escape in 
immortalised macrophage-like cell lines  (Burtnick et al, 2008; Stevens et al, 2002) hence acts 
as a positive control for the assay. After 30 minutes of incubation, the media were aspirated 
and the BMDMs were washed with PBS before replacing with new media containing 250µg/ml 
kanamycin for another 3 hours. Then chloroquine (50μg/ml) was added to relevant wells and 
the cells incubated for a further 1.5 hours. The concentration of chloroquine used in this study 
was optimised so that it exerted minimal cytotoxic effect on the BMDMs (data not shown). 
Cells were lysed at 5hpi and viable bacteria enumerated.  In Figure 3.6, the percentage refers 
to the proportion of bacteria that were localised in the cytoplasm compared with the total 
number of bacteria localised both in phagosomes and cytoplasm (which was taken as 100%). 
No significant differences were observed in the recovery of WT and ∆bimA mutant bacteria in 
BALB/C macrophages, in the presence of kanamycin alone, or in the presence of both 
kanamycin and chloroquine. As expected, low numbers of bacteria were recovered from bsaZ 
infected BMDMs treated with both kanamycin and chloroquine, indicating that this is a robust 
assay for determining the ability of B. pseudomallei to escape from phagosomes into the 
cytoplasm of infected cells (Figure 3.6). It can therefore be concluded that the intracellular 
survival defect of the ∆bimA mutant in BMDMs is independent of uptake and macrophage 
phagosomal killing mechanisms. The findings here were consistent with previous observations 
by Stevens et al (2005b) in J774.2 cells. Using confocal microscopy, they observed that the 
intracellular bimA::pDM4 mutant bacteria did not significantly co-localise with the lysosome-
associated membrane glycoprotein-1 (LAMP-1), a marker for late endosomes/lysosomes. This 
suggests that the bimA::pDM4 mutant was able to escape from endosomes and gain access to 
the cytoplasm. While in the same experiment, bsaZ mutant bacteria were almost exclusively 






Figure 3.6 Proportion of cytoplasmic bacteria after 5 hours post infection. The bar chart shows the 
intracellular load of WT, ΔbimA mutant and T3SS bsaZ mutant in BALB/C BMDMs using a 
kanamycin-protection assay in the presence or absence of 50µg/ml chloroquine. The cells were infected 
at an MOI of 2 for 30 minutes. The media was then replaced with media containing kanamycin for a 
further 3 hours. Then, chloroquine was added in one set of samples while in the second set, cells were 
left with kanamycin alone, and incubated for a further 1.5 hours. Cells were lysed at 5 hours post 
infection. The percentage refers to the proportion of bacteria that were localised in the cytoplasm 
compared with the total number of bacteria localised both in phagosomes and cytoplasm. Data 
represents the mean bacterial recoveries (cfu + standard error per well of a 96-well plate) from four 
independent experiments with triplicate technical measurements. Statistical significance was 




3.2.4 Autophagy does not play a role in the clearance of the ∆bimA mutant in 
infected BMDMs 
 
       Autophagy is a tightly regulated host cell process of targeting unwanted molecules, 
damaged intracellular organelles and proteins to the degradation pathway. Autophagy is known 
to be involved in cell survival following nutrient deprivation, cell development and also tumour 
suppression (Mehrpour et al, 2010; Mizushima et al, 2010). Many studies have shown that 
autophagy is also important for controlling intracellular pathogens, being implicated as a key 
part of the cell-autonomous innate immune response (reviewed in Wileman, 2013). It has 
previously been demonstrated that B. pseudomallei induces autophagy in immortalised 
RAW264.7 macrophage-like cells at early stages of infection which can be further activated 
upon rapamycin treatment, an inducer of autophagy (Cullinane et al, 2008). Studies carried out 
by Cullinane and colleagues showed that B. pseudomallei is targeted in the phagosome through 
the non-canonical autophagy pathway known as LAP (LC3 associated phagosomes). LAP is a 
mechanism where LC3 molecules are recruited directly to the bacteria-containing phagosomes 
rather than sequestered in canonical double-membrane autophagosomes which can be observed 
by electron microscopy (Gong et al, 2011). B. pseudomallei has been shown to effectively 
evade autophagy upon escape from the phagosomal compartment (Gong et al, 2011). 
Phagosomal escape is dependent on a functional Bsa Type III secretion system (T3SS), mutants 
lacking the genes encoding the T3SS effector protein BopA or the translocator protein BipD, 
demonstrated a delay or lack of escape from phagosomes, with considerable co-localisation of 
the mutants with LC3 and reduced bacterial survival (Gong et al, 2011).  
     Gong et al (2011) reported that cytoplasmic WT B. pseudomallei was rarely taken up by 
canonical autophagosomes, however their experiments did not extend to time points later than 
6 hpi. Once in the cytoplasm, B. pseudomallei replicates, disseminates both inter- and 
intracellularly, processes mediated by the BimA protein and fusion of adjacent cells to form 
multinucleated giant cells (MNGC) in a Type 6 Secretion System -dependent manner. It is 
possible that autophagy plays a role in the detection and elimination of these cytosolic bacteria. 
Indeed the avoidance of autophagy has been observed in cases of other intracellular and 
cytosolic bacterial pathogens. For example, for Listeria monocytogenes, the bacterial factor 
required for actin-based motility ActA has been shown to mask autophagic recognition of the 
bacterium by recruiting host cellular proteins Arp2/3 and VASP proteins, which results in 
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camouflage of the bacterium from being targeted by this host defence mechanism (figure 3.7). 
We speculated that BimA mediates escape of cytoplasmic B. pseudomallei from autophagy in 
infected cells leading to the observed reduction in intracellular ∆bimA numbers at 16hpi in 
BALB/C BMDMs (Figure 3.3).  
 
 
Figure 3.7 Schematic diagram illustrating how autophagy acts as an innate mechanism against 
cytoplasmic bacteria. Autophagy involves different stages starting from vesicle nucleation (formation 
of the isolation membrane), vesicle elongation and completion to form a double-membrane 
autophagosome. A lysosome then fuses with the autophagosome to form the autophagolysosome. This 
step is followed by the lysis of the autophagolysosome inner membrane and bacterial degradation. 
Using a L. monocytogenes actA mutant as a bacterial model for infection, Yoshikawa et al (2009) 
demonstrated that when the L. monocytogenes actA mutant escapes from the phagosome and gains 
access to the cytoplasm, the bacterium is ubiquitinated and labelled with the autophagy adaptor p62, 
followed by LC3 molecules. This subsequently targets the bacterium for autophagosome docking and 
degradation, indicating autophagy as an innate mechanism to suppress the survival of intracellular 
bacteria (figure adapted from Yoshikawa, Y. et al (2009). Listeria monocytogenes ActA-mediated 
escape from autophagic recognition. Nature Cell Biology, 11(10), 1233–1240. Copyright © 2009 with 




        The contribution of the autophagic pathway in the elimination of the ∆bimA mutant strain 
in macrophages can be monitored by measuring LC3-II conversion during infection. Upon 
autophagic induction in response to bacterial infection, the cytosolic form of LC3 (LC3-I) is 
conjugated to a highly lipophilic phosphatidylethanolamine (PE) moiety to generate the 
autophagosomal-associated form (LC3-II). In short, LC3-II correlates well with the formation 
of autophagosomes. Due to the higher hydrophobicity of LC3-II, this molecule migrates more 
rapidly in SDS-PAGE than LC3-I. This can be assayed by Western blotting analysis of infected 
cell lysates with anti-LC3B antibodies. There are three isoforms of LC3 in mammalian cells; 
LC3A, LC3B and LC3C, but only LC3B correlates with increased autophagic vesicle 
formation (Barth et al, 2010). The fold change in LC3-II conversion (LC3-II/ total LC3) of 
each sample relative to uninfected or untreated cells at respective time points can be determined 
by quantitative densitometric analysis. We first investigated if autophagy can be further 
activated above its basal level by treating BMDMs with the autophagy inducer, rapamycin for 
2, 8 and 16 hours. Rapamycin was used at a concentration of 4µM, similar to previous studies 
by Cullinane et al (2008). The solvent Dimethyl sulfoxide (DMSO) was included as a vehicle 
control in this experiment. In the presence of rapamycin, autophagy could be stimulated up to 
1.6 fold and 1.5 fold over basal levels in the untreated BMDMs at 2 hours and 8 hours 
respectively (figure 3.8). The slight decrease in LC3-II conversion over time could be explained 
by the balance of LC3-II formation and degradation, where LC3-II degradation is more rapid 
than its formation when cells were treated pharmacologically with rapamycin (Barth et al, 
2010; Mizushima et al, 2010; Mizushima & Yoshimori, 2007).  
        To determine whether autophagy is involved in the detection and elimination of the ∆bimA 
mutant, BMDMs were infected with B. pseudomallei WT or the ∆bimA mutant at an MOI of 2 
at 2 hpi, 8 hpi and 16 hpi in a kanamycin-protection manner as described previously. 
Uninfected BMDMs were also included as a control for basal levels of autophagy. At the 
indicated times post infection, BMDMs were lysed and subjected to SDS-PAGE and Western 
blotting as described in Section 2.10. Analysis of LC3-II conversion showed that there was no 
significant difference in the ratio of LC3-II: total LC3 signal among the non-infected BMDMs 
and BMDMs infected with WT and ∆bimA mutant at all time points (Figure 3.9). This suggests 
that autophagy is not involved in targeting B. pseudomallei, either WT or ∆bimA mutant strains, 
at any of the time points tested. Although Cullinane et al (2008) described that there was about 
a 2-fold increase in LC3 conversion upon infection with B. pseudomallei at 2hpi in 
immortalised RAW264.7 macrophage-like cells, we were unable to show that autophagy was 
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differentially activated in BMDMs infected either with WT or ∆bimA strains compared to 
uninfected cells. This may due to the differences in cell types and B. pseudomallei strains used 
for the studies.  
        Next, confocal microscopy was used to observe if there is any significant co-localisation 
of LC3 molecules with the ∆bimA mutant. Confocal microscopy confirmed that neither WT 
nor bacteria lacking bimA showed co-localisation with LC3 molecules (Figure 3.10). This 
confocal analysis corresponds to the immunoblot analysis in Figure 3.9, indicating that host 
autophagy is not differentially activated in cells infected with the ∆bimA mutant compared to 






Figure 3.8 Immunoblot analysis of LC3 conversion in BMDMs treated with the autophagy 
inducer rapamycin. BMDMs were seeded at 5 x 105 per well in a 24-well plate. BMDMs were treated 
with 4µM of rapamycin or the control DMSO for 2, 8 and 16 hours before being lysed and proceeded 
for Western Blot as described in Materials and Methods 2.10. (A) Mean densitometric measurements 
of LC3-II conversion as compared to DMSO control from four independent experiments and the error 
bars represent the standard error. Significance was assessed using an unpaired Student’s t-test, where * 
= p<0.05. (b) A representative immunoblot where the LC3-I (cytosolic) and LC3-II (lipid conjugated) 






Figure 3.9 Immunoblot analysis of LC3 conversion in cell lysates from uninfected BMDMs (UN) 
and cells infected either with B. pseudomallei WT and ∆bimA mutant. (a) The mean densitometric 
measurements of the LC3-II conversion as compared to uninfected control from four independent 
experiments and the error bars represent the standard error. Statistical analysis was performed using an 
unpaired Student’s t-test of two groups; infected with either B. pseudomallei WT or ∆bimA mutant, 
compared to the uninfected control cells at respective time points. (b) A representative immunoblot 
where the LC3-I (cytosolic) and LC3-II (lipid conjugated) forms were detected with a monoclonal 








Figure 3.10 LC3 co-localisation analysis of BMDMs infected with B. pseudomallei WT or ΔbimA 
mutant bacteria. BMDMs were seeded on coverslips at 5 x 105 cells per well before infected with WT 
or ΔbimA mutant bacteria at an MOI of 2 in a kanamycin protection manner as described in Materials 
and Methods 2.6. BMDMs infected with WT or ΔbimA mutant bacteria were incubated for the indicated 
times before fixing and staining for confocal microscopy. Bacteria were stained red with mouse anti-B. 
pseudomallei LPS and anti-mouse Ig-Alexa 568 antibodies. LC3 molecules were stained green with 
rabbit anti-LC3B and anti-rabbit Ig-Alexa Fluor 488. Large green dots as indicated by arrows are 




        To further investigate the role of autophagy-related processes in the clearance of the 
∆bimA mutant in infected cells, we next carried out confocal microscopy to explore the 
ubiquitination of cytoplasmic bacteria as shown in Figure 3.7. It has recently been recognised 
that ubiquitination provides a signal for the autophagic targeting of bacteria for degradation. 
We stained the infected BMDMs with the FK2 monoclonal antibody, which has affinity for 
both mono- and poly-ubiquitinated proteins tagged regardless of ubiquitin linkage location, but 
does not react with free ubiquitin (Fujimuro et al, 1994). Interestingly, the cytosol-adapted 
pathogen L. monocytogenes has been shown previously to avoid recognition by the ubiquitin 
system by moving rapidly in the cytosol of host cells via actin-based motility (Yoshikawa et 
al, 2009; Perrin et al, 2004). These studies demonstrated that the ∆actA mutant showed 
extensive co-localisation with ubiquitin moieties compared to the WT bacteria (Yoshikawa et 
al, 2009; Perrin et al, 2004). However, in our confocal analysis, we observed a strong signal 
for ubiquitin that co-localised with the bacterial surface of the majority of both WT and ∆bimA 
mutant bacteria at 8 hpi and 16 hpi (Figure 3.11), with no obvious differences between strains 
or time points. This suggests that ubiquitination, which is part of the cellular innate surveillance 
system, however, does not specifically target the bacteria that are unable to undergo actin-based 
motility.  
          We then investigated if p62 (also known as sequestome 1, SQSTM1) molecules interact 
with these poly-ubiquitinated bacteria. p62 is an autophagy adaptor protein which has two 
domains; an ubiquitin-binding domain and an LC3-binding domain. In general, p62 interacts 
with poly-ubiquitinated protein aggregates through its ubiquitin-binding domain (UBA), 
targeting these aggregates for autophagy degradation through its LC3 binding domain (LIR). 
p62 has been shown to be involved in targeting ubiquitinated bacteria for autophagy (Zheng et 
al, 2009). Hence, if the bacteria are targeted for autophagy, we would observe co-localisation 
of p62 molecules with bacteria as demonstrated in Yoshikawa et al (2009) and Zheng et al 
(2009). However, neither WT nor ∆bimA mutant showed significant co-localisation with p62 
by confocal microscopy analysis (Figure 3.12).   
        The experiments described in this chapter have included LC3-conversion assays, LC3-
bacteria and p62-bacteria co-localisation studies, none of which explained the intracellular 
survival defect of the ∆bimA mutant. Hence, we hypothesise that actin-based motility mediates 





Figure 3.11 Ubiquitin co-localisation analysis of BALB/C BMDMs infected with the WT or ΔbimA 
mutant. BMDMs were seeded on coverslips at 5 x 105 cells per well before infected with WT or ΔbimA 
mutant bacteria at an MOI of 2 in a kanamycin protection manner as described in Materials and Methods 
2.6.  BMDMs infected with WT or ΔbimA mutant bacteria were incubated for the indicated times before 
fixing and staining for confocal microscopy. Bacteria were stained red with rabbit anti-B. pseudomallei 
LPS and anti-rabbit Ig-Alexa 568 antibodies. While Ub molecules were stained green with rabbit anti-









Figure 3.12 p62 co-localisation analysis of BALB/C BMDMs infected with the WT or ΔbimA 
mutant bacteria. BMDMs were seeded on coverslips at 5 x 105 cells per well before infected with WT 
or ΔbimA mutant bacteria at an MOI of 2 in a kanamycin protection manner as described in Materials 
and Methods 2.6. BALB/C BMDMs infected with WT or ΔbimA mutant bacteria were incubated for 
the indicated times before fixing and staining for confocal microscopy. Bacteria were stained red with 
mouse anti-B. pseudomallei LPS and anti-mouse Ig-Alexa 568 antibodies. p62 molecules were stained 
green with rabbit anti-LC3B and anti-rabbit Ig-Alexa Fluor 488. Scale bar = 10μm. 
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3.3 DISCUSSION  
 
        Infection with Burkholderia pseudomallei has a high mortality of up to 40% in endemic 
areas such as Thailand. To elucidate how the bacterium evades host defences, it is important to 
understand the pathogenesis in host macrophages, as they represent a first line of defence 
against many infectious agents.   Intracellular bacteria such as Listeria monocytogenes, Shigella 
flexneri and Burkholderia pseudomallei have evolved to escape from the harsh environment of 
phagosomes and enter the nutrition-rich cytosol as a niche for replication. In the cytoplasm, 
they are continuously being exposed to multiple host innate mechanisms to restrict their 
intracellular survival. By moving from cell to cell by actin-based motility, L. monocytogenes, 
S. flexneri and B. pseudomallei escape from such host innate responses to continue to replicate 
and survive. In our in vitro system using murine bone marrow derived macrophages (BMDMs), 
a B. pseudomallei ΔbimA mutant which is unable to undergo actin-based motility showed a 
marked decrease in intracellular survival compared the WT strain, suggesting that cellular 
innate responses play a critical role in control of the cytoplasmic B. pseudomallei that lack the 
ability to undergo actin-based motility. This is in line with in vivo studies that have previously 
been conducted in our laboratory, where bimA mutant strains exhibit attenuation in both murine 
(unpublished data; Stevens, J.M. and Bancroft, G.) (Figure 5.5) and Galleria mellonella models 
of melioidosis (unpublished data, Stevens J.M.). BMDMs seem to be better able to control the 
intracellular survival of B. pseudomallei when compared to the immortalised murine 
macrophage-like RAW264.7 cells (Varintip Srinon, manuscript in preparation). Infection of 
RAW264.7 cells with either the WT or ∆bimA mutant strains resulted in identical patterns of 
replication and survival over time with no significant levels of killing (Varintip Srinon, 
manuscript in preparation), indicating that BMDMs are more relevant for the studies described 
in this thesis. This is perhaps predictable as selective pressure imposed by continual subculture 
of immortalised cells, usually results in the loss of genes that are not essential for multiplication 
but are key for macrophage immune functions. Chamberlain et al (2008) have demonstrated 
that murine BMDMs cells exhibit significantly higher expression of some inflammatory 
cytokines for example TNF-α, IL-6, IL-12 and MCP-1 compared to RAW264.7 cells in 
response to LPS stimulation. Our in vitro system using resting, non-primed/non-activated 
murine BALB/C BMDMs cells show that both WT and the ∆bimA mutant strains are capable 
of escaping from the phagosomes, and that the WT strain is capable of forming actin-tails as 
observed by confocal microscopy.  
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        Antibacterial autophagy (xenophagy) is appreciated as a cell-autonomous immune 
response to invading intracellular bacteria namely Salmonella (Zheng et al, 2009), Shigella 
(Dupont et al, 2009) and Listeria (Yoshikawa et al, 2009). Upon invasion, some bacteria 
actively modify their vacuolar compartments to prevent autophagosomal fusion, while others 
escape into the cytosol for replication. Host autophagy is highly dynamic and can target 
pathogens at any intracellular stage, either when they are residing in the vacuolar compartment 
or within the cytosol. In RAW264.7 macrophage-like cells, LC3 was shown to be recruited 
directly to the bacteria localised in a single-membrane phagosome at early time point, a process 
termed LC3-associated phagocytosis (LAP), resulting in decreased intracellular survival of B. 
pseudomallei (Gong et al, 2011). This LAP formation is distinct from the double-membrane 
canonical autophagosomes observed during clearance of organelles or proteins, or elimination 
of other bacterial species. This recruitment of LC3 molecules to phagosomal B. pseudomallei 
has also been observed in primary human neutrophils, but through novel membranous 
structures composed of partial  phagosome-like single membranes and partial elongated 
membranes (Rinchai et al, 2015). Both studies by Rinchai et al (2015) and Gong et al (2011) 
have determined that cytoplasmic B. pseudomallei is rarely sequestered in double-membrane 
canonical autophagosomes as observed by transmission electron microscope (TEM). This 
suggests that B. pseudomallei actively evades the autophagic innate immune response once the 
bacterium has successfully escaped from the phagosome, a process mediated by the Bsa Type 
III secretion system  (Rinchai et al, 2015; Gong et al, 2011; Cullinane et al, 2008). Once B. 
pseudomallei enters the cytoplasm, B. pseudomallei forms actin tails in a BimA-dependent 
manner to propel itself to the neighbouring cell (Stevens et al, 2005) and also to escape from 
the host innate immune responses in order to survive.  Hence, this is the first report 
investigating if the ΔbimA mutant is being targeted by autophagy in primary murine BMDMs. 
It has been shown that WT B. pseudomallei can form actin tails in infected BMDMs (Figure 
3.5), unlike in B. pseudomallei-infected primary human neutrophils (Rinchai et al, 2015). On 
the other hand, the ΔbimA mutant strain did not form actin tails at all, but the phenotype was 
restored in the complemented strain (Figure 3.5). 
        In BALB/C BMDMs, the intracellular survival of the B. pseudomallei ∆bimA mutant was 
significantly impaired at 16 hpi when compared to the WT strain.   However, both an LC3-
conversion assay and LC3-co-localisation studies could not demonstrate a specific role for 
autophagy in this defect in intracellular survival. Notably, the low infection rate in BMDMs 
may limit the experimental power to investigate the autophagy pathway upon infection. 
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Approximately, 500 CFU was produced per 1 x 105 BMDMs (which accounts <0.5% of the 
BMDMs were infected) in the kanamycin protection assay whereas in the immortalised cell 
line RAW264.7, B. pseudomallei WT produced up to 106 CFU per 1 x105 BMDMs at 16 hpi 
using the same MOI (data not shown). Furthermore, in contrast to the RAW264.7 cells, there 
was no replication of intracellular B. pseudomallei over time in infected BMDMs (data not 
shown). Very few MNGC were formed  in B. pseudomallei WT infected BMDMs at late times 
post-infection (16hpi) with less than 5  nuclei per MNGC,  unlike infected RAW264.7 cells 
where the majority formed MNGC with tens of  nuclei, as observed under the confocal 
microscopy (data not shown). As cell lines may not adequately represent primary cells as 
discussed above, differences in the ability to control intracellular bacterial survival and MNGC 
formation are perhaps predictable.  
        In several studies of autophagy, it is common to include drugs such as rapamycin or 3-
methyladenine (3MA) to pharmacologically induce or inhibit autophagy activity respectively. 
For example, Rinchai et al (2015) successfully demonstrated that survival of B. pseudomallei 
in human neutrophils was greatly enhanced in 3MA-treated cells. While Cullinane et al (2008) 
reported that rapamycin stimulation of autophagy in RAW264.7 and murine embryonic 
fibroblast (MEF) cell lines resulted in increased co-localisation of B. pseudomallei with LC3, 
and subsequently reduced intracellular survival of the bacteria.  Application of these drugs in 
our experimental conditions would only be essential and worthwhile if there is clear evidence 
showing that autophagy does play a role in controlling bacterial intracellular survival.  
        Interestingly, although we did not observe co-localisation of B. pseudomallei WT and 
∆bimA mutant strains with LC3, we identified that both strains were ubiquitinated once they 
enter the cytoplasm. Although Yoshikawa et al (2009) and Perrin et al (2004) reported that L. 
monocytogenes evades host ubiquitin system via actin-based motility, in our analysis we found 
no evidence to suggest that B. pseudomallei avoids such recognition in the same manner. Based 
on our preliminary observation by confocal microscopy, we identified a similar level of co-
localisation of ubiquitin with both WT and ∆bimA mutant strains in the cytosol. However, these 
studies need to be repeated over a time course and the data quantified. Ubiquitin has the ability 
to interact subsequently with several ubiquitin-binding proteins namely p62/SQSTM1, 
NDP52/CALCOCO2, NBR1 and optinuerin that facilitate ubiquitinated cargo engulfment by 
autophagosomes or degradation through the proteasomal pathway (Kraft et al, 2010). Several 
studies have reported that p62 is involved in targeting the polyubiqitinated bacteria to the 
autophagy pathway (Zheng et al, 2009; Yoshikawa et al, 2009). In L. monocytogenes, Perrin 
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et al (2004) demonstrated that the ∆actA mutant strain, lacking the ability to form actin-tails, 
co-localised extensively with ubiquitin molecules and Yoshikawa et al (2009) further 
demonstrated this mutant strain co-localised significantly with p62 molecules in the cytosol 
when compared to the WT strain. These together target the ∆actA mutant to the autophagic 
degradation machinery for destruction. However, our confocal microscopy analysis does not 
show any co-localisation of p62 molecules with either the B. pseudomallei WT or ∆bimA 
mutant strains. This suggests that although B. pseudomallei is ubiquitinated, the ubiquitin 
labelling does not target B. pseudomallei (neither WT strain nor ∆bimA mutant) for autophagy 
via p62/LC3. Alternatively, the ubiquitination of B. pseudomallei might direct the bacteria for 
degradation in proteasomes which has not been investigated in this chapter. This ubiquitin-
proteosomal degradation can be investigated in future by observing the colocalisation of 
ubiquitin-coated B. pseudomallei with proteasome-associated molecules by confocal 
microscopy. In addition to p62 adaptor molecules, other adaptor proteins such as 
NDP52/CALCOCO2, NBR1 and optinuerin have not yet been investigated.   
        In contrast with our findings on the co-localisation of ubiquitin with B. pseudomallei 
10276 (both WT and ∆bimA mutant), Pumirat et al (2014) and Tan et al (2010) reported low 
levels of Ubiquitin-bacteria co-localisation for B. pseudomallei strain K96243. This could be 
explained by the fact that different bacterial strains may express a different repertoire of 
virulence protein(s) to manipulate various host innate mechanisms. For example, B. 
pseudomallei K96243 expresses CHBP (cycle inhibiting factor), a bacterial protein that inhibits 
Ub ligase-catalysed Ub-chain synthesis by specifically deamidating Gln40 of ubiquitin 
(Pumirat et al, 2014). In addition, Boh et al (2011) demonstrated that CHBP may interfere with 
the interaction of ubiquitin with p62 molecules. However, the strain used in these studies (B. 
pseudomallei 10276) does not encode this effector protein (Pumirat et al, 2014). Tan et al 
(2010) have characterised another bacterial virulence protein involved in manipulating host 
ubiquitination-related pathways, TssM. The T6SS TssM effector protein possesses 
deubiquitinase activity which removes ubiquitin from proteins attached to the bacterial surface. 
Although polyubiquitin-labelled bacteria may be targeted by autophagy for destruction, there 
is no clear evidence yet to show that such ubiquitin manipulations by B. pseudomallei are 
relevant for autophagy evasion (reviewed in Allwood et al, 2011).  In summary, the mechanism 
by which B. pseudomallei evades host autophagy remains to be defined. 
     In addition to recruitment of ubiquitin, p62, and LC3 molecules to cytoplasmic bacteria to 
target them for autophagy, Mostowy et al (2011) identified a novel septin-caging mechanism 
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that entraps cytosolic bacteria for autophagy destruction.  Septins have been demonstrated to 
play a crucial role in the control of cytosolic Shigella flexneri. Septins are conserved GTP-
binding and filament-forming proteins which are essential for cell division, cytoskeletal 
dynamics, vesicle trafficking and membrane remodelling (Hall & Russell, 2004). Septins are 
cytoskeletal components associating with cellular membranes, actin filaments and 
microtubules to form filaments. In epithelial cells infected with Shigella flexneri, septins are 
recruited around the bacterial bodies, and compartmentalise the bacteria within cage-like 
structures (Mostowy et al, 2010). This septin-caging entraps the cytosolic bacteria for 
destruction by autophagy, and hence prevents bacterial dissemination. SEPT2 and its binding 
partner SEPT9 were shown to be responsible for the septin ring assembly. Depletion of SEPT2 
and SEPT9 resulted in significantly fewer cages and more actin tail formation by Shigella.  To 
our knowledge, the role of septins in controlling cytosolic B. pseudomallei has not been 
investigated so far and it would be interesting to study in future. Interestingly, these cage-like 
structures have also been observed to compartmentalise Shigella icsA mutant bacteria which 
are defective in actin-based motility (Mostowy et al, 2010), leading us to predict that septin-
caging might entrap the B. pseudomallei ∆bimA mutant.   Hence, it would be interesting to 
investigate the co-localisation of septin proteins with B. pseudomallei WT and ∆bimA strains, 
and determine if such co-localisation is more prominent for the ∆bimA mutant. If there is a 
clear evidence showing that ∆bimA mutant significantly compartmentalises with septins, it 
would be desirable to knock down the appropriate septin gene(s) by siRNA and determine if 
the intracellular survival of the mutant could be restored.  
        In addition to the mechanisms of septin caging and autophagy, bacteria that successfully 
escape from vacuoles or phagosomes can be sensed by the innate sensors galectins. Galectins 
are evolutionary conserved β-galactoside-binding lectins implicated in inflammatory responses 
as well as in cell adhesion (Di Lella et al, 2011). Galectins are abundant in innate immune cells 
and epithelial cells, and an increase in galectin expression may be associated with their roles 
in host-pathogen interactions. Galectin-3 and galectin-8 are among the ones that are commonly 
associated with modulating the host immune response.  For example, in vivo studies using mice 
reported heightened galectin-3 expression in the lungs of animals infected with Francisella 
novida (Mishra et al, 2013) and Streptococcus pneumoniae (Sato et al, 2002). Galectins can 
sense various bacterial molecular components such as glycans on the capsule polysaccharide 
of Streptococcus pneumonia, or LPS from Klebsiella pneumonia and Escherichia coli 
(reviewed in Chen et al, 2014). Binding of galectins to the bacteria can have bacteriostatic or 
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bactericidal effects. In relation to autophagy, galectin-8 was shown to be recruited to vacuoles 
containing Salmonella Typhimurium, interacting directly with NDP52 to target the bacteria for 
autophagy (Thurston et al, 2012). To our knowledge, the role of galectins in B. pseudomallei 
intracellular survival have not been reported so far. Therefore, it would be of interest in future 
to knock down the appropriate galectin gene(s) by siRNA and determine if the intracellular 
survival of the mutant could be restored. As ubiquitin, septin caging and certain galectins are 
crucial for cell-autonomous immunity mechanisms, elucidating their role in detection and 





4 CHAPTER 4: INVESTIGATING THE CONTRIBUTION OF MyD88- AND TRIF-
DEPENDENT PATHWAYS, AND INFLAMMASOME ACTIVATION, IN 
CONTROLLING THE INTRACELLULAR FATE OF BURKHOLDERIA PSEUDOMALLEI  
 
4.1 INTRODUCTION  
 
        The innate immune system plays a critical role in the early recognition of invading 
pathogens and subsequently activating the pro-inflammatory response against the pathogen. 
Activation of innate immune cells begins with the recognition of highly conserved microbial 
structures, termed pathogen-associated molecular patterns (PAMPs) or host derived molecules 
that signal the presence of tissue injury known as damage-associated molecular patterns 
(DAMPs), by a limited set of germline-encoded pattern recognition receptors (PRRs). Some 
PRRs such as TLRs (Toll-like receptors) are located on the cell surface or in endosomes, and 
some such as NLRs (nucleotide-binding oligomerisation domain-like receptors), RLRs 
(retinoic-acid inducible gene I-like receptors) and CLRs (C-type lectin-binding domain 
receptors) are present in the cytoplasm of innate immune cells (reviewed in Kawai & Akira, 
2011). Upon PAMP recognition, PRRs relay the signal to the host cell and activate a multitude 
of intracellular signalling transduction pathways, including adaptor molecules, kinases and 
transcription factors. These ultimately switch-on gene expression and synthesis of different 
cytokines, chemokines, cell adhesion molecules and immunoreceptors that contribute to the 
innate host response to infection, and also links to the adaptive immune response (reviewed in 
Kawai & Akira, 2011).  
        Among PRRs, TLRs have been studied most extensively in melioidosis both in vitro and 
in vivo. Three TLRs namely TLR2, TLR4 and TLR5 have been implicated in the recognition 
of Burkholderia pseudomallei ( West et al. 2013; West et al, 2012; West et al, 2008; Wiersinga 
et al, 2007).  TLR2 is a receptor involved in the recognition of bacterial peptidoglycans, 
lipoteichoic acid and lipoproteins, while TLR4 and TLR5 are receptors for bacterial LPS and 
flagellin respectively. Upon ligand binding to TLRs, MyD88 (Myeloid differentiation primary 
response gene 88) adaptor-protein is recruited to activated TLRs, except TLR3 and certain 
TLR4s. The downstream cascade results in the activation of the MAPK and NF-κB pathways 
leading to the production of many cytokines and chemokines, and is known as the MyD88-
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dependent pathway (reviewed in O’Neill & Bowie, 2007). Another major pathway emanating 
from TLRs depends on TIR-domain containing adaptor-inducing IFNβ protein (TRIF). This is 
known as the TRIF-dependent or MyD88-independent pathway which appears to be 
specifically induced by TLR3 and some TLR4. The downstream signalling mediates 
recruitment of IFN regulatory factors (IRF) transcription factor such as IRF3 and IRF7 to the 
nucleus, which induces expression of Type I IFN including IFNβ. The TRIF-dependent 
signalling pathway also mediates NF-κB and MAPK signalling pathways similar to the 
MyD88-dependent pathway, but with delayed kinetics (reviewed in O’Neill & Bowie, 2007).  
        Cooperation and cross-talk between innate immune receptors are common in 
macrophages which facilitate a tailored and optimal host response to a pathogen. An example 
of such cooperation is the synthesis and secretion of mature IL-1β. IL-1β mRNA expression is 
driven downstream of TLR-activation, but the release of pro-inflammatory IL-1β depends on 
the activation of caspase-1, which is regulated by an NLR-containing complex, known as the 
canonical inflammasome (reviewed in Netea et al, 2010). Hence, secretion of the mature IL-
1β requires signals from different PRRs, one from the TLR system and one from the NLR 
system. In addition to this canonical inflammasome, there are several reports describing the 
involvement of a non-canonical inflammasome pathway during the immune response to Gram-
negative bacteria  (Oficjalska et al, 2015; Aachoui et al, 2013; Case et al, 2013; Gurung et al, 
2012; Rathinam et al, 2012). Instead of caspase-1 activation, this non-canonical inflammasome 
is dependent on the activation of murine caspase-11 (a homologue of caspase 4 and caspase 5 
in humans). Caspase-11 is a caspase-1-like inflammatory protease which upon activation, leads 
to the maturation of IL-1α and secretion of the danger signal high-mobility group box 1 
(HMGB1). This pathway is initiated specifically by TLR4 via the TRIF-dependent signalling 
pathway.  TLR4 senses cytosolic LPS and activation of the TRIF-cascade leads to expression 
of more Type I IFN commonly IFNβ. Whether the activation of the Type I IFN signalling 
pathway induces pro-caspase-11 expression, in which the expression itself is sufficient for 
caspase-11 autoactivation (Rathinam et al, 2012), or requires an additional as yet unknown 
bacterial signal (Broz et al, 2012), still remains in controversy. Last but not least, activation of 
caspase-1 and caspase-11 lead to pyroptotic cell death, an efficient strategy to limit bacterial 
replication and hence, intracellular survival of pathogens (Aachoui et al, 2013;  Breitbach et al, 
2009; Cervantes et al, 2008; Raupach et al, 2006).  
        In this study, we evaluated the contribution of MyD88- and TRIF- dependent signalling 
in controlling the intracellular fate of B. pseudomallei in BALB/C BMDMs. Despite the 
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importance of macrophages as innate immune cells, B. pseudomallei manipulates macrophages 
as a vehicle for bacterial dissemination and forms multi-nucleated giant cells (MNGC) 
(Kespichayawattana et al, 2000). B. pseudomallei uses actin-based motility to move intra- and 
intercellularly (Stevens et al, 2005), therefore evading recognition by macrophage cell-
autonomous pathways and survives intracellularly. We observed an impaired survival of the 
ΔbimA mutant previously at 16 hpi, a mutant that is unable to establish actin-based motility. 
We would like to investigate if the impaired survival of the ΔbimA mutant at 16 hpi in BALB/C 
BMDMs could be mediated by the MyD88- or TRIF-signalling pathways. If one of these 
pathways is involved, inhibiting the pathway would restore the bacterial intracellular survival. 
To address this question, we utilised a gene silencing technique using short interfering RNAs 
(siRNAs) to knockdown the MyD88 transcripts, and in a separate experiment using MyD88- 
or TRIF-blocking peptides. Then we assayed the intracellular survival of B. pseudomallei WT 
and ΔbimA mutant strain as described previously.   
        Activation of a TLR signaling cascade leads to the downstream activation of canonical 
and non-canonical inflammasome pathways which are both essential for host innate immunity 
against B. pseudomallei (Bast et al, 2014; Aachoui et al, 2013; Breitbach et al, 2009). We 
investigated the maturation of caspase-1 and caspase-11 by Western blot. In addition, secretion 
of the proinflammatory cytokines IL-1α and IL-1β into the supernatant of infected 
macrophages were measured by enzyme-linked immunosorbent assay (ELISA). This thesis 
chapter aims to gain more insight into the role of MyD88- and TRIF-dependent signalling, as 
well as the inflammasomes, in BALB/C BMDMs during infection with B. pseudomallei WT 
and the ∆bimA mutant. The specific aims of the work described in this chapter are:  
1) To assess macrophage activation by measuring TNF-α secretion  
2) To identify other cytokines/chemokines expressed in B. pseudomallei-infected 
BMDMs  using a Profiler Mouse Cytokine Array 
3) To investigate if MyD88- or TRIF- dependent signalling pathway affect the 
intracellular survival of B. pseudomallei WT and ∆bimA strains in BMDMs 
4) To investigate activation of the canonical and non-canonical inflammasomes upon 





4.2.1 BALB/C macrophages are activated upon infection with B. pseudomallei, as 
indicated by TNF-α secretion  
  
        Macrophages are major producers of pro-inflammatory cytokines such as TNFα. TNFα 
has been shown to play a central role in regulating the cytokine cascade in many inflammatory 
disease states and is therefore regarded as a ‘master regulator’ of inflammatory cytokine 
production (reviewed in Parameswaran & Patial, 2010). Here we measured the secretion of 
TNFα to indicate the activation of macrophages upon infection with B. pseudomallei.  BMDMs 
were infected at an MOI of 2 with two different strains, the WT and the ΔbimA mutant at three 
different time points (2 hpi, 8 hpi and 16 hpi). TNFα secretion into the supernatant of the 
infected cells was measured by ELISA, and data from three independent experiments (each 
with duplicate technical replicates) plotted (Figure 4.1). At 2 hpi, secretion of TNFα was below 
the detection limit of the assay for all samples, suggesting a delay in macrophage activation.  
The TNFα concentration increased significantly at 8 hpi and 16 hpi in BMDMs infected with 
either WT or ΔbimA strain when compared to the uninfected control cells. At 8 hpi, BMDMs 
infected with the WT strain secreted about 115pg/ml of TNFα, a similar level to that observed 
at 16hpi (~111pg/ml). While in BMDM cells infected with the ΔbimA strain, the TNFα 
secretion at 8hpi was about 85pg/ml, and slightly decreased to 64pg/ml at 16 hpi. The observed 
delay in macrophage activation could be due to the absence of a priming agent such as IFNγ in 
our cell system. Pre-activation of macrophages with IFNγ would prevent the bacteria from 
escaping the phagosome and enter the cytosol as shown by Utaisincharoen et al, (2004) and 
Myers et al (2003). On the other hand, quiescent/resting macrophages ensures the survival of 
intracellular bacteria via rapid phagosomal escape followed by replication in the cytosol (Tsang 
et al, 2000). Therefore our in vitro system, where we do not use a priming agent, is more 
suitable for studies with the purpose of investigating innate mechanism/s involved in detection 
and clearance of cytosolic B. pseudomallei. 
        TNFα secretion in response to infection of BMDMs with WT B. pseudomallei was much 
less than the levels of TNFα secreted in response to E.coli LPS (500ng/ml), which produced 
about 587pg/ml of TNFα after 8 hours of stimulation (~5-fold higher)(Figure 4.1). It has been 
100 
 
suggested previously that the relatively weaker level of macrophage activation by B. 
pseudomallei may be correlated with its unique LPS structure, which is significantly different 









Figure 4.1 Secretion of the inflammatory cytokine TNF-α by infected BMDMs. BMDMs were 
seeded at 1 x 105 cells per well in 96-well plate, followed by infection with B. pseudomallei WT (blue) 
or the ∆bimA mutant (orange) at 2, 8 and 16 hpi. The concentration of TNFα (pg/ml) in the supernatant 
of uninfected BMDMs (beige) or infected BMDMs were then calculated at the indicated time points by 
ELISA as shown in Materials and Methods 2.11.The bar chart represents the mean + SE from three 
independent experiments. The statistical analysis was done using a Student’s t-test between two groups 




4.2.2 Several other B. pseudomallei-induced cytokines and chemokines can be 
detected in infected BMDM lysates using the Profiler Mouse Cytokine Array 
 
        Besides TNF- α, we were also interested in identifying other cytokines or chemokines 
produced in B. pseudomallei-infected BALB/C BMDMs, and to assess if their production is 
distinct in cells infected with the B. pseudomallei WT strain from those infected with the ΔbimA 
mutant strain at 8 hpi and 16 hpi. The high-throughput Mouse Cytokine Array (Panel A) can 
detect 40 cytokines and chemokines in a single array. This was utilised as an initial screen to 
identify any candidate differentially expressed molecules, which would later be validated on 
multiple samples using an alternative cost-effective assay, for example an ELISA. BMDMs 
were infected with B. pseudomallei WT or the ∆bimA strain as described in section 2.6 for 8 
hpi and 16 hpi. For the positive control, BMDMs were stimulated with E. coli LPS for 8 hours. 
Uninfected BMDMs at respective time points served as a baseline for concentration fold-
change calculations. At respective time points, cells were lysed in 1% Triton X-100 in PBS for 
5 minutes. The cell lysates were mixed with a cocktail of biotinylated detection antibodies 
followed by incubation with the array, which is spotted in duplicate with capture antibodies to 
specific target proteins. The array was then incubated with IRDye 800CW Streptavidin and 
scanned using a LI-COR Odyssey Infrared Imaging System. After scanning, the spot intensities 
were quantified using Image Studio software (Figure 4.2 and Figure 4.3). The intensity of each 
spot is proportional to the amount of analyte bound.  
         We included BMDMs incubated with 500ng/ml LPS for 8 hours as a positive control to 
ensure that the BMDMs were competent and produced cytokines/chemokines in response to 
LPS. LPS is a ligand for TLR4 and can stimulate both MyD88- and TRIF-dependent pathways 
(reviewed in Takeda & Akira, 2004). In comparison with the uninfected cells 8 hpi, it is clear 
that the expression of many cytokines and chemokines increased in response to LPS treatment 
(Figure 4.2). The elevated cytokines include TNF-α, IFNγ, IL-1α, IL-1β, IL-2, IL-6, IL-10, IL-
17, IL-23, of which all are pro-inflammatory except the anti-inflammatory cytokine IL-10. 
While the increased chemokines included CXCL10, CXCL1, CCL2, CCL12, CCL4, CXCL2, 
RANTES/CCL5. Some spots did not appear on the array of the samples from the uninfected 
cells, but appeared at high intensity for this positive control array.  
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      At 8 hpi infection, BMDMs infected with either the B. pseudomallei WT or ΔbimA mutant 
strains displayed a slightly increased production of IL-1α, IL-1β, CXCL10, CXCL11, CXCL2 
and TNFα with a fold-change exceeding 1.5, but less than 2.6. BMDMs infected with the WT 
strain demonstrated an increase in IL-12p70 and IL-13 proinflammatory cytokines, but these 
were not increased in cells infected with the ΔbimA mutant. While at 16hpi infection, pro-
inflammatory cytokines IL-1α and IL-1β, and the chemokine CXCL12 were induced upon 
infection, both with B. pseudomallei WT and the ΔbimA mutant (<5.0 fold change). 
Furthermore, there were several other cytokines and chemokines that were elevated in response 
specifically to the ΔbimA mutant namely GM-CSF, IL-6, IL-17, IL-23, and RANTES/CCL5. 
IL-17 has been described previously as an inflammatory initiator as it can induce many pro-
inflammatory cytokines such as TNFα, IL-1β and IL-6 in macrophages (reviewed in Gaffen, 
2008; Jovanovic et al, 1998), while IL-23 could in turn increase the expression of IL-17. While 
RANTES/CCL5 plays an active role in recruiting immune cells including macrophages as a 
part of the inflammatory response (Hiura et al, 1999). We chose IL-1α and IL-1β to be validated 
with a more sensitive ELISA. ELISA data for the secretion of IL-1α and IL-1β, which are the 
downstream products of the activation of non-canonical and canonical inflammasomes 




Figure 4.2 Global cytokine and chemokine response determined using a Proteome Profiler Mouse Cytokine Array.  The table on the upper right shows 
the analytes detected and their location on the membrane.  The circled spots are those with increased levels of cytokine/chemokine (>1.5 fold change) in cell 
lysate from cells infected either with B. pseudomallei WT (blue circle) or ∆bimA (orange circle), as compared to the uninfected cell lysate at the respective hour 





Figure 4.3 Relative levels of different cytokines/chemokines using a Proteome Profiler Cytokine Array.  The cytokines/chemokines in the cell lysates of 
BMDMs infected either with B. pseudomallei WT (blue) or ∆bimA (orange) were compared with those in uninfected BMDMs at 8 hpi (top) and 16 hpi (bottom). 
Data obtained from a single experiment. 
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4.2.3 MyD88 depletion and inhibition do not affect the intracellular survival of B. 
pseudomallei  
 
        To investigate the role of MyD88-dependent signalling in response to intracellular B. 
pseudomallei, we utilised RNA interference (RNAi) to silence MyD88 gene expression post-
transcriptionally in BALB/C BMDM cells. There is no available BALB/C MyD88 knockout 
mouse, hence the need for gene silencing instead.  In the cell cytoplasm, exogenous dsRNA is 
initially recognised by the Dicer protein, an RNase that processes the dsRNA into 21-23 
nucleotide short interfering RNA molecules (siRNA). The siRNAs and target RNA form a 
complex with the RNA-induced silencing complex (RISC) which cleaves any complementary 
mRNA, thus silencing the target gene. Delivery of exogenous siRNA into primary 
macrophages is technically difficult and challenging, but there are several reports of successful 
gene silencing in primary macrophages using lipid-based transfection methods (Jensen et al, 
2014;  Troegeler et al, 2014; Zhang et al, 2009). Electroporation is less preferable as this 
method can cause a high proportion of cell death (Jensen et al, 2014). A short siRNA sequence 
of less than 30 base pairs should not induce a potent interferon response, an innate immune 
response of macrophages in recognition of viral RNA (Reynolds et al, 2006). Furthermore, the 
transfection of a low concentration of synthetic RNA (<100μM) does not detrimentally affect 
cell viability (Jensen et al, 2014; Reynolds et al, 2006). 
        Pre-designed MyD88 siRNA was purchased from Ambion Life Technology (Silencer 
Select Pre-designed siRNA). siRNA was then delivered into BMDMs using Lipofectamine 
RNAiMAX (Invitrogen), a transfection reagent that consistently gives the best target gene-
knockdown with minimal cytotoxicity and IFN-induced response as reported by Jensen et al 
(2014). Lipofectamine reagents are formulated from cationic lipids which form liposomes in 
aqueous conditions. The positively charged liposomes form complexes with nucleic acid to 
form liposome: nucleic acid transfection complexes which interact with the negatively charged 
cell membrane before entering cells through endocytosis. These ‘liposomes’ not only assist the 
cellular uptake of siRNA but also prevent endogenous enzymatic degradation during 
endocytosis (Gooding et al, 2012). The BMDMs were transfected with a mixture of 
Lipofectamine: siRNA at a final concentration of 70μM for 24 hours. The medium was then 
replaced with fresh medium and the cells cultured for a further 24 hours before being infected 
with B. pseudomallei WT or the ∆bimA strain. These conditions were used to minimise the off-
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target effects caused by the transfection reagents as demonstrated in Jensen et al (2014). We 
included MISSION Universal Negative siRNA control (Sigma-Aldrich) at the same 
concentration in each experiment as a non-targeting siRNA control.  This siRNA control does 
not share homology with any known mammalian gene. Transfection with the siRNA targeting 
mouse MyD88 resulted in statistically significant knockdown of 70% in BALB/C BMDMs as 
compared to the non-targeting negative control (Figure 4.4 (A) and (B)). The efficiency of gene 
silencing was determined by RT-PCR (reverse transcriptase PCR) and normalised to the 
expression of β-actin. The role of MyD88 in phagocytosis remains in debate as one study 
reported that MyD88-deficiency reduces the phagocytic activity of macrophages (Blander & 
Medzhitov, 2006), whilst Laroux et al (2005) found no difference in phagocytosis of MyD88-
deficient macrophages by FACS-based analysis. In our studies, depletion of MyD88 does not 
obviously impair the phagocytic activity of BMDMs as observed by confocal microscopy 
(Figure 4.4 (C)). 
        After establishing the conditions for MyD88 gene silencing in BMDMs, we measured 
bacterial intracellular survival by carrying out the kanamycin-protection assay as described 
previously. The experiment showed that depletion of MyD88 did not improve the intracellular 
survival of either the B. pseudomallei WT or ∆bimA mutant strain, as there was no difference 
in CFU between MyD88-depleted and non-depleted BMDMs at all three time points of 2 hpi, 
8 hpi and 16 hpi (Figure 4.5). These data suggest that the impaired survival of the ΔbimA 
mutant at 16 hpi is not dependent on MyD88, as depletion of MyD88 does not rescue the 




          
                  
 
Figure 4.4 Knockdown efficiency of siRNA targeting MyD88 in BALB/C BMDMs and 
phagocytosis assay of siRNA-treated BMDMs. (A) RT-PCR analysis of MyD88 knockdown 
efficiency in BMDMs as compared to the control. BMDMs were seeded at density of 5 x 105 cells per 
well in 24-well plates. BMDMs were then transfected with MyD88 siRNA or non-targeting siRNA 
control using Lipofectamine as described in Materials and Methods 2.14.1. The β-actin gene was used 
as a control gene for normalisation. Densitometric quantification was performed using Image J software 
and is represented by the bar chart (B).  (B) Bar chart represents the means + S.E. of three independent 
experiments. Statistical analysis was done using unpaired Student’s t-test between MyD88 siRNA-
treated and non-targeting siRNA-treated as a control, **p<0.01. (C) Confocal microscopy images of 
BALB/C BMDMs with phagocytosed fluorescently-labelled Zymosan beads (green). BMDMs were 
seeded on coverslips at 5 x 105 per well in 24-well plates. BMDMs were pre-treated with non-targeting 
siRNA (left) or MyD88 siRNA (right) before incubating with the beads for an hour, followed by fixation 
as described in Materials and Methods 2.14.1 and 2.4. The cell nuclei were stained with DAPI (blue) 
and the actin was stained with phalloidin (red). Images were captured using a Leica DMLB fluorescence 













Figure 4.5 Bacterial intracellular survival in siRNA-treated BMDMs. BMDMs pre-treated with 
non-targeting siRNA (checked bars) or MyD88 siRNA (horizontal striped bars) were infected with B. 
pseudomallei WT (blue bar) or the ΔbimA mutant strain (orange bar) at an MOI of 2, for 2 hpi, 8 hpi 
and 16 hpi. The assay was carried out in a kanamycin-protection manner as described previously in 
Materials and Methods 2.6. The data represent the means + SE from two independent experiments. 
Statistical analysis was done using unpaired Student’s t-test between CFU in negative control- and 




        Depletion of MyD88 mRNA may not necessarily correlate with reduced protein levels 
within the BMDMs so we also performed experiments using a pharmacological inhibitor of 
MyD88 activity. We inhibited MyD88 pharmacologically in BALB/C BMDMs using the 
MyD88 homodimerisation inhibitor purchased from Novus Biologicals (NBP2-29328). The 
MyD88 protein possesses a death domain (DD) at the N-terminus and a Toll/IL-1R receptor 
(TIR) domain at the C-terminus separated by a short linker domain. The TIR domain is also 
present in the TLR/IL-1R receptor where upon ligand stimulation, MyD88 is recruited to the 
receptor by this TIR-TIR interaction. TIR domains of both MyD88 and the receptor TLR/IL-
1R have a common structure composed of five β-strands alternating with five α-helices, 
connected by loops. A loop known as the BB loop connects the second β-strand and the second 
α-helix and is crucial for MyD88 homodimerisation, and activation of the TLR/MyD88 
signalling pathway (Loiarro et al, 2005; Xu et al, 2000; Poltorak et al, 1998). The MyD88 
inhibitor is designed to bind to the TIR domain of MyD88 to block its homodimerisation. The 
inhibitor contains a sequence from the MyD88 TIR homodimerisation domain (RDVLPGT) 
(Loiarro et al, 2005) preceded by a protein transduction sequence derived from Drosophila 
known as the Antennapedia homeodomain (RQIKIWFQNRRMKWKK) to facilitate the 
translocation of the peptide through the cell membrane (Derossi et al, 1994). The control 
peptide in this experiment was a peptide consisting of the Antennapedia sequence only.  
        We pre-treated the BMDMs with 100µM inhibitory peptide or its peptide control for 24 
hours as recommended by the manufacturer and also as described previously (Murshid et al, 
2015; Nguyen et al, 2010). This was then followed by stimulation with 4µg/ml TLR2 agonist 
Pam3-Cys-Ser-Lys4 (Pam3CSK4) for the next 24 hours. Pam3CSK4 is a synthetic bacterial 
lipopeptide which is the prototype ligand for the heterodimeric TLR1/TLR2 complex. TLR2 
propagates its signalling solely through the MyD88 adaptor protein and does not appear to use 
a MyD88-independent arm for signal transduction (reviewed in Takeda & Akira, 2004). Upon 
ligand binding to TLR, the downstream signalling cascade via MyD88 induces activation of 
the transcription factor NF-κB or AP-1, leading to expression of various proinflammatory 
cytokines such as IL-6 and IL-1β. IL-6 and IL-1β expression are dependent on MyD88 as 
macrophages from MyD88-knockout mice are unable to produce such cytokines upon 
activation with LPS (Kawai et al, 1999). To demonstrate that the MyD88 peptide was active in 
our hands, we measured the mRNA expression of IL-6 and IL-1β by qPCR. We determined 
that in the presence of the TLR2 agonist Pam3CSK4 alone, that the mRNA expression of IL-6 
and IL-1β increased by approximately 400- and 70- fold as compared to unstimulated BMDMs 
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(Figure 4.6). In the presence of both the MyD88 peptide inhibitor and TLR2 agonist, we 
achieved a reduction in IL-6 and IL-1β mRNA expression of about 35% and 25% respectively, 
as compared to the peptide control (Figure 4.7). Phagocytic activity was not affected by the 
MyD88-blocking peptide as shown in Figure 4.8. This is the optimum reduction that we could 
achieve since increasing the peptide concentration did not lead to a further increase in inhibition 
of the TLR2 response, in fact it resulted in more cell death (data not shown). Even use of the 
MyD88-control peptide and MyD88-inhibitory peptide at 100µM resulted in 22.7+2.99 % and 
21.5+2.98% cell cytotoxicity respectively, as determined using an LDH release assay (data not 
shown).  
        To evaluate the impact of MyD88 inhibition on B. pseudomallei intracellular survival in 
BMDMs, we performed a kanamycin protection assay as described previously. After pre-
treating the BMDMs with MyD88 inhibitor or the control peptide for 24 hours, the BMDMs 
were infected with B. pseudomallei and viable counts obtained at 2 hpi, 8 hpi and 16 hpi. The 
results show that MyD88 is unlikely to play a role in intracellular survival of either the B. 
pseudomallei WT or the ∆bimA mutant strain at any of the time points tested. There was no 
difference in CFU numbers in BMDMs-treated with the MyD88 inhibitor compared to the 
control peptide, similar to the result obtained using siRNA targeted gene knockdown (figure 
4.9).  Despite the importance of MyD88 in innate immune pathways, we found that MyD88 
deficiency in BMDMs fails to increase the growth of B. pseudomallei intracellularly, indicating 
that alternative pathways are likely required for detection and elimination of the bacterium. An 
alternative explanation could be that knocking down the gene by siRNA did not abrogate the 
gene expression enough to lead to an effect. The small amount of residual MyD88 gene 
expression could be adequate for MyD88-dependent signalling. Similarly, the imperfect 
blocking of MyD88 function may not have resulted in a significant suppression of the function 
of the MyD88-mediated immune response. The latter possibility could be tested in future by 
application of CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats- 







Figure 4.6 Relative expression of IL-1β (top) and IL-6 (bottom) as determined by qPCR in the 
presence of TLR2 agonist Pam3CSK4 as compared to unstimulated BMDMs. Total RNA from 
BMDMs was extracted after stimulation with (grey bar) or without Pam3CSK4 (black bar) for 24 hours 
as described in Materials and Methods 2.16. cDNA was then synthesised from the total RNA and qPCR 
was carried out as described in Materials and Methods 2.17 and 2.19 respectively. GAPDH was used 
as a reference gene for normalisation. The data represent the means + SE of two independent 
experiments. Unpaired Student’s t-test was used to determine the statistical significance in gene 








Figure 4.7 Relative expression of IL-1β (top) and IL-6 (bottom) genes as determined by qPCR 
upon different peptide treatments. Total RNA from BMDMs treated with MyD88-blocking peptide 
(black bar) or MyD88-control peptide (grey bar) was extracted after stimulation with TLR2 agonist 
Pam3CSK4 for 24 hours as described in Material and Methods 2.16. cDNA was then synthesised from 
the total RNA and qPCR was carried out as described in Materials and Methods 2.17 and 2.19 
respectively. GAPDH and Csnk2a2 were used as reference genes for normalisation. The data represent 
the means + SE of three independent experiments. Unpaired Student’s t-test was used to determine the 












Figure 4.8 Phagocytosis assay of BMDMs pre-treated with control peptide (left) or MyD88-
blocking peptide (right). Confocal microscopy images of BALB/C BMDMs with phagocytosed 
fluorescently-labelled Zymosan beads (green). BMDMs were seeded on coverlips at density of 5 x 105 
per well in 24-well plates. BMDMs were first pre-treated with the respective peptide for 24 hours before 
incubating with the beads for an hour and fixation as described in Materials and Methods 2.4. The cell 
nuclei were stained with DAPI (blue) and the actin was stained with phalloidin (red) as shown in 
Materials and Methods 2.9. Images of a single plane were captured using a Zeiss LSM confocal laser 








Figure 4.9 Bacterial intracellular survival in BMDMs pre-treated with MyD88-control peptide 
(checked bar) or MyD88-blocking peptide (horizontal-striped bar). The peptide-treated BMDMs 
were infected with B. pseudomallei WT (blue bar) or ΔbimA mutant (orange bar) at an MOI of 2, for 
three different time points of 2 hpi, 8 hpi and 16 hpi. The assay was carried out in a kanamycin-
protection manner as described previously in Materials and Methods 2.6. The data represent the mean 
+ SE from three independent experiments. Statistical analysis was performed using an unpaired 
Student’s t-test between CFU in BMDMs pre-treated with two different peptides of respective strains 









4.2.4 The TRIF-dependent pathway may be involved in the intracellular survival of 
B. pseudomallei   
 
        We next investigated the importance of the TRIF-adaptor protein in the host cell response 
to B. pseudomallei. We hypothesised that BMDMs may utilise TRIF-dependent TLRs to 
recognise and initiate the bacterial clearance. To investigate this, we used a TRIF-inhibitor 
known as Pepinh-TRIF (purchased from InvivoGen) to block TRIF-dependent signalling. As 
described for the MyD88-blocking peptide previously, Pepinh-TRIF is also designed to contain 
amino acids that correspond to the sequence of the BB loop of TRIF (FCEEFQVPGRGELH) 
(Toshchakov et al, 2005) linked to the cell-penetrating segment of the Antennapedia 
homeodomain (RQIKIWFQNRRMKWKK) (Derossi et al, 1994). This Pepinh-TRIF inhibitor 
blocks the TIR-TIR interaction of the TLR and the TRIF protein while the control peptide 
contains a scrambled peptide sequence (SLHGRGDPMEAFII) preceded with the 
Antennapedia homeodomain. TLR3 is the only TLR that is known to exert its effects through 
TRIF (MyD88-independent) alone (reviewed in Takeda & Akira, 2004). TLR3 recognises 
double-stranded RNA (dsRNA), a PAMP associated with viral infection and poly(I:C) is a 
synthetic analogue of dsRNA.  Downstream of TLR3, TRIF activation of the interferon (IFN) 
regulatory factor (IRF)-3/7 pathway leads to secretion of Type I IFN (IFNα/IFNβ) (Yamamoto 
et al, 2003). Therefore, the effect of abrogating TRIF-dependent signalling can be determined 
by measuring IFNβ mRNA expression. To determine the efficiency of Pepinh-TRIF to block 
activity, we measured the gene expression of IFNβ after stimulation of BMDMs with the TLR3 
agonist poly(I:C) (polyinosinic-polyctidylic acid). In the presence of poly(I:C), IFNβ mRNA 
expression increased by approximately 9-fold compared to unstimulated BMDMs (Figure 
4.10).  
 We next pre-treated BMDMs with 40µM Pepinh-TRIF, or Pepinh-control as 
recommended by the manufacturer for 4 hours. Treating BMDMs with Pepinh-control and 
Pepinh-TRIF resulted in low cell cytotoxicity of 15.0+0.9 % and 16.2+2.88 % respectively, as 
determined by LDH release assay (data not shown). After incubation with the peptides for 4 
hours, the cells were then stimulated with 25µg/ml of poly(I:C) for 6 hours. We then isolated 
the RNA from BMDMs and carried out qPCR to measure the expression of IFNβ. Application 
of the Pepinh-TRIF blocker to the Poly(I:C)-induced BMDMs resulted in a significant 
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reduction in IFNβ expression by approximately 60% (Figure 4.11 (A)), while the phagocytic 
activity was not affected by the inhibitor (Figure 4.11 (B)).         
       To assess whether the inhibitory activity of Pepinh-TRIF affects the course of intracellular 
survival of B. pseudomallei, we pre-treated the BMDMs with Pepinh-TRIF or the control 
peptide for 4 hours, followed by infection with B. pseudomallei strains. Viable counts were 
obtained at 2, 8 and 16 hpi in a kanamycin-protection manner as described previously. We 
included the B. pseudomallei ∆bimA mutant strain to investigate if the apparent intra-
macrophage growth defect observed for the ΔbimA mutant is dependent on TRIF-dependent 
signalling. We hypothesised that if TRIF-dependent signalling is essential for cellular defence 
against B. pseudomallei, the bacterial intracellular load would be higher in the presence of the 
Pepinh-TRIF inhibitor compared to that in the presence of control peptide.  The bar graph in 
Figure 4.12 shows that at 2 hpi and 8 hpi, the peptide inhibitor had no effect on bacterial 
survival as there were no differences in CFU counts in cells pre-treated with the control peptide 
or TRIF inhibitor. However, there was greater than a 3-fold increase in WT B. pseudomallei at 
the 16 hour time point in BMDMs pre-treated with Pepinh-TRIF inhibitor compared to the 
Pepinh-control. As expected, far fewer ∆bimA mutant bacteria were recovered compared to the 
WT strain at this time point. However, intracellular survival of the ∆bimA mutant was 
unaffected by the presence of the Pepinh-TRIF inhibitor. Although there was no statistically 
significant difference in CFU counts of WT bacteria between cells treated with Pepinh-TRIF 
and Pepinh-control, we believe that more independent repeats may reduce the high variability 
in the data and the results may become statistically significant. We hypothesise that TRIF-
dependent signalling plays a role in intracellular survival of B. pseudomallei, but this pathway 
is less prominent for the ΔbimA mutant strain. Unfortunately, due to time constraints of the 








Figure 4.10 Relative expression of IFNβ in BMDMs as determined by qPCR in the presence of 
TLR3 agonist poly(I:C) as compared to unstimulated BMDMs. Total RNA from BMDMs was 
extracted after stimulation with or without poly(I:C) for 6 hours as described in Materials and Methods 
2.16. cDNA was then synthesised from the total RNA and qPCR was carried out as described in 
Materials and Methods 2.17 and 2.19 respectively. GAPDH and Csnk2a2 were used as reference genes 
for normalisation. The data represent the mean + SE of three independent experiments. Unpaired 
Student’s t-test was used to determine the statistical significance in gene expression in the presence of 






Figure 4.11 Relative expression of IFNβ and phagocytosis assay of BMDMs treated with different 
peptides. (A) Total RNA from BMDMs treated with Pepinh-control (black bar) or Pepinh-TRIF (grey 
bar) was extracted after stimulation with TLR3 agonist Poly(I:C) as described in Materials and Methods 
2.16. cDNA was then synthesised from the total RNA and qPCR was carried out as described in 
Materials and Methods 2.17 and 2.19 respectively. GAPDH and Csnk2a2 were used as reference genes 
for normalisation. The data represent the mean + SE of three independent experiments. Student’s t-test 
was used to determine the statistical significance in gene expression between the two different 
treatments. **p<0.01. (B) Confocal microscopy images of BALB/C BMDMs with phagocytosed 
fluorescently-labelled Zymosan beads (green). BMDMs were seeded on coverslips at density of 5 x 105 
cells per well in 24-well plates. BMDMs were then pre-treated with Pepinh-control (left) or Pepinh-
TRIF (right) before incubating with the beads for an hour and fixation as described in Materials and 
Methods 2.4. The cell nuclei were stained with DAPI (blue) and the actin was stained with phalloidin 
(red) as shown in Materials and Methods 2.9. Images were captured using a Zeiss LSM confocal laser 











Figure 4.12 Bacterial intracellular survival in BMDMs pre-treated with Pepinh-control (left-bar) 
or Pepinh-TRIF (right bar). The pre-treated BMDMs were infected with B. pseudomallei WT (blue 
bar) or ΔbimA strains (orange bar) at an MOI of 2, for 2, 8 and 16 hpi. The assay was carried out in a 
kanamycin-protection manner as described previously in Materials and Methods 2.6. The data represent 
the mean + SE from three independent experiments. Statistical analysis was done using Student’s t-test 





4.2.5 Non-canonical inflammasome activation upon B. pseudomallei infection of 
BALB/C BMDMs            
 
        Partially blocking the TRIF adaptor protein led to a trend towards improving the survival 
of intracellular B. pseudomallei at 16hpi, suggesting this pathway could be involved in the 
cellular response to B. pseudomallei. Several studies have shown that TRIF along with Type I 
IFNs mediate non-canonical inflammasome activation in response to the presence of Gram-
negative bacteria namely Escherichia coli, Citrobacter rodentium, Salmonella Typhimurium 
and Shigella flexneri (Rathinam et al, 2012; Gurung et al, 2012; Broz et al, 2012) (Figure 4.13). 
The inflammasome is a multiprotein complex that assembles with members of the NOD-like 
receptor (NLR) and PYHIN protein families in response to PAMPs or danger signals. Upon 
inflammasome activation, procaspase-1 is cleaved to its active form of caspase-1 which then 
promotes the maturation of pro-inflammatory cytokines such as IL-1β and IL-18 (reviewed in 
Latz et al, 2013). The inflammasome is regarded as a key component of cytosolic surveillance. 
Recently, a new non-canonical inflammasome pathway has been described that activates 
caspase-11, a caspase-1 related protease (reviewed in Broz & Monack, 2013). Several studies 
suggest that bacterial LPS mediates the priming of caspase-11 and that activation is dependent 
on TRIF and Type I IFN (Casson et al, 2015; Kayagaki et al, 2013). At the transcriptional level, 
caspase-11 and genes involved in interferon signalling were found to be significantly up-
regulated in BMDMs infected with B. pseudomallei (WT and ∆bimA) as demonstrated by our 
microarray analysis (refer to Chapter 5).  Furthermore, the involvement of interferon-mediated 
signalling in infected BALB/C BMDMs as described in Chapter 5 is further supported by in 
vivo tissue transcriptomic changes in an acute animal model of melioidosis in BALB/C mice 
(Chin et al, 2010). The contribution of caspase-11-dependent mechanism in the pathogenesis 
of B. pseudomallei infection has been reported by Bast et al (2014).  These findings together 
suggest that the non-canonical inflammasome pathway could potentially be an innate 






Figure 4.13 Proposed integrative model of TLR and NLR pathways during the inflammatory 
response to Gram-negative bacteria. Activation of the TLR4-TRIF-dependent pathway in sensing 
cytosolic Gram-negative bacteria upregulates the expression of Type I IFN. Increase in Type I IFN 
signalling induces the expression of caspase-11 and its processing into active caspase-11 (signal 3), 
which leads to cell death and secretion of endogenous alarmins IL-1α and HMGB-1. While activation 
of TLR4 through the MyD88 adaptor protein switches on the transcription of IL-1β and Nlrp3 mRNA 
(signal 1). Different stimuli such as bacterial mRNA in the cytosol triggers NLRP3 inflammasome 
assembly (signal 2). The NLRP3 complex together with activated caspase-11 synergises the activation 
of caspase-1 and maturation of pro-inflammatory cytokines IL-1β and IL-18 (figure reprinted from 
Rathinam, V.A.K. et al (2012). TRIF licenses caspase-11-dependent NLRP3 inflammasome activation 




        To directly examine the activation of the non-canonical inflammasome by B. pseudomallei, 
we analysed caspase-11 maturation in cell lysates of BMDMs infected with B. pseudomallei 
WT and the ΔbimA mutant strain. Pro-caspase-11 transcription is largely induced through 
activation of Type I IFN signalling via the TRIF-adaptor protein (Rathinam et al, 2012; Broz 
et al, 2012). Nevertheless, resting macrophages or dendritic cells (DCs) still express low levels 
of pro-caspase-11, as additional pathways could also contribute to its expression (Freigang et 
al, 2013; Broz et al, 2012). However, whether the processing of procaspase-11 into its active 
form involves an auto-activation mechanism (Rathinam et al, 2012) or requires an as yet 
undefined bacterial signal (Broz et al, 2012) remains controversial. We carried out Western 
blots to detect the level of pro-caspase-11 (43kDa) and its processing into active caspase-11 
(30kDa) from three independent experiments (Figure 4.14). We then measured the intensity of 
the indicated bands and carried out relative densitometry analysis using ImageJ software.  
        The caspase-11 locus encodes two isoforms of 43kDa and 38kDa, but the antibody used 
in this studies only detects the 43kDa species according to the manufacturer’s description.  The 
processed form of caspase-11 is about 30kDa. Pro-caspase-11 levels were slightly higher in 
BMDMs infected with the B. pseudomallei ∆bimA mutant in one experiment. However, when 
the experiment was repeated a further two times, there was no statistical difference in pro-
caspase-11 in BMDMs infected with either the ∆bimA strain or the WT strain in comparison to 
uninfected BMDMs at all-time points (Figure 4.12 (A)). Despite no statistical significance in 
the data we observed a trend towards higher levels of cleaved caspase 11 at 8 hours post-
infection of cells with the ∆bimA mutant strain (Figure 4.12 (B)). Later, we carried out a more 
sensitive ELISA assay to measure the secretion of IL-1α as a product of activation of caspase-
11.   




    
 
Figure 4.14 Immunoblot analysis of pro-caspase 11 and cleaved caspase 11 in BMDMs upon B. 
pseudomallei infection. (A) BMDMs were infected with B. pseudomallei WT or ∆bimA mutant strains 
at an MOI of 2 for 2, 8 and 16 hpi as described previously in Materials and Methods 2.6. Presence of 
pro-caspase 11 at the protein level and the activation by cleavage into caspase-11 was determined by 
Western blotting of cell lysates. (B) The bar chart shows the mean densitometric measurements of the 
pro-caspase 11 (left) and cleaved caspase-11 (right) in infected lysates as a fold change from that in 
uninfected cell lysate. The mean was taken from three independent experiments and the error bars 
represent the standard error. GAPDH is the loading control. Student’s t-test was used to determine the 






        Activation of caspase-11 has also been shown to lead to the secretion of endogenous 
alarmins namely IL-1α and high mobility group B1 (HMGB) (Kayagaki et al, 2011). In our 
analysis using the Proteomic Profiler Array we found a higher expression of IL-1α in infected 
cell lysates compared to uninfected cell lysates at 8 hpi and 16 hpi. Following on from this 
analysis, we measured the concentration of IL-1α in the supernatant of uninfected and infected 
cells by ELISA from three independent experiments. At 2 hpi and 8 hpi, the secretion of IL-1α 
was minimal (<5pg/ml) from both infected and uninfected BMDMs.  We included a positive 
control where we stimulated the BMDMs with the TLR4 agonist LPS (500ng/ml) for 8 hours, 
which led to significant secretion of IL-1α at a concentration of ~43 pg/ml. However, at 16hpi, 
the BMDMs infected with WT B. pseudomallei showed a significant increase in IL-1α 
secretion compared to the uninfected BMDMs and also to BMDMs infected with the ∆bimA 
mutant (Figure 4.15). The higher amount of IL-1α secretion in BMDMs infected with the WT 
strain compared to the mutant strain could be associated with the higher bacterial burden of 
WT B. pseudomallei in these cells at this time point (Figure 3.3). In these experiments with 
naïve non-primed BMDMs, we were able to detect the secretion of IL-1α upon infection 
suggesting that the non-canonical inflammasome is activated as a global response to B. 
pseudomallei rather than a specific response to the ∆bimA mutant. The non-canonical 
inflammasome could be an important host innate mechanism against B. pseudomallei which 








Figure 4.15 Secretion of the inflammatory cytokine IL-1α by ELISA. BMDMs were seeded at 1 x 
105 cells per well in 96-well plate, followed by infection with B. pseudomallei WT (blue) or the ∆bimA 
mutant (orange) at 2, 8 and 16 hpi. The concentrations of IL-1α (pg/ml) in the supernatant of uninfected 
BMDMs (beige) or infected BMDMs were determined by ELISA as described in Materials and 
Methods 2.11. The bar chart represents the mean + SE from three independent experiments. The 








        Caspase-11 does not process pro-IL-1β directly; however it is required for the activation 
of caspase-1 by promoting the assembly of the NLRP3 inflammasome complex (Kang et al, 
2000). Our microarray analysis in Chapter 5 shows that B. pseudomallei infection in BALB/C 
BMDMs induces the expression of IL-1β transcript while at the protein level, we found a small 
fold increase of IL-1β in infected lysates as compared to the uninfected lysate, as determined 
using a Profiler Mouse Cytokine Array (Figure 4.2).  We carried out an IL-1β ELISA to detect 
secretion of IL-1β in cell supernatants to investigate if such transcriptional induction leads to 
its maturation into active IL-1β. However, we were not able to detect any IL-1β in cell 
supernatants by ELISA in all samples (both uninfected and infected BMDMs with B. 
pseudomallei WT and ∆bimA mutant) (data not shown). Surprisingly, we detected a huge 
increase in expression of IL-1β in the positive control containing LPS (500ng/ml) using the 
Profiler Cytokine Array, but we observed no secreted IL-1β in the cell supernatants. This leads 
us to suggest that there is a defect in activation of the IL-1β-converting caspase-1 in BALB/C 
BMDMs.    
        We also carried out Western blotting using a caspase-1 antibody that can detect both the 
pro-caspase-1 precursor and the cleaved caspase-1. We could detect pro-caspase-1, however, 
we were unable to detect any cleaved caspase-1 in any of the samples, including the positive 
control (Figure 4.16). For the positive control, we primed the BMDMs with LPS for 4 hours to 
increase the cellular expression of NLRP3 via NF-κB signalling. We then added ATP for the 
next 30 minutes to activate the NLRP3 inflammasome as described in Boriushkin et al (2016). 
However, we still could not detect any cleaved caspase-1 in the positive control lysate, leading 
us to believe that the canonical inflammasome in our cell system might be inhibited by an 
unknown mechanism. Recently, Boriushkin et al (2016) demonstrate that such inflammasome 
activation and IL-1β maturation in BMDMs can be suppressed by endogenous molecular 
chaperone p58IPK. p58IPK has been shown to inhibit the double-stranded RNA dependent 
protein kinase (PKR) protein, where PKR is important in mediating inflammasome activation 
and also the TLR4 induction of NF-κB and JNK MAPK pathways. However, further studies 
are needed in future to confirm if the inhibition of canonical inflammasome activation in 







Figure 4.16 Western blot of pro-caspase 1 in BMDMs upon B. pseudomallei infection. (A) BMDMs 
were infected with B. pseudomallei WT or ∆bimA mutant strains at an MOI of 2 for 2, 8 and 16 hpi as 
described previously in Materials and Methods 2.6. Presence of pro-caspase 1 at the protein level was 
determined by Western blotting of cell lysates. However, none of the samples showed band of cleaved 
active caspase-1 including the positive control where the BMDMs were primed with LPS, followed by 
activation of inflammasome by ATP. Activated canonical inflammasome cleaves the procaspase-1 into 







      Innate immune signalling constitutes the frontline of host defence against infection. The 
innate immune system is not specific and depends on recognition of conserved features of 
pathogens known as PAMPs. TLRs occupy a prominent position in the innate immune system 
by virtue of their ability to recognise various bacterial components and drive the expression of 
many pro- and anti-inflammatory cytokines, which together orchestrate the inflammatory 
response.  In septicaemic melioidosis, there is increased expression of TLR1, TLR2, TLR4 and 
CD14 on the surfaces of circulating monocytes and granulocytes and increased levels of mRNA 
encoding TLR1, TLR2, TLR3, TLR4, TLR5, TLR8, TLR10, CD14 and MD-2 in leukocytes 
(Wiersinga et al, 2007). Melioidosis patients have elevated pro-inflammatory cytokines 
including IL-12, IL-18 and IL-15, IFNγ and TNFα (Lauw et al, 1999; Supputtamongkol et al, 
1992), and patients who die from melioidosis have excessive serum levels of IL-6 and IL-8 
compared to those who survive (Lauw et al, 1999; Friedland et al, 1992). In a murine 
melioidosis model, TLR2, TLR4 and TLR5 have been implicated in the recognition of B. 
pseudomallei (West et al, 2013; West et al, 2012; West et al, 2008; Wiersinga et al, 2007) and 
expression of IL-1β, IL-6 and TNFα is increased in the liver of mice infected with B. 
pseudomallei (Ulett et al , 2000). 
        TLR signalling can proceed via two distinct routes either through the MyD88- or TRIF-
adaptor protein. Infection with B. pseudomallei has previously been shown to activate TLRs 
through the MyD88-dependent pathway rather than the TRIF-dependent pathway both in vitro 
and in vivo (Tangsudjai et al, 2010; Wiersinga et al, 2008). Wiersinga et al (2008) demonstrated 
that MyD88-, but not TRIF-dependent signalling contributes to host protection against B. 
pseudomallei in mice, at least in part by rapidly recruiting activated neutrophils towards the 
primary site of infection for bacterial clearance. As compared to wild-type mice, the MyD88 
knockout mouse shows increased mortality accompanied with significant bacterial burden in 
the lung, liver and blood (Wiersinga et al, 2008). However, in vitro studies in the RAW264.7 
macrophage cell line show that WT B. pseudomallei induced expression of genes downstream 
of the MyD88-dependent pathway, indicating MyD88 is an important adaptor protein of TLRs 
in controlling B. pseudomallei in this immortalised macrophage-like cell line (Tangsudjai et al, 
2010). Despite the importance of MyD88 in controlling B. pseudomallei in vitro and in vivo, 
however, we were unable to demonstrate the same role of MyD88 in BALB/C BMDMs. We 
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knocked down MyD88 gene expression using siRNA technology and also in a separate 
experiment using a MyD88 homodimerisation inhibitor to block the MyD88-mediated 
signalling cascade. MyD88 siRNA transfection did not attain 100% gene silencing while the 
MyD88 homodimerisation inhibitor did not fully inhibit the downstream pathway. It is 
important to highlight here that in combination of incomplete abrogation of the MyD88 
function with relatively low infection rate of B. pseudomallei in BMDMs (as discussed in 
Chapter 3), these collectively may reduce the impact of the findings. The residual activation of 
MyD88-dependent pathway may be adequate to compensate the low number of infected 
BMDMs. Alternatively, utilising CRISPR-Cas9 (Clustered Regularly Interspaced Short 
Palindromic Repeats- CRISPR associated protein-9 nuclease) gene editing technology to delete 
the MyD88-encoding gene in BMDMs could be considered in future. In our experimental 
system with the incomplete depletion of MyD88, we believe that MyD88 is not needed for 
controlling B. pseudomallei (both WT and ∆bimA mutant) in BALB/C BMDMs. In support of 
this statement, it should be noted that we were unable to observe any difference in downstream 
activation of NF-κB transcription factor in infected lysates (both WT and ∆bimA mutant) as 
compared to the uninfected in BALB/C BMDMs. This activation of NF-κB was determined by 
Western blot on the nuclear translocation of the p65 component of the complex (data not 
shown).  
        MyD88 is regarded as a major protein adaptor of TLRs as it signals downstream of all 
TLRs except TLR3 and some TLR4. MyD88-mediated signalling contributes to expression of 
many cytokines including TNFα. We found that the production of TNFα in the supernatant of 
cells infected with B. pseudomallei strain is about 5-fold less than the cells stimulated with E. 
coli LPS as measured by ELISA. This suggests that B. pseudomallei contributes to a weaker 
level of macrophage activation compared to BMDMs stimulated with E. coli LPS, which could 
explain why MyD88 may not seem important in controlling the pathogen in BALB/C BMDMs. 
Furthermore, the Proteome Profiler Mouse Cytokine Array identified only a few candidate 
proinflammatory cytokines and chemokines as elevated upon infection with B. pseudomallei, 
while there were many more expressed with much higher fold-change in E. coli LPS stimulated 
BMDMs . Utaisincharoen et al (2001) demonstrated that infection of B. pseudomallei in 
RAW264.7 cells leads to poor secretion of TNF-α as well as low expression of inducible nitric 
oxide synthase (iNOS). Consistent with this data, we were unable to detect secreted nitric oxide 
by Griess assay in B. pseudomallei-infected BMDM (both with WT and ΔbimA) at any 
experimental time points (data not shown). By being a weaker macrophage activator, B. 
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pseudomallei can be inconspicuous to the host immune system, potentially allowing the 
pathogen to persist intracellularly for a period of time.  
        TRIF is an adaptor protein mainly for TLR3 and for some TLR4. TRIF-dependent 
signalling drives the expression of Type I IFN including IFNβ. The TRIF-dependent signalling 
pathway also mediates NF-κB and MAPK signalling pathways similar to the MyD88-
dependent pathway, but with delayed kinetics. Interestingly, recent findings suggest that TRIF-
IFNβ signalling is associated later with the non-canonical inflammasome pathway. This non-
canonical inflammasome pathway is dependent on activation of caspase-11, and later secretion 
of IL-1α. In a murine melioidosis model, Wiersinga et al (2008) reported that TRIF-dependent 
signalling does not protect the host, but Aachoui et al (2013) recently demonstrate that Casp11-
/- knockout mice succumbed to death upon B. pseudomallei challenge, indicating that caspase-
11 is critical for host survival against B. pseudomallei. In our in vitro model using BALB/C 
BMDMs, the WT bacteria appear to proliferate better (albeit at a statistically non-significant 
difference) when the TRIF-dependent pathway is inhibited, indicating that TRIF may be 
required for controlling B. pseudomallei intracellular fate.  
      In terms of non-canonical inflammasome activation, we found a slightly higher, but not 
statistically significant, level of caspase-11 cleavage in infected BMDMs at 8hpi compared to 
uninfected BMDMs. Activation of caspase-11 leads to secretion of IL-1α, suggesting that more 
caspase-11 cleavage would lead to secretion of more IL-1α. We found more secretion of IL-1α 
in BMDMs infected with both the WT and ∆bimA mutant strains compared to uninfected 
BMDMs at 16hpi. These data together suggest that the TRIF-IFNβ-non-canonical 
inflammasome pathway could potentially be involved in immunity against intracellular B. 
pseudomallei, but not specifically towards the ∆bimA mutant in BALB/C BMDMs. However, 
more evidence and experiments are needed before we could firmly conclude that the 
TLR/TRIF-IFNβ-non canonical inflammasome pathway contributes to the host cell innate 
response against B. pseudomallei.  
        On the other hand, the canonical inflammasome depends on the activation of caspase-1 
and leads to secretion of IL-1β. In our hands, we could not promote activation of caspase-1 as 
demonstrated by Western blot analysis nor the secretion of IL-1β by ELISA, including in the 
positive control samples that were stimulated with E.coli LPS and ATP. We predict that there 
is a defect in activation of the IL-1β-converting enzyme caspase-1 in BALB/C BMDMs to 
secrete mature IL-1β.  
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        Both canonical and non-canonical inflammasome pathways induce a lytic form of 
programmed cell death called ‘pyroptosis’. We have measured cell death by LDH release assay 
as stated in the previous chapter. However, we do not observe any significant cell death upon 
B. pseudomallei infection at any experimental time point.  This could be due to the fact that we 
have used naïve BMDMs without a priming agent. This may result in poor levels of 
inflammasome activation relative to BMDMs primed with an agent such as IFNγ, IFNβ or LPS 
(Finethy et al, 2015; Hagar et al, 2013). Several studies also reported that in the absence of a 
priming agent, the expression of caspase-11 in unstimulated macrophages is low; therefore 
investigation of its function requires a priming step (Broz et al, 2012; Gurung et al, 2012; 
Rathinam et al, 2012). Another explanation could be due to the low MOI used in this study 
where the activation of the canonical and/or non-canonical inflammasome is not distinct or 
obvious, therefore it is not noticeable if there is a difference upon B. pseudomallei infection. 
Bast et al (2014) have successfully demonstrated pyroptosis in BMDMs infected with B. 
pseudomallei but with a very high MOI of 200. However, such cell death was not observed 
when carrying out the same infection experiment at MOI of 2, the MOI used for infection in 
this thesis.  
        Aachoui et al (2013) demonstrate that caspase-11 contributes to host protection against B. 
pseudomallei in a murine model of melioidosis. Activation of the non-canonical inflammasome 
pathway has been observed in response to a number of other Gram-negative bacteria namely 
Escherichia coli, Citrobacter rodentium, Shigella flexneri, and Salmonella Typhimurium (Broz 
et al, 2012; Rathinam et al, 2012; Kayagaki et al, 2011). However, such activity is not observed 
with Gram-positive bacteria, indicating that the pathway is a conserved mechanism for the 
detection of Gram-negative bacteria. This also suggests that the Gram negative bacterial LPS 
could be the caspase-11 agonist. Consistently, transfection of ultrapure Salmonella LPS into 
BMDMs results in caspase-11 dependent pyroptosis (Hagar et al, 2013). This process requires 
TLR4 and TRIF-dependent interferon production. TRIF is required but MyD88 is dispensable 
for the pathway (Rathinam et al, 2012).  In some scenarios, this TRIF-dependent-non-canonical 
inflammasome pathway requires another arm of Type I Interferon signalling as reported in 
several studies (reviewed in Broz & Monack, 2013;  Rathinam et al, 2012; Kayagaki et al, 
2011). Our analysis here is further supported in Chapter 5 by our microarray analysis, where 
we found that the Type I Interferon signalling pathway is involved as a global response to B. 
pseudomallei. At this point, we would predict that the non-canonical inflammasome could be 
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involved in host protection against B. pseudomallei. Unfortunately, none of the above 
mechanisms discussed above was responsible for the clearance of the ∆bimA at 16 hpi.  
       Interestingly, a recent study suggests that caspase-11 activation is also dependent on the 
small IFN-inducible GTPases termed guanylate-binding proteins (GBPs) in response to 
intracellular bacteria  (Kim et al, 2016; Finethy et al, 2015; Pilla et al, 2014; Meunier et al, 
2014). Meunier et al (2014) have shown that GBP helps to promote the lysis of vacuoles 
containing pathogens which subsequently exposes the LPS to the cytosol for downstream 
detection by the inflammasome machinery. This GBP-dependent LPS detection could be an 
alternative mechanism for bacterial LPS that bypasses the recognition by TLR4 receptor in a 
TRIF-independent fashion (Meunier et al, 2014). As described previously, B. pseudomallei is 
a weak macrophage activator, possibly due to its unique LPS structure that poorly engages with 
TLR4 (West et al, 2008; Matsuura et al, 1996). In fact, TLR4 knockout mice are as resistant to 
B. pseudomallei infection as wild-type mice (Wiersinga et al, 2007). We propose that this GBP-
dependent LPS detection coupled with non-canonical inflammasome activation could also be 
a backup host innate mechanism in response to invading B. pseudomallei. In fact, the family 
of GBPs has also been shown to be required for cell autonomous immunity to limit the 
replication of Mycobacterium bovis, Listeria monocytogenes and Salmonella Typhimurium 
(reviewed in Kim et al, 2016; reviewed in Randow et al, 2013; Rupper & Cardelli, 2008). In 
addition to vacuolar lysis, a few studies have revealed that at least one family of the GBPs can 
complex with the inflammasome and promote inflammasome assembly in response to 
intracellular pathogens (Kim et al, 2016; Finethy et al, 2015; Shenoy et al, 2012). However, 
the stimulus involved in GBP-dependent inflammasome activation is as yet undefined (Shenoy 
et al, 2012). In the next chapter, we have found that several GBPs are elevated at the 
transcriptional level in response to infection of BALB/C BMDMs with B. pseudomallei, 
namely GBP1, GBP2, GBP2a, and GBP5. With the knowledge of the various roles played by 
GBP family members in inflammasome activation and host defence, it is tempting to 






5 CHAPTER 5: PROFILING MACROPHAGE TRANSCRIPTOMIC 
RESPONSES TO INFECTION WITH BURKHOLDERIA PSEUDOMALLEI  
 
5.1 INTRODUCTION    
 
        The complex interaction between a microbial pathogen and a host is the underlying basis 
of pathogenesis. When host cells respond to the presence of a pathogen, phenotypic changes 
are often manifested by marked changes in gene expression. Gene expression profiling by the 
advent of DNA microarray technology and the more recent introduction of RNA sequencing 
approaches has greatly expanded the ability of scientists to monitor the transcriptional changes 
in the host that accompany infection at a genome-wide scale. Microarray technology has been 
used extensively in studies of host responses to different pathogens including Mycobacterium 
tuberculosis (Xu et al, 2003), Salmonella (Eckmann et al, 2000), Listeria monocytogenes (Ng 
et al, 2005), adenovirus (Zhao et al, 2003), human immunodeficiency virus 1 (Geiss et al, 2000) 
as well as the parasite Trypanosoma cruzi (Mukherjee et al, 2003). In fact, Jenner and Young 
commented in 2005 that at least 160 papers had been published by that time on host 
transcriptomic profiling following infection with 26 different bacterial species, 30 different 
types of viruses as well as yeasts, protozoa and helminths (Jenner & Young, 2005). Although 
nowadays next generation sequencing such as RNA-sequencing (RNA-Seq) also holds great 
potential for defining host-pathogen interactions, a microarray approach still offers a number 
of advantages over RNA-Seq. These include a fast pipeline from sample preparation to result 
analysis, lower cost and the requirement for simpler bioinformatics.  
        Microarray technology has revolutionised our understanding of host responses during B. 
pseudomallei pathogenesis, as well as the virulence mechanisms or adaptations deployed by 
the pathogen for the survival in different host environments. Multiple in vitro studies have been 
designed to mimic diverse host environments and whole-genome microarray used to identify 
expression of genes that may be necessary for B. pseudomallei growth under a specific 
condition. For example, B. pseudomallei adapts to low-iron conditions by increasing the 
expression of genes associated with pyochelin- and hydroxamate-mediated iron-acquisition for 
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efficient iron uptake during infection and also by utilising alternative metabolic pathways for 
energy production (Tuanyok et al, 2005). Similar findings have been observed in an in vivo 
gene expression study of B. pseudomallei in a hamster model of melioidosis (Tuanyok et al, 
2006). Besides, Chieng et al (2012) investigated the global B. pseudomallei transcriptome 
profile during infection of human macrophage-like U937 cells, an in vitro assay used to mimic 
cellular host defence. B. pseudomallei rapidly adapts to the intracellular milieu through 
reducing its metabolic activity and growth rate, as well as evading host immune responses by 
shutting down expression of known virulence factors such as the capsular polysaccharide, 
lipopolysaccharide (LPS) and flagella (Chieng et al, 2012). Furthermore, Ooi et al (2013) have 
integrated whole genome transcriptional data of B. pseudomallei exposed to more than 80 
diverse physical, chemical and biological conditions to generate a transcriptional condition 
compendium of B. pseudomallei as a community resource for biological discovery.   
        A number of studies have been carried out to study the host transcriptome changes upon 
B. pseudomallei infection both in vitro and in vivo. Chin et al (2010) used the BALB/C mouse 
model of melioidosis to determine host gene signatures in the spleen and liver during acute 
melioidosis by microarray.  They found numerous cellular processes were altered in B. 
pseudomallei intravenously-infected mice which included genes involved in the immune 
response, stress response, cell cycle regulation, proteosomal degradation, cellular metabolism, 
and signal transduction pathways (Chin et al, 2010). Most notably, Toll-like receptor (TLR2) 
expression was greatly enhanced, the dysregulation of innate immunity via TLR2 has been 
postulated to underlie the tissue damage observed during acute infection. Besides the mouse 
model, Lee et al (2013) have studied the global host transcriptomic changes in Caenorhabditis 
elegans following infection with B. pseudomallei. In their study, they identified that in a B. 
pseudomallei T3SS dependent manner, the bacterium targets a specific cellular transcription 
factor known as ELT-2 for ubiquitin-proteosomal degradation. ELT-2 protein is a key regulator 
of innate immune responses through its activity as a GATA transcription factor (Shapira et al, 
2006), therefore degradation of this factor means a reduction in the host’s ability to produce an 
effective antimicrobial defence and therefore leads to immune suppression (Lee et al, 2013).  
        Several in vitro experiments have been conducted in different cell models namely A549 
human lung epithelial cells (Vellasamy et al, 2016), THP-1 human monocytes (Perumal Samy 
et al, 2015), and primary human monocytes (Kulsantiwong et al, 2016). In A549 cells infected 
with B. pseudomallei, Vellasamy et al (2016) found an increase in the activation of host 
carbohydrate metabolism and apoptosis after 3 hours of infection, but a suppression in several 
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components of the innate immune response. The bacteria utilise the host metabolic pathways 
to gain energy sources and metabolites to promote their proliferation and survival inside the 
host cell.  Additionally, this metabolic regulation can be associated with cellular responses such 
as specific innate immune responses and inflammation (reviewed in Eisenreich et al, 2013). 
Apoptosis is regarded as a host defence mechanism to prevent bacterial replication within the 
host, while suppression of several components in innate immune response increases the 
chances of immune evasion by the bacteria (Vellasamy et al, 2016). Unlike innate immune 
suppression in B. pseudomallei-infected A549 cells, B. pseudomallei infection in THP-1 
monocytes (Perumal Samy et al, 2015) and primary human monocytes (Kulsantiwong et al, 
2016) resulted in upregulation of host innate immune response. Perumal Samy et al (2015) 
reported several inflammatory genes were differentially expressed in the host when infected 
with B. pseudomallei namely IL-1β, TNFα, IL-8, IL-6, IL-13 and many others.  Kulsantiwong 
et al (2016) reported in comparison to a B. pseudomallei LPS mutant, a B. pseudomallei wild-
type (WT) strain led to expression of significantly more IL-23 in infected primary human 
monocytes.  
         Macrophages are important host immune cells in the control of B. pseudomallei, yet the 
pathogen is also capable of manipulating host responses to promote its own survival. Here, in 
this thesis, utilisation of BALB/C BMDMs as an in vitro model may provide insights into the 
macrophage cellular response following infection with B. pseudomallei and also the bacterial 
evasion of host responses in a BimA-dependent manner.  It has been described in the previous 
chapter that a strain lacking the bimA gene had impaired survival in BALB/C BMDMs when 
compared to the WT strain. Hence, using microarray technology in this chapter we aim:  
1. To profile the global macrophage transcriptomic response to Burkholderia 
pseudomallei strain 10276 
2. To identify any specific macrophage response at the transcriptomic level elicited by the 
∆bimA mutant strain 





5.2 RESULTS  
 
5.2.1 Introduction to the microarray technology and choice of optimal time points 
for sampling  
 
        This thesis has applied the recent technology of GeneChip microarray, to be precise the 
GeneChip Mouse Gene 2.0 ST Array.  GeneChips (Affymetrix, Santa Clara, CA) comprise 
high-density in-situ synthesised oligonucleotide microarrays. Because in-situ synthesised 
probes are typically short (20-25 base pairs), multiple probes per transcript are included to 
improve sensitivity, specificity and statistical accuracy (Dalma-Weiszhausz et al, 2006). In the 
GeneChip Mouse Gene 2.0 ST Array, each unique probe is 25 bases in length where each 
transcript is designed with a median of 22 unique probes. This means that the array measures 
a median of 550 bases per transcript, interrogates across entire genes or exons and hence, 
provides extremely high coverage of the transcribed genome. 
       As it was of interest to investigate the transcriptomic changes associated with detection 
and elimination of the ∆bimA mutant, we first determined the optimal time points for sampling 
for microarray analysis. As presented in Chapter 3, the intracellular survival of the ∆bimA 
mutant was significantly impaired compared to the WT strain in BALB/C BMDMs at 16 hpi, 
but not significantly different at 8hpi. A pilot study was conducted to include more time points 
between 8 hpi and 16 hpi to identify the time point where the intracellular survival of ∆bimA 
mutant began to differ from that of the parental strain. The time points included in the studies 
were 8 hpi, 10 hpi, 12 hpi, 14 hpi and 16 hpi. BMDMs were infected at an MOI of 2 in a 
kanamycin-protection manner as described previously in Section 3.2.2. At the indicated time 
point of post-infection, the infected cell monolayers were subsequently lysed with 0.1% Triton 
X-100 in PBS, serially diluted and plated on Luria-Bertani (LB) agar. Bacterial colony forming 
units (CFUs) were recorded after 2 days incubation at 37oC. This pilot study was conducted 
twice and the results suggested that the intracellular survival of the ∆bimA mutant started to 
differ from the WT strain as early as 12 hpi, but not at 10 hpi (data not shown). Similar 
intracellular survival assays were then repeated taking viable counts at 8 hpi and 12 hpi as 
shown in Figure 5.1. The intracellular survival between the B. pseudomallei WT and the ∆bimA 








Figure 5.1 Intracellular survival of WT (blue) and ΔbimA mutant (orange) in BALB/C BMDMs. 
The mean bacterial recoveries (cfu + standard error) per well of a 96-well plate from four independent 
experiments at 8 hpi and 12 hpi. Kanamycin-resistant bacteria were recovered at 8 hpi and 12 hpi after 
infection of BALB/C BMDMs at an MOI of 2 as described in Materials and Methods 2.6. Statistical 




5.2.2 Assessing the quality of the cellular RNA  
 
       For this study, three independent experiments were carried out to generate biological 
replicates for analysis by microarray. In each experiment RNA was harvested from uninfected 
BMDMs and BMDMs infected at an MOI of 2 with B. pseudomallei WT or the ∆bimA mutant 
strain, at two different time points (8 hpi and 12 hpi). This experimental design gave a total of 
18 samples for analysis. Total RNA of the infected or uninfected BMDMs was isolated using 
an RNeasy Plus Mini Kit (Qiagen). This RNeasy technology integrates unique gDNA 
Eliminator spin columns to eliminate gDNA contamination during isolation, hence avoiding 
the need for DNase digestion. In addition, QIAshredder homogenisers were used to 
homogenise cell lysates to further improve the RNA yields. Each sample was pooled from two 
or three wells of a 24-well plate (where each well contained approximately 5 x 105 cells per 
well) to provide enough total RNA for microarray (2µg of each, with a concentration of 
approximately 100ng/µl). The concentration was quantified using a Nanodrop ND-100 
(NanoDrop Technologies). The samples were then outsourced to SourceBioscience 
(Nottingham, UK) for assessment of the RNA quality, as well as the processes of 
complementary RNA (cRNA) amplification, labelling, hybridisation and array scanning. 
       The RNA integrity was verified by Source BioSciences using an Agilent 2100 Bioanalyser 
(Agilent Technologies). All the samples used for microarray passed the QC requirement (Table 
5.1).  All 18 samples prepared were high quality producing two major peaks when assessed by 
the Bioanalyser, corresponding to the 2 major ribosomal RNA species of 28S and 18S (Figure 
5.2). Low quality RNA would show a broad peak or multiple peaks. All the samples were free 
from protein and genomic DNA contamination, as well as organic solvent contamination as 
they had 260/280 ratio >2.0 and 260/230 ratio >1.5 respectively, as determined using a 
Nanodrop ND-100 (Table 5.1). It is crucial in the beginning to prepare high quality samples as 
low quality samples with the presence of contaminants can severely affect the processing steps 
in a typical microarray experiment.  
        After RNA isolation, the RNA samples were transformed into cRNA using an in vitro 
transcription (IVT) method, which provides amplification of the target. This IVT technology 
was originally described by Eberwine and colleagues (Van Gelder et al, 1990). Prior to 
hybridisation, cRNA was labelled with biotin and fragmented to 50- to 200-base fragments 
(Figure 5.3 (b)). All these steps were performed using an Affymetrix GeneChip WT PLUS 
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reagent Kit, following the manufacturer’s instructions at Source BioSciences. These cRNA 
fragments were added to the hybridisation cocktail which contains salts, blocking agents and 
bacterial RNA spike-in controls, subsequently injected into the GeneChip array hybridisation 
chamber and incubated at 45°C for 16 hours. Next, the arrays were subjected to a series of 
washing and staining steps, where the fluorescent dyes were attached to the biotin labels. These 
processes were automated using an Affymetrix Fluidics station. This results in an increase in 
abundance of biotinylated cRNA molecules on the probes. The intensity of fluorescence, which 
corresponds to the abundance of cRNA fragments hybridised to the probe, was then determined 
by scanning the array, inferring the relative abundance of specific mRNA sequences in a 
sample (Figure 5.3(a)). Next, raw signal intensities for each probe pair were randomly 
permuted to create CEL files and the CEL files were supplied for the downstream analysis 
carried out at the Roslin Institute.  The CEL files corresponding to the 18 individual samples 


















Description RNA integrity number (RIN) 
by Agilent Bioanalyser  
RNA Quality by NanoDrop 
RIN Number  Pass/Fail 260/280 260/230 Pass/Fail  
A2 
Uninfected BMDMs  
8 hours  
10 Pass 2.1 1.67 Pass 
A3 10 Pass 2.06 1.85 Pass 
A4 Not provided Pass 2.09 1.76 Pass 
B2 BMDMs infected 
with B. pseudomallei 
WT 8hpi  
10 Pass 2.08 1.88 Pass 
B3 10 Pass 2.07 1.63 Pass 
B4 Not provided Pass 2.11 1.66 Pass 
C2 BMDMs infected 
with B. pseudomallei 
∆bimA 8hpi  
10 Pass 2.09 1.72 Pass 
C3 10 Pass 2.07 1.73 Pass 
C4 10 Pass 2.07 1.79 Pass 
D2 
Uninfected BMDMs  
12 hours  
10 Pass 2.1 1.69 Pass 
D3 10 Pass 2.11 1.77 Pass 
D4 10 Pass 2.06 1.89 Pass 
E1 BMDMs infected 
with B. pseudomallei 
WT 12hpi 
10 Pass 2.08 1.59 Pass 
E2 10 Pass 2.06 1.81 Pass 
E4 10 Pass 2.11 1.87 Pass 
F1 BMDMs infected 
with B. pseudomallei 
∆bimA 12hpi  
10 Pass 2.08 1.66 Pass 
F2 10 Pass 2.12 1.7 Pass 
F4 10 Pass 2.07 1.51 Pass 
Table 5.1 RNA integrity and quality of the samples. RNA integrity number (RIN) estimates the RNA 
integrity of the samples, provided by Agilent Bioanalyser software. Nanodrop estimates the RNA 




Figure 5.2 Electropherograms of RNA samples generated by the Agilent Bioanalyser. RNA 
samples were separated by electrophoresis on a micro-fabricated chip and detected via laser-induced 
fluorescence emission. All 18 samples show high-quality intact RNA with two distinct ribosomal peaks 
(18S and 28S), and a flat baseline between the marker (the most left small peak) and the ribosomal 









Figure 5.3 Flowchart of a typical genechip system microarray experiment. (A) Once the total RNA has 
been isolated and the QC determined for its integrity and quality, the samples were amplified and labelled 
with biotin. This labelled sample was then injected into the array and hybridised overnight in the 
hybridisation oven. This was followed by probe array washing and staining on the fluidics system. Finally, 
the arrays were scanned and the fluorescence intensity were translated into transcript abundance. (B) 
Flowchart of sample amplification and biotin-labelling. The first strand of cDNA was reverse-transcribed 
from T7-oligo(dT) primer, a primer that consists of poly(T) tail and a T7 polymerase-binding site. This was 
then followed by the synthesis of second cDNA by RNaseH and E.coli DNA polymerase I, producing a 
double-stranded cDNA. This cDNA was then made blunt-ended with T4 DNA polymerase and later used as 
a template for in vitro transcription (IVT) using T7 RNA polymerase and biotinylated ribonucleotides, 
forming biotin-labelled cRNA sample. The biotin-labelled cRNA was then purified and fragmented before 
hybridised to the array (both figure (A) and (B) were self-drawn). 
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5.2.3 Affymetrix Expression Console Software: Preprocessing steps 
 
        The microarray data presented in this thesis were RMA (Robust Multi-array Average) -
background adjusted, normalised across arrays by quantile normalisation, and summarised by 
the median polish algorithm using Affymetrix Expression Console Software 1.4.1. This 
software can be accessed for free from Affymetrix Software Downloads. Normalisation is 
needed to reduce any sources of variation that could arise due to differences in sample 
preparation, production and processing of arrays. The intensity of the individual probe signals 
were then summarised into a single expression of each probe set in the form of log2 transformed 
values. This probe set summarisation was then converted into CHP files from the CEL files 
using GeneChip Command Console (AGCC) for further downstream analysis. Relevant 
NetAffx library files were downloaded from the Affymetrix website and imported into the 
software for the probe set annotation.  
        Once the probe set summarisation was completed, quality evaluation was necessary to 
identify poor-quality arrays or outlier arrays. Boxplots were used to look at individual arrays 
to detect any with divergent probe intensity distributions (Figure 5.4). All of the boxplots 
generated from the data from the 18 arrays were properly aligned and no obvious divergence 
from the median value were seen (the red line) (Figure 5.4(C)), hence none of the arrays were 
considered to be an outlier and all were included for further downstream analysis.  
        In addition to generating box plots, Expression Console Analysis software also includes 
several other Quality Control (QC) functionalities, namely hybridisation control (Figure 5.5 
(A)) and labelling control (Figure 5.5 (B)). The hybridisation efficiency of the samples on the 
arrays was assessed through the use of Hybridisation Controls termed bacterial spikes. These 
bacterial spikes are mRNA transcripts derived from genes in the biotin synthesis pathway of E. 
coli (bioB, bioC and bioD) and cre is the recombinase gene from P1 bacteriophage. These 
mRNAs were biotinylated and fragmented independently from the starting RNA samples and 
injected directly into the hybridisation cocktail onto the GeneChip probe arrays to assess the 
consistency of hybridisation, washing and staining procedures across all samples, hence the 
overall microarray performance. The probe set for these genes were represented on the 
GeneChips. The hybridisation controls were added at different concentrations (1.5pM, 5pM, 
25pM and 100pM for bioB, bioC, bioD and cre respectively), and the signal intensity increased 
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according to their relative concentration indicating the hybridisation passed this quality control 
step (AFFX-r2-Ec-bioB<bioC<bioD<cre) (Figure 5.5 (A)).  
        The efficiency of target labelling can be evaluated by using exogenous positive control 
Poly-A RNAs spikes, where these RNAs were spiked in to the starting RNA prior to cDNA 
synthesis and were amplified and labelled together with the RNA samples. These poly-A 
mRNA spikes are in vitro synthesised polyadenylated transcripts for B. subtilis genes that are 
absent in eukaryotic samples (lys, phe, thr, and dap). The probe set for these genes were 
represented on the GeneChips. The controls were added in different proportions to the isolated 
RNA (1:100,000, 1:50,000, 1:25,000 and 1:7,500 for lys, phe, thr, and dap respectively), and 
therefore, the labelling was considered to have passed the quality control when the signal values 
increased in the order AFFX-r2-Bs-lys<phe<thr<dap (Figure 5.5 (B)). The lys gene was added 
at the lowest proportion (1:100,000 of the total RNA) which is close to the sensitivity level of 
microarray. From the data presented in Figure 5.5, all 18 arrays showed the expected results, 





Figure 5.4 Boxplots of log-intensity distribution across all 18 GeneChips. (A) The probe cell 
intensity box plots were generated from CEL files before normalisation, therefore some differences in 
the distributions are to be expected. Figure (B) shows the Signal Box Plot produced from the 
summarised probe set signal values in CHP files. The x-axis shows the GeneChip with sample identity 
and y-axis shows the log2 intensity of probes for (A) and (B). Figure (C) shows the Relative Signal Box 
Plot where the distribution of probe set signal values on each array is set to the median array for the 






Figure 5.5 Hybridisation and polyA controls. The x-axis is the GeneChips with sample identity while 
the y-axis is the signal intensity of these genes that have been log2 transformed. (A) shows line graphs 
of signal intensity of hybridisation controls with increasing intensity from bioB<bioC<bioD<Cre.  (B) 





5.2.4 Principal Component Analysis  
 
         Principal component analysis (PCA) is an exploratory multivariate statistical tool to 
visualise any variations, and hence the patterns among the samples used for transcriptome 
analysis. The fundamental principle of PCA is to reduce the dimensionality of the data matrix 
by identifying a new set of variables (PCA1, PCA2, PCA3) that account for as much  of the 
variance in the original data set (Raychaudhuri et al, 2000). The first principal component 
(PCA1) samples the largest sources of gene expression signal variance in the data. While the 
remaining variability that is not accounted for by PCA1 is represented by PCA2. PCA3 
captures the remaining variability from PCA2. The PCA plot in figure 5.6 was derived from 
log-transformed intensity data of 18 arrays; three independent biological replicates of six 
different cell populations that were addressed in the present study ((i) uninfected BMDMs at 8 
hours, (ii) BMDMs infected with WT strain at 8 hpi, (iii) BMDMs infected with ΔbimA strain 
at 8hpi, (iv) uninfected BMDMs at 12 hours, (v) BMDMs infected with WT strain at 12hpi and 
(vi) BMDMs infected with ΔbimA strain at 12hpi). It would be ideal if the PCA data 
demonstrated six distinct clusters representing each of the cell populations. However, in our 
analysis, no obvious separate clustering between the populations could be observed (Figure 
5.6), but instead all the cell populations were mixed between replicates and between 
experimental conditions. By analysing the data more closely, the uninfected BMDM samples 
at 8 hours were paired with uninfected BMDM samples at 12 hours in at least two sets of 
samples. Likewise, the WT-infected BMDMs was paired with the BMDMs infected with 
∆bimA at respective time points, indicating that there was only a small variance of gene 
expression in the host cells when infected either with WT B. pseudomallei or the ∆bimA strain. 
In general, these data imply that variables between the replicates rather than the experimental 
factor itself accounted for the non-clustering within the plot. Differences in serum-containing 
cell culture, variation in cells grown and differentiation of BMDMs, differences in sample 
collection or sample handling, all these factors can affect the sensitivity of the high-throughput 
microarray, to a degree that can dominate biological changes, making it difficult to maintain 
consistent, reproducible results (Coombes et al, 2005). In addition, the variance of PCA1, 
PCA2 and PCA3 were relatively small (total of 33.4%) indicating that there were not many 





Figure 5.6 Principal component analysis (PCA) of 18 samples. Samples are coloured according to 
the sample populations. The percent variations accounted for by the first (PCA1), second (PCA2) and 




5.2.5 Identifying the Differentially Expressed Genes using Affymetrix TAC 
Software 
 
        Affymetrix Transcriptomic Analysis Console (TAC) is a user-friendly software provided 
by Affymetrix Corporation for researchers to identify differentially expressed genes (DEGs). 
Firstly, the CHP files generated from the Expression Console (EC) software were imported 
into the TAC software. The imported files were then grouped to the appropriate group window; 
biological replicates for each experimental condition were considered in the same group. There 
were two different analyses performed; the first included three separate groups (i.e. uninfected 
BMDMs, BMDMs infected with WT strain, and BMDMs infected with ΔbimA strain) at 8 hpi 
while the second analysed the 12 hpi data. The workflow for the microarray analyses is 
illustrated in figure 5.7. Gene-level analysis was performed to compute differential expression 
between the three groups. Next, pairwise comparison was selected between two groups; WT 
infected BMDMs versus uninfected BMDMs, and ΔbimA infected BMDMs versus uninfected 
BMDMs (Figure 5.7). DEGs were selected if the p-value was <0.05, and fold change exceeded 
1.5 (both upregulated and downregulated) between two groups (Table 5.2). The level of 
significance was tested using the One-Way ANOVA p-value. The average intensity of all the 
samples in a condition was based on Tukey’s Bi-Weight Average Signal. The Volcano Plot 
Graph of each comparison pair was included to identify changes in datasets. Table 5.2 shows 
a summary of the number of DEGs in the pairwise comparison. Tables 5.3 to 5.10 list the top 





Figure 5.7 Workflow of microarray data analyses. The CEL files were first imported into Affymetrix 
Expression Console (ES) software for pre-processing the microarray data. QC of the arrays were also 
determined by generating box plots, line graphs for hybridisation and  polyA labelling controls, as well 
as PCA plot. When the arrays met the quality control criteria, the output data in the form of CHP files 
were imported into Affymetrix Transcriptomic Analysis Software (TAC) to identify the differential 
expressed genes (DEGs). The transcript level was compared pairwise between the infected BMDMs 
versus uninfected BMDMs. DEGs were selected when the fold expression change exceeded 1.5 with a 
p-value <0.05. The expression profiles were then compared by Venn diagram to identify the common 





 BMDMs infected with WT 
vs uninfected BMDMs 
BMDMs infected with ∆bimA 
vs uninfected BMDM 
Number of up-regulated genes  141 153 
Number of down-regulated 
genes  
36 39  
Total number of genes  177 192 
 
 BMDMs infected with WT 
vs uninfected BMDM 
BMDMs infected with ∆bimA 
vs uninfected BMDM 
Number of up-regulated genes  231 239 
Number of down-regulated 
genes  
106 93  
Total number of genes  337 332 
Table 5.2 Number of differential expressed genes (DEGs) that met the criteria of p-value <0.05 
and fold change exceeding 1.5 for each pairwise comparison 
 
 
Figure 5.8 Venn diagram comparison of DEGs identified from Affymetrix TAC software. Blue 
and orange circles represent the DEGs in BMDMs when infected with WT and ∆bimA strains 
respectively. Numbers represent total genes that were significantly up or down -regulated in comparison 
to uninfected cells. The number shown in the overlap of the Venn circles denotes the common host 
transcriptomic changes upon infection with B. pseudomallei. The non-overlapping orange circle 








Figure 5.9 Volcano Plots of each comparison pair. X-axis is the linear fold change from comparison 
pair and Y-axis is -10log10 p-value of the ANOVA p-values. Red dots represent the upregulated 




        With the cut-off described above, 177 genes (141 upregulated and 36 downregulated) and 
192 genes (153 upregulated and 39 downregulated) were identified as differentially expressed 
in BMDMs infected with WT strain and ΔbimA strain respectively at 8hpi. At at 12hpi, more 
DEGs were identified with 337 genes (231 upregulated and 106 downregulated) and 332 genes 
(239 upregulated and 93 downregulated) in BMDMs infected with WT strain and ΔbimA strain 
respectively (summarised in Table 5.2). By comparing the time points, the number of DEGs 
were much greater (approximately 1.5 fold) at 12hpi as compared to 8hpi. The majority of the 
genes that were differentially expressed were upregulated, and only about 20-30% were 
downregulated (Table 5.2). The Volcano plots also demonstrate this trend (Figure 5.9). 
Upregulated genes demonstrated up to an 11-fold change, especially at the later time point of 
12hpi, but the majority of downregulated genes were below a -3.0-fold change, regardless of 
any pairwise comparison (Figure 5.9).   
        In general, the upregulated genes that were consistently present in all groups were pro-
inflammatory mediators namely interleukin-6 (Il-6), interleukin-1 beta (IL-1β), interleukin-1 
alpha (IL-1α), prostaglandin-endoperoxide synthase 2 (PTGS2), and the chemokine ligand 3 
(CXCL3). This cluster of genes constitutes a general ‘alarm signal’ for inflammatory responses 
(Jenner & Young, 2005). Several IFN-stimulating genes (ISGs) and IFN-inducible chemokine 
genes were also upregulated, which were more profound in cells infected at 12 hours with both 
the WT and ΔbimA strains. This cluster of genes includes ISG15, OASL1 (2’,5’-oligoadenylate 
synthetase-like 1), OASL2, OAS2 and CXCL10. This expression signature has been shown to 
be upregulated in macrophages that have been stimulated with other bacteria, and highlights 
its importance in defence against bacteria (Jenner & Young, 2005). However, the 
downregulated genes were difficult to analyse since many of them were predicted genes that 
have not yet been characterised. Besides, the genes listed as down-regulated were not obviously 
associated with innate mechanisms.  
          The resulting lists of genes were then compared between the BMDMs infected with WT 
and ΔbimA at each time point by generating Venn diagrams using VENNY tool version 2.1, an 
interactive tool developed by Juan Carlos Oliveros in 2007 
(http://bioinfogp.cnb.csic.es/tools/venny/index.html) (Figure 5.8). The list of DEGs in the 
overlapping region of the Venn diagram represents the common response of BMDMs towards 
B. pseudomallei. While the non-overlapping regions are where the genes were unique to either 
infection with the WT or the ΔbimA mutant strain. Of these, for infection at 8 hpi, 39% were 
unique to the WT strain versus uninfected, 19.4% were shared with both strains and 42.7% 
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were unique to ΔbimA.  While for infection at 12 hpi, more genes were found in the overlapping 
region with a percentage of 39%, about 31% were unique to the WT strain, and the remaining 
30% were unique to ΔbimA (Figure 5.8). Although the total number of DEGs were not different 
between the macrophages infected with WT or the ΔbimA mutant, surprisingly the percentage 
of genes shared with both strains was relatively small (20% at 8hpi and 40% at 12hpi). These 


























IL-6 interleukin 6 10.74 1.22E-02 
IL-1β interleukin 1 beta 6.33 2.26E-03 
PTGS2 prostaglandin-endoperoxide synthase 2 5.14 3.42E-03 
IL-12β interleukin 12b 4.40 1.40E-02 
IL-1α interleukin 1 alpha 4.13 1.34E-02 
IFIT1 
interferon-induced protein with tetratricopeptide 
repeats 1 3.48 2.86E-02 
CMPK2 
cytidine monophosphate (UMP-CMP) kinase 2, 
mitochondrial 3.32 1.47E-03 
RSAD2 radical S-adenosyl methionine domain containing 2 3.24 4.49E-03 
CXCL1 chemokine (C-X-C motif) ligand 1 3.15 2.12E-02 
FPR1 formyl peptide receptor 1 3.12 1.00E-02 
CXCL3 chemokine (C-X-C motif) ligand 3 3.03 2.96E-04 
RTP4 receptor transporter protein 4 2.96 5.48E-04 
GBP2B guanylate binding protein 2b 2.85 2.10E-03 
GBP5 guanylate binding protein 5 2.79 4.32E-02 
OASL2 2-5 oligoadenylate synthetase-like 2 2.65 2.48E-03 
GM22197 predicted gene, 22197 2.65 4.07E-02 
NOS2 nitric oxide synthase 2, inducible 2.60 1.13E-02 
IRG1 immunoresponsive gene 1 2.53 6.42E-04 
GBP2 guanylate binding protein 2 2.49 1.83E-02 
FPR2 formyl peptide receptor 2 2.41 1.28E-02 
OLR1 oxidised low density lipoprotein (lectin-like) receptor 1 2.39 7.35E-03 
IFI44L interferon-induced protein 44 like 2.37 1.81E-02 
CLEC4E C-type lectin domain family 4, member e 2.36 1.17E-03 
OASL1 2-5 oligoadenylate synthetase-like 1 2.29 7.84E-03 
GM22023 predicted gene, 22023 2.25 1.86E-02 
IFI204 interferon activated gene 204 2.17 1.41E-02 
ISG15 ISG15 ubiquitin-like modifier 2.17 9.17E-04 
GBP3 guanylate binding protein 3 2.16 9.25E-03 
GM4745 predicted gene 4745 2.14 4.24E-02 
GM23601 predicted gene, 23601 2.13 2.85E-02 
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Table 5.4 Top 30 downregulated transcripts in BMDMs infected with WT versus uninfected at 
8hpi 





TCRG-V4 T cell receptor gamma, variable 4 -3.72 1.65E-03 
TRGJ1 T cell receptor gamma joining 1 -2.99 3.16E-02 
GM22571 predicted gene, 22571 -2.98 1.16E-02 
GM17655 predicted gene, 17655 -2.22 1.34E-02 
GM24334 predicted gene, 24334 -2.17 2.74E-03 
GM24763 predicted gene, 24763 -2.00 5.66E-03 
GM22321 predicted gene, 22321 -1.93 8.05E-03 
P2RY12 purinergic receptor P2Y, G-protein coupled 12 -1.91 3.69E-02 
VMN1R157 vomeronasal 1 receptor 157 -1.87 1.89E-02 
GM22769 predicted gene, 22769 -1.85 2.59E-02 
MIR541 microRNA 541 -1.81 4.88E-02 
GM25914 predicted gene, 25914 -1.80 2.64E-02 
KLRA9 
killer cell lectin-like receptor subfamily A, 
member 9 -1.74 4.18E-02 
MYH4 myosin, heavy polypeptide 4, skeletal muscle -1.72 3.56E-02 
OLFR390 olfactory receptor 390 -1.71 7.28E-03 
OLFR99 olfactory receptor 99 -1.69 3.78E-02 
GM25796 predicted gene, 25796 -1.68 1.03E-02 
SPEER2 
spermatogenesis associated glutamate (E)-rich 
protein 2 -1.67 4.30E-03 
n-R5S52 nuclear encoded rRNA 5S 52 -1.66 3.47E-02 
GM24384 predicted gene, 24384 -1.66 1.84E-02 
MUP4 major urinary protein 4 -1.64 4.20E-02 
GM23325 predicted gene, 23325 -1.59 4.39E-02 
IGHV1-73 immunoglobulin heavy variable 1-73 -1.56 4.43E-02 
SULT2A2 
sulfotransferase family 2A, 
dehydroepiandrosterone (DHEA)-preferring, 
member 2 -1.56 8.09E-03 
GM15758 predicted gene 15758 -1.56 2.95E-02 
GM22805 predicted gene, 22805 -1.56 3.78E-02 
HIST1H2BM histone cluster 1, H2bm -1.53 3.78E-02 
LIFR leukaemia inhibitory factor receptor -1.53 6.92E-04 
GM22586 predicted gene, 22586 -1.53 1.27E-02 
PTGER3 prostaglandin E receptor 3 (subtype EP3) -1.52 1.25E-03 
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Table 5.5 Top 30 upregulated transcripts in BMDMs infected with ∆bimA versus uninfected at 
8hpi 





IL-6 interleukin 6 4.47 5.56E-03 
IL-1β interleukin 1 beta 3.66 1.15E-03 
PTGS2 prostaglandin-endoperoxide synthase 2 3.54 2.75E-03 
GBP5 guanylate binding protein 5 2.96 2.06E-02 
IL-12β interleukin 12b 2.89 1.19E-02 
RSAD2 radical S-adenosyl methionine domain containing 2 2.74 1.01E-02 
GM22271 predicted gene, 22271 2.65 9.96E-04 
IL-1α interleukin 1 alpha 2.64 1.03E-02 
GBP2B guanylate binding protein 2b 2.57 3.41E-02 
FPR1 formyl peptide receptor 1 2.45 3.05E-03 
RTP4 receptor transporter protein 4 2.43 2.18E-03 
CMPK2 
cytidine monophosphate (UMP-CMP) kinase 2, 
mitochondrial 2.35 2.22E-02 
NOS2 nitric oxide synthase 2, inducible 2.34 1.01E-02 
CXCL3 chemokine (C-X-C motif) ligand 3 2.33 1.19E-03 
GBP2 guanylate binding protein 2 2.25 3.81E-02 
GM20461 predicted gene 20461 2.17 8.03E-03 
GBP3 guanylate binding protein 3 2.15 4.70E-02 
ADAM23 a disintegrin and metallopeptidase domain 23 2.14 4.11E-02 
IFI44L interferon-induced protein 44 like 2.11 2.40E-02 
OASL2 2-5 oligoadenylate synthetase-like 2 2.08 8.36E-03 
FNBP1L formin binding protein 1-like 2.05 2.17E-02 
OLFR344 olfactory receptor 344 2.05 4.09E-02 
IRG1 immunoresponsive gene 1 2.04 7.04E-04 
USP18 ubiquitin specific peptidase 18 2.02 4.25E-02 
DDX60 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 1.99 3.97E-03 
4930433I11RIK RIKEN cDNA 4930433I11 gene 1.99 2.16E-02 
CXCL1 chemokine (C-X-C motif) ligand 1 1.97 6.10E-03 
GM24651 predicted gene, 24651 1.97 6.90E-04 
IFI204 interferon activated gene 204 1.96 1.32E-02 
CLEC4E C-type lectin domain family 4, member e 1.96 8.75E-04 
159 
 
Table 5.6 Top 30 downregulated transcripts in BMDMs infected with ∆bimA versus uninfected at 
8hpi 





TRGJ1 T cell receptor gamma joining 1 -3.10 3.33E-02 
TCRG-V4 T cell receptor gamma, variable 4 -2.52 2.65E-02 
GM6909 predicted gene 6909 -1.95 7.00E-06 
GM24727 predicted gene, 24727 -1.85 2.90E-02 
PRL2C5 prolactin family 2, subfamily c, member 5 -1.82 1.99E-02 
OLFR390 olfactory receptor 390 -1.79 1.15E-02 
SNORA44 small nucleolar RNA, H/ACA box 44 -1.75 3.54E-02 
MYH4 myosin, heavy polypeptide 4, skeletal muscle -1.74 4.06E-02 
GM24384 predicted gene, 24384 -1.70 4.37E-03 
SNORD110 small nucleolar RNA, C/D box 110 -1.69 4.21E-02 
KLK1B22 kallikrein 1-related peptidase b22 -1.68 1.82E-02 
SNORD61 small nucleolar RNA, C/D box 61 -1.67 4.37E-02 
AKR1CL aldo-keto reductase family 1, member C-like -1.66 1.44E-02 
1700023C21RIK RIKEN cDNA 1700023C21 gene -1.66 6.42E-03 
IGJ immunoglobulin joining chain -1.65 9.49E-03 
DEFB2 defensin beta 2 -1.65 2.58E-02 
SNORD42B small nucleolar RNA, C/D box 42B -1.64 2.92E-02 
INS2 insulin II -1.64 2.20E-02 
GM25276 predicted gene, 25276 -1.63 2.46E-03 
PRR27 proline rich 27 -1.63 9.79E-03 
DEFB10 defensin beta 10 -1.61 2.59E-02 
OLFR135 olfactory receptor 135 -1.60 8.52E-03 
ZFP763 zinc finger protein 763 -1.59 1.15E-02 
GM16066 predicted gene 16066 -1.59 6.35E-03 
MRGPRA3 MAS-related GPR, member A3 -1.59 1.93E-03 
GM561 predicted gene 561 -1.58 3.83E-02 
GM24314 predicted gene, 24314 -1.58 1.39E-02 
KRTAP5-2 keratin associated protein 5-2 -1.58 4.47E-02 
OLFR1362 olfactory receptor 1362 -1.55 6.33E-04 
GM23803 predicted gene, 23803 -1.54 8.53E-03 
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Table 5.7 Top 30 upregulated transcripts in BMDMs infected with WT versus uninfected at 12hpi 





IL-6 interleukin 6 11.66 1.68E-02 
IFIT1 
interferon-induced protein with tetratricopeptide 
repeats 1 8.30 1.01E-02 
PTGS2 prostaglandin-endoperoxide synthase 2 7.61 8.71E-03 
TRIM30D tripartite motif-containing 30D 6.28 1.71E-02 
IL-1β interleukin 1 beta 5.75 6.06E-03 
RTP4 receptor transporter protein 4 5.27 1.67E-03 
IL-1α interleukin 1 alpha 4.77 1.06E-02 
OASL2 2-5 oligoadenylate synthetase-like 2 4.61 1.24E-03 
CXCL3 chemokine (C-X-C motif) ligand 3 4.54 1.30E-02 
RSAD2 radical S-adenosyl methionine domain containing 2 4.49 4.88E-03 
CXCL10 chemokine (C-X-C motif) ligand 10 4.39 8.16E-03 
CMPK2 
cytidine monophosphate (UMP-CMP) kinase 2, 
mitochondrial 4.37 7.65E-03 
OASL1 2-5 oligoadenylate synthetase-like 1 4.29 1.27E-02 
ISG15 ISG15 ubiquitin-like modifier 4.27 5.31E-03 
IFI44L interferon-induced protein 44 like 4.26 2.03E-02 
OAS3 2-5 oligoadenylate synthetase 3 4.18 3.96E-03 
GBP5 guanylate binding protein 5 4.01 1.29E-02 
MNDA myeloid cell nuclear differentiation antigen 3.63 7.65E-03 
IRF7 interferon regulatory factor 7 3.60 3.63E-02 
OAS2 2-5 oligoadenylate synthetase 2 3.44 1.43E-02 
GM12250 predicted gene 12250 3.39 8.29E-03 
CXCL5 chemokine (C-X-C motif) ligand 5 3.36 1.76E-02 
IFI205 interferon activated gene 205 3.34 2.74E-02 
DDX58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 3.27 5.28E-03 
IFI204 interferon activated gene 204 3.27 1.84E-02 
TRIM30C tripartite motif-containing 30C 3.25 4.04E-02 
SLFN1 schlafen 1 3.20 4.37E-02 
IFIT2 
interferon-induced protein with tetratricopeptide 
repeats 2 3.19 1.03E-02 
MX2 myxovirus (influenza virus) resistance 2 3.14 1.75E-02 
EPSTI1 epithelial stromal interaction 1 (breast) 3.10 1.27E-02 
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Table 5.8 Top 30 downregulated transcripts in BMDMs infected with WT versus uninfected at 
12hpi 





TCRG-V4 T cell receptor gamma, variable 4 -2.68 3.17E-03 
CD34 CD34 antigen -2.66 7.58E-03 
CD209A CD209a antigen -2.43 1.85E-02 
RGS18 regulator of G-protein signalling 18 -2.17 1.62E-02 
VWA5B2  von Willebrand factor A domain containing 5B2 -2.14 4.61E-03 
PTPN22 
protein tyrosine phosphatase, non-receptor type 22 
(lymphoid) -2.07 3.12E-02 
OLFR458 olfactory receptor 458 -1.88 6.04E-03 
GM22305 predicted gene, 22305 -1.87 2.37E-02 
GM23763 predicted gene, 23763 -1.86 8.14E-03 
OLFR1216 olfactory receptor 1216 -1.85 1.86E-03 
MAGEB1 melanoma antigen, family B, 1 -1.83 9.60E-03 
DEFA-PS13 defensin, alpha, pseudogene 13 -1.83 4.13E-02 
RGS2 regulator of G-protein signalling 2 -1.82 2.59E-02 
GM24839 predicted gene, 24839 -1.80 2.46E-03 
SNORD37 small nucleolar RNA, C/D box 37 -1.79 3.38E-02 
CDH1 cadherin 1 -1.79 1.26E-02 
ALOX5 arachidonate 5-lipoxygenase -1.78 3.36E-03 
FCRLS Fc receptor-like S, scavenger receptor -1.76 5.76E-03 
GM22236 predicted gene, 22236 -1.76 7.00E-03 
TRGV2 T cell receptor gamma variable 2 -1.76 6.30E-03 
GM8126 predicted gene 8126 -1.76 4.12E-02 
OLFR136 olfactory receptor 136 -1.75 4.50E-02 
CCR2 chemokine (C-C motif) receptor 2 -1.74 4.33E-03 
SNORA33 small nucleolar RNA, H/ACA box 33 -1.74 3.05E-02 
GM23819 predicted gene, 23819 -1.74 5.59E-03 
ASGR2 asialoglycoprotein receptor 2 -1.73 3.08E-03 
OLFR803 olfactory receptor 803 -1.73 3.08E-02 
CD300E CD300e antigen -1.71 6.30E-03 
VRK1 vaccinia related kinase 1 -1.71 3.34E-03 




Table 5.9 Top 30 upregulated transcripts in BMDMs infected with ∆bimA versus uninfected at 
12hpi 





IL-6 interleukin 6 10.20 1.49E-02 
IFIT1 
interferon-induced protein with tetratricopeptide 
repeats 1 8.86 1.18E-02 
PTGS2 prostaglandin-endoperoxide synthase 2 8.35 7.07E-03 
TRIM30D tripartite motif-containing 30D 6.78 2.86E-02 
TRIM30C tripartite motif-containing 30C 6.40 2.55E-02 
RTP4 receptor transporter protein 4 5.58 3.57E-03 
CXCL10 chemokine (C-X-C motif) ligand 10 5.44 1.04E-02 
RSAD2 
radical S-adenosyl methionine domain 
containing 2 5.35 4.76E-03 
GBP5 guanylate binding protein 5 5.29 1.02E-02 
IL-1β interleukin 1 beta 5.11 1.14E-02 
IFI204 interferon activated gene 204 5.09 1.84E-02 
CMPK2 
cytidine monophosphate (UMP-CMP) kinase 2, 
mitochondrial 5.00 7.82E-03 
IFI44L interferon-induced protein 44 like 4.98 1.77E-02 
OASL2 2-5 oligoadenylate synthetase-like 2 4.87 2.45E-03 
IFIT2 
interferon-induced protein with tetratricopeptide 
repeats 2 4.81 5.78E-03 
GBP4 guanylate binding protein 4 4.52 1.14E-02 
MX2 myxovirus (influenza virus) resistance 2 4.48 1.19E-02 
IL-1α interleukin 1 alpha 4.23 1.32E-02 
ISG15 ISG15 ubiquitin-like modifier 4.21 7.26E-03 
EPSTI1 epithelial stromal interaction 1 (breast) 4.12 2.12E-02 
IIGP1 interferon inducible GTPase 1 3.93 2.49E-02 
GM12250 predicted gene 12250 3.91 1.98E-02 
OAS3 2-5 oligoadenylate synthetase 3 3.86 7.85E-03 
CXCL3 chemokine (C-X-C motif) ligand 3 3.84 2.31E-02 
OASL1 2-5 oligoadenylate synthetase-like 1 3.83 1.19E-02 
IFI205 interferon activated gene 205 3.82 2.20E-02 
MNDA myeloid cell nuclear differentiation antigen 3.77 1.30E-02 
GM4951 predicted gene 4951 3.62 1.26E-02 
GBP9 guanylate-binding protein 9 3.59 2.44E-02 
DDX60 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 3.58 8.04E-03 
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Table 5.10 Top 30 downregulated transcripts in BMDMs infected with ∆bimA versus uninfected 
at 12hpi 





TCRG-V4 T cell receptor gamma, variable 4 -2.94 9.73E-03 
TRGJ1 T cell receptor gamma joining 1 -2.81 4.97E-02 
CD34 CD34 antigen -2.51 9.32E-03 
GM23763 predicted gene, 23763 -2.32 5.54E-04 
ALOX5 arachidonate 5-lipoxygenase -2.22 8.82E-03 
TCRG-C3 T cell receptor gamma, constant 3 -2.16 7.24E-03 
GM24142 predicted gene, 24142 -2.06 2.30E-02 
PTPN22 
protein tyrosine phosphatase, non-receptor type 22 
(lymphoid) -2.04 4.20E-02 
CCR2 chemokine (C-C motif) receptor 2 -2.02 4.91E-03 
MAGEB1 melanoma antigen, family B, 1  -1.93 2.71E-02 
GM25799 predicted gene, 25799 -1.93 4.96E-02 
RAB26OS RAB26, member RAS oncogene family -1.89 2.20E-02 
SNORA33 small nucleolar RNA, H/ACA box 33 -1.88 3.37E-02 
SNORD37 small nucleolar RNA, C/D box 37 -1.87 3.54E-02 
CD209A CD209a antigen -1.85 1.91E-02 
GM26345 predicted gene, 26345 -1.82 2.31E-02 
GM22797 predicted gene, 22797 -1.82 3.83E-02 
RGS18 regulator of G-protein signalling 18 -1.81 4.61E-02 
GM25970 predicted gene, 25970 -1.81 3.29E-02 
FCRLS Fc receptor-like S, scavenger receptor -1.79 1.35E-02 
CDH1 cadherin 1 -1.78 3.11E-02 
GM26354 predicted gene, 26354 -1.78 3.79E-02 
AKR1C19 aldo-keto reductase family 1, member C19 -1.77 1.22E-02 
GM5643 
heterogeneous nuclear ribonucleoprotein A1 
pseudogene -1.76 3.46E-02 
GM20461 predicted gene 20461 -1.75 3.16E-02 
MIR743 microRNA 743 -1.74 1.07E-02 
CD300E CD300e antigen -1.74 2.55E-02 
MCM7 minichromosome maintenance deficient 7 -1.74 4.97E-02 
GM22303 
predicted gene, 22303; topoisomerase (DNA) II 
alpha -1.72 2.60E-02 
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5.2.6 Functional Classification of Differentially Expressed Genes by IPA 
      
        The next step after differential expression analysis was to categorise the list of DEGs into 
functions, interactions and pathways that reflect the underlying biological processes. This 
process is known as Functional Enrichment Analysis where a statistical algorithm is used to 
find functional annotations that the set of genes are significantly associated with. Nowadays, 
there are several Pathway Analysis Software (PAS) available for biologists to carry out such 
analysis without requiring advanced computer skills. Among the common ones are the free 
online web interface Database for Annotation, Visualisation and Integrated Discovery 
(DAVID) and the commercial software Ingenuity Pathway Analysis (IPA) (QIAGEN). This 
analysis relies on biological databases where DAVID and IPA functional enrichment annotate 
pathways based on the DAVID Knowledgebase and IPA’s proprietary Knowledgebase 
respectively (Sherman et al, 2007). The data presented here were analysed using IPA software, 
where this software provides additional graphical representation of biological pathways, a 
feature which is not available in DAVID. This feature is invaluable to researchers as it 
visualises the networks of interacting genes, hence allowing insights into specific 
molecular/cellular pathways based on known biological interactions.  
        A list of DEGs in each group were uploaded and imported into IPA. Core Analysis was 
performed with default settings in IPA. Right-tailed Fisher’s exact tests were used to calculate 
a p-value for each of the biological functions assigned to the uploaded list of DEGs. The 
Canonical Pathway Analysis in IPA associates the genes with canonical pathways in 
Ingenuity’s Knowledgebase and returns three measures of association: (1) a list of associated 
molecules that maps to the pathway, (2) a p-value of the Fisher’s exact test and (3) ratio of 
DEGs mapping to each specific pathway divided by the total number of genes in the pathway.   
        Out of 60 DEGs that represent the common host response to both strains at 8 hpi, 55 were 
mapped by IPA and resulted in 69 canonical pathways. Table 5.11 shows the ranking of the 
top 30 IPA canonical pathways of common host responses to infection at 8hpi. The majority 
of the top ranking IPA-identified canonical pathways were involved in immune-related 
signalling and communication associated with host innate and adaptive immune responses. 
Among them are ‘Communication Between Innate and Adaptive Immune Cells’ which was 
identified at the top of the analysis, ‘Role of Cytokines in Mediating Communication between 
Immune Cells’ (rank 5), ‘Crosstalk between Dendritic Cells and Natural Killer Cells’ (rank 
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11), ‘TREM1 Signalling’ and ‘Toll-like Receptor Signalling’ (rank 18) in which the pro-
inflammatory mediators IL-6, IL-1β, IL-1α, and Tumor Necrosis factor (TNF) were the 
common associated molecules between them. Some of these signalling pathways were also 
found at 12hpi (Table 5.11). 
        At 12hpi, 166 DEGs were found in the overlapping region of differential transcripts to 
both strains, of which 150 were mapped by IPA and generated 58 canonical pathways. Table 
5.12 shows the ranking of the top 30 IPA canonical pathways of common host responses to 
infection by B. pseudomallei at 12hpi. IPA analysis identified several pathways related to 
Interferon signalling in response to B. pseudomallei at 12hpi (Table 5.12). The most 
significantly enriched canonical pathway in this category is ‘Activation of Interferon 
Regulatory Factors (IRF) by Cytosolic Pattern Recognition Receptors’ followed by ‘Interferon 
Signalling’. Interestingly, this interferon-dependent cellular pathway is mainly involved in the 
host recognition of viral PAMPs, yet it was also upregulated in response to B. pseudomallei.  
The genes that were upregulated in the pathway include the cytosolic PRRs retinoic acid 
inducible gene-1 (RIG-1) (also known as DDX58) and RIG-1 like receptors (RLR), namely 
melanoma differentiation gene-5 (MDA-5) (also known as IFIH) and laboratory of genetics 
and physiology 2 (LGP2) (also known as DHX58). Upon RNA recognition, RIG-1 and MDA-
5 are recruited to mitochondria to bind with the adaptor protein MAVS (mitochondrial anti-
viral signalling). This results in a signalling cascade leading to nuclear translocation of the 
transcription factors Interferon Regulatory Factor 3 (IRF3) and IRF7 (reviewed in Reikine et 
al, 2014). IRF3 and IRF7 induce the expression of interferon and interferon-stimulated genes 
(ISGs), of which IFNα4 and ISG15 were among the genes upregulated in the dataset. Genes 
encoding transcription factors involved in generating an IFN response namely STAT1 and 
STAT2, together with their partner IRF9, were also found to be significantly upregulated 
(reviewed in Platanias, 2005). In addition to the involvement of PRR-signalling through RIG-
1 and RLRs, the analysis also identified more PRR-related signalling pathways namely ‘Role 
of Pattern Recognition Receptors in Recognition of Bacteria and Viruses’ (3rd rank) and ‘Toll-
like receptor signalling’ (13th rank). Given the previously identified role of programmed cell 
death during B. pseudomallei infection in vitro (Bast et al, 2014), ‘Death receptor signalling’ 
was identified at 17th rank. Several poly-(ADP)ribose polymerase (PARP) molecules were 
associated with the pathway namely PARP9 (BAL1), PARP10, PARP12 and PARP14 (BAL2) 
which were also found in other pathways namely ‘Retinoic Acid Mediated Apoptosis Signalling’ 
(rank 6th) and ‘UVA-induced MAPK signalling’ (rank 16th). The PARP proteins are involved 
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in post-translational modification of ADP-ribose protein using NAD+ as a substrate, a process 
known as poly(ADP-ribosyl)ation. This mechanism is important in modulating several 
intracellular pathways including the DNA damage response, protein stability and cell death 
(Vyas & Chang, 2014; Schreiber et al, 2006).  
       For the canonical pathways that were identified uniquely to the B. pseudomallei WT strain, 
they were generally similar to the canonical pathways of common host response to both strains 
as described above, but with additional specific molecules. Interferon-related immune 
canonical pathways ‘Activation of IRF by Cytosolic Pattern Recognition Receptors’ and ‘Role 
of RIG1-like receptors in Antiviral Innate Immunity’ were also identified at both 8hpi and 12hpi 
in this category (Table 5.13 and 5.14). Interestingly, both cytoplasmic sensors of viral nucleic 
acids Interferon Induced with Helicase C domain 1 (IFIH1) and Z-DNA binding protein 1 
(ZBP-1/DAI) were found to be uniquely increased at 8hpi in response to B. pseudomallei WT 
strain. At 12 hpi, the transcription factor IRF7 involved in expression of interferon-related 
genes was found to be significantly expressed along with the pro-inflammatory cytokine TNF 
(tumour necrosis factor). Noticeably, the inhibitory gene NFKBIE of the NF-kB signalling 
pathway was found to be upregulated in this category both at 8 hpi and 12 hpi. An increase in 
the expression of such an inhibitory gene is an equally important aspect of the response to re-
balance the host cell to its inactivated state when the inflammatory stimulus is no longer present.   
        In contrast, very few IPA canonical pathways with significant p-value (less than 0.05) 
could be mapped with the list of DEGs describing the specific response of macrophages to the 
ΔbimA mutant (2 pathways for 8 hpi and 12 pathways for 12 hpi) (Table 5.15 and 5.16). Up to 
40% of the genes were not characterised in IPA pathways. 53 genes out of 132 DEGs and 52 
genes from 149 DEGs, identified at 8hpi and 12hpi respectively, could not be mapped by IPA. 
This indicates that the genes involved in detection and elimination of the B. pseudomallei  
ΔbimA mutant are likely to be novel. The NOS2 (Type 2 nitric oxide synthase, also known as 
iNOS) gene was upregulated specifically in response to ΔbimA, and was mapped to ‘Citrulline-
Nitric Oxide Cycle’ and ‘Superpathway of Citrulline Metabolism’ pathways based on IPA 
analysis. Nos2/iNOS enzyme is expressed in activated macrophages, synthesises nitric oxide 
(NO) production for controlling replication of other Gram-negative bacteria such as E. coli and 
S. typhi, but not in response to B. pseudomallei (Utaisincharoen et al, 2001). B. pseudomallei 
has previously been shown to be capable of evading Nos2/iNOS-dependent macrophage killing 
(Utaisincharoen et al, 2001), hence, an increase in the expression here could be a specific 
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response to the ΔbimA strain. Additionally, the FAS gene was also increased in expression in 
this study where Fas protein is expressed on the surface of macrophages to interact with its 
ligand (FasL), resulting in FasL-induced apoptosis. This apoptotic mechanism effectively 
controlled the intracellular viability of Mycobacterium tuberculosis (Oddo et al, 1998), hence 
could represent a potential mechanism to the reduced intracellular survival of the ΔbimA 
mutant. The FAS gene was mapped to three different IPA canonical pathways namely, ‘p53 
signalling’, ‘Type I Diabetes Mellitus Signalling’, ‘Allograft Rejection Signalling’ and ‘Aryl 
Hydrocarbon Receptor Signalling’. In addition to NOS2 and FAS, FNBP1L (formin binding 
protein-1 like) gene (also known as TOCA-1) was also differentially expressed in response to 
ΔbimA at 12hpi, but was not mapped to any canonical pathway. TOCA-1 was shown to have a 
role in antibacterial autophagy to restrict intracellular replication of Salmonella enterica 
serovar Typhimurium (Huett et al, 2009), hence, another potential innate mechanism to target 
the B. pseudomallei ΔbimA mutant.  
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Table 5.11 Top 30 IPA canonical pathways of common host responses to infection by B. 
pseudomallei at 8hpi. The table ranks the pathways from the lowest to the highest p-value based on 
Fisher’s exact test. The ratio is calculated as the number of DEGs in the given pathway (listed as 
associated molecules) divided by the total number of genes annotated in each canonical pathway in IPA. 
 
Canonical pathways from IPA p-value Ratio Associated molecules 
1 Communication Between Innate and 
Adaptive Immune Cells 
6.13E-12 8/63 
(0.127) 
CCL5, CCR7, CD40, IL-
6, IL-12β, IL-1α, IL-1β, 
TNF  




CCL5, CCL20, CXCL2, 
CXCL3, FPR1, FPR2, 
IL-1α, IL-1β, MMP25, 
TNF  
3 Role of Hypercytokinemia/ 
Hyperchemokinemia in the 
Pathogenesis of Influenza  
8.87E-11 6/27 
(0.222) 
CCL5, IL-6, IL-12β, IL-
1α, IL-1β, TNF  
4 Differential Regulation of Cytokine 
Production in Macrophages and T 
Helper cells by IL-17A and IL-17F 
3.74E-10 5/15 
(0.333) 
CCL5, IL-6, IL-12β, IL-
1β, TNF  
5 Role of Cytokines in Mediating 




IL-6, IL-12β, IL-1α, IL-
1β, TNF  
6 Altered T cell and B cell Signalling 
in Rheumatoid Arthritis  
6.41E-08 6/77 
(0.078) 
CD40, IL-6, IL-12β, IL-
1α, IL-1β, TNF  
7 Dendritic Cell Maturation  1.37E-07 7/146 
(0.048) 
CCR7, CD40, IL-6, IL-
12β, IL-1α, IL-1β, TNF  
8 Activation of IRF by Cytosolic 
Pattern Recognition Receptors 
2.45E-07 5/50 
(0.100)  
CD40, DHX58, IL-6, 
ISG15, TNF 
9 LXR/RXR Activation 4.85E-07 6/108 
(0.056) 
IL-6, IL-1α, IL-1β, 
NOS2, PTGS2, TNF  
10 Role of PRR in Recognition of 
Bacteria and Viruses 
7.03E-07 6/115 
(0.052) 
CCL5, IL-6, IL-12β, IL-
1α, IL-1β, TNF  
11 Crosstalk between Dendritic Cells 
and Natural Killer Cells 
1.16E-06 5/68 
(0.074) 
CCR7, CD40, IL-6, IL-
12β, TNF  
12 Atherosclerosis Signalling  1.25E-05 5/110 
(0.045) 
CD40, IL-6, IL-1α, IL-
1β, TNF  
13 Graft-versus-Host disease Signalling  2.20E-06 4/34 
(0.118) 
IL-6, IL-1α, IL-1β, TNF  
14 HMGB1 Signalling  1.37E-05 5/112 
(0.045) 
IL-6, IL-12β, IL-1α, IL-
1β, TNF 
15 T-helper Cell Differentiation  2.50E-05 4/62 
(0.065) 
CD40, IL-6, IL-12β, 
TNF 
16 IL-10 Signalling  3.01E-05 4/65 
(0.062) 
IL-6, IL-1α, IL-1β, TNF  
17 TREM1 Signalling  3.60E-05 4/68 
(0.059) 
CD40, IL6, IL1B, TNF  
18 Toll-like Receptor Signalling  4.04E-05 4/70 
(0.057) 
IL-12β, IL-1α, IL-1β, 
TNF  




IL-6, IL-12β, IL-1α 
20 Hepatic Cholestasis 5.58E-05 5/150 
(0.033) 
IL-6, IL-12β, IL-1α, IL-
1β, TNF  




CD40, IL-6, IL-1α, IL-
1β, TNF  
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22 Glucocorticoid Receptor Signalling  7.81E-05 6/258 
(0.023) 
CCL5, IL-6, IL-1β, 
NOS2, PTGS2, TNF 
23 PPAR Signalling  1.04E-04 4/89 
(0.045) 
IL-1α, IL-1β, PTGS2, 
TNF  
24 Role of Macrophages, Fibroblasts 




CCL5, IL-6, IL-1α, IL-





IL-1α, IL-1β, PTGS2, 
TNF  
26 Type I Diabetes Mellitus Signalling  1.45E-04 4/97 
(0.041) 
IL-12β, IL-1β, NOS2, 
TNF  
27 Allograft Rejection Signalling  1.66E-04 3/39 
(0.077) 
CD40, H2-M2, TNF  
28 MSP-RON Signalling  2.23E-04 3/43 (0.07) IL-12β, NOS2, TNF  
29 IL-6 Signalling 2.60E-04 4/113 
(0.035) 
IL-6, IL-1α, IL-1β, TNF  










Table 5.12 Top 30 IPA canonical pathways of common host responses to infection by B. 
pseudomallei at 12hpi. The table ranks the pathways from the lowest to the highest p-value based on 
Fisher’s exact test. The ratio is calculated as the number of DEGs in the given pathway (listed as 
associated molecules) divided by the total number of genes annotated in each canonical pathway in IPA. 
  Canonical Pathways from IPA p-value Ratio Associated molecules 
1 Activation of IRF by Cytosolic 
Pattern Recognition Receptors  
4.96E-17 13/50 
(0.26) 
ADAR, CD40, DDX58/RIG-1, 
DHX58/LGP2, IL-6, ISG15, 
IFIH1/MDA-5, IFIT2, IRF9, 
STAT1, STAT2, IFNα4, ZBP1   
2 Interferon Signalling  4.97E-11 8/30 
(0.267) 
IFIT1, IRF1, IRF9, ISG15, 
OAS1, STAT1, STAT2, TAP1 
3 Role of Pattern Recognition 
Receptors in Recognition of 
Bacteria and Viruses   
8.03E-11 12/115 
(0.104) 
IL-1α, IL-1β, OAS1, OAS2, 
OAS3, Oas1b, CCL5, 
DDX58/RIG-1, IFNα4 




CCL5, CXCL12, CXCL3, 
CXCL6, CXCL9, CXCL10, 
CXCL11, FPR1, FPR2, IL-1α, 
IL-1β, SDC4 




CCL5, CD34, CXCL2, 
CXCL3, CXCL6, CXCL9, 
CXCL10, CXCL11, IL-1α, IL-
1β, SDC4 




IFNα4, IRF1, PARP9, 
PARP10, PARP12, PARP14 
7 Role of Hypercytokinemia/ 
Hyperchemokinemia in the 
Pathogenesis of Influenza  
4.75E-08 6/27 
(0.222) 
CCL5, CXCL10, IFNα4, IL-6, 
IL-1α, IL-1β  
8 Communication Between Innate 
and Adaptive immune cells 
8.60E-06 6/63 
(0.095) 
CCL5, CD40, CXCL10, IL-6, 
IL-1α, IL-1β  
9 Role of RIG1-like Receptors in 





10 Role of Cytokines in Mediating 
Communication Between 
Immune Cells  
1.62E-04 4/36 
(0.111) 
IFNα4, IL6, IL-1α, IL-1β 
11 Role of IL-17F in Allergic 
Inflammation Airway Disease 
1.80E-04 4/37 
(0.108) 
CXCL6, CXCL10, IL-6, IL-1β  
12 Differential regulation of cytokine 
production in macrophages and T 




CCl5, IL-6, IL-1β  
13 Toll-like receptor Signalling  2.04E-04 5/70 
(0.071) 
IL-1α, IL-1β, TNFAIP3, 
TRAF1, EIF1AK2  
14 Atherosclerosis signalling  2.04E-04 6/110 
(0.055) 
ALOX5, CCR2, CD40, IL-6, 
IL-1α, IL-1β  
15 Differential Regulation of 
Cytokine Production in Intestinal 




CCL5, IL-1α, IL-1β  
16 UVA-Induced MAPK Signalling  5.24E-04 5/86 
(0.058) 
PARP9, PARP10, PARP12, 
PARP14, STAT1  
17 Death Receptor Signalling  5.53E-04 5/87 
(0.057) 




18 IL-15 production  7.96E-04 3/24 
(0.125) 
IL-6, IRF1, STAT1 




CCL5, CXCL10  
20 Dendritic Cell Maturation  9.23E-04 6/146 
(0.041) 
CD40, IL-6, IL-1α, IL-1β, 
STAT1, STAT2  
21 CD40 Signalling  1.39E-03 4/63 
(0.063) 
CD40, PTGS2, TNFAIP3, 
TRAF1 
22 Role of Lipids/Lipid Rafts in the 








IL-6, IL-1α, IL-1β  
24 Hepatic fibrosis/Hepatic Stellate 
Cell Activation  
2.33E-03 6/175 
(0.034)  
CCL5, CD40, IL-6, IL-1α, IL-
1β, STAT1  
25 Altered T cell and B cell 




CD40, IL-6, IL-1α, IL-1β  
26 Role of PKR in Interferon 
Induction and Antiviral Response 
3.31E-03 3/39 
(0.077) 
EIF2AK2, IRF1, STAT1 
27 Role of IL-17A in Arthritis  6.30E-03 3/49 
(0.061)  
CCL5, CXCL6, PTGS2 




CD40, IFNα4, IL-6, IL-1α, IL-
1β 
29 NF-ΚB Signalling  7.88E-03 5/160 
(0.031) 
CD40, EIF2AK2, IL-1α, IL-
1β, TNFAIP3  
30 LXR/RXR Activation  9.63E-03 4/108 
(0.037) 






Table 5.13 Top 30 IPA canonical pathways exclusive to the WT strain of B. pseudomallei at 8hpi. 
The table ranks the pathways from the lowest to the highest p-value based on Fisher’s exact test. The 
ratio is calculated as the number of DEGs in the given pathway (listed as associated molecules) divided 
by the total number of genes annotated in each canonical pathway in IPA. 
  Canonical Pathways from IPA p-value Ratio Associated 
molecules 
1 Activation of IRF by Cytosolic Pattern 
Recognition Receptors  
8.90E-06 4/50 (0.08) IFIH1, NFKBIE, 
STAT1, ZBP1  
2 UVA-Induced MAPK Signalling  1.51E-03 3/86 (0.035) PARP9, PARP12, 
STAT1 
3 Death Receptor Signalling  1.56E-03 3/87 (0.034)  NFKBIE, PARP9, 
PARP12  
4 TNFR2 Signalling  2.64E-03 2/29 (0.069) NFKBIE, TRAF1  
5 Role of RIG1-like Receptors in Antiviral 
Innate Immunity  
2.82E-03 2/30(0.067) IFIH1, NFKBIE 
6 2-1BB Signalling in T Lymphocytes  2.82E-03 2/30 (0.067)  NFKBIE, TRAF1  
7 Interferon Signalling  2.82E-03 2/30 (0.067) IFIT1, STAT1 
8 TWEAK Signalling  3.41E-03 2/33 (0.061)  NFKBIE, TRAF1  
9 Role of Pattern Recognition Receptors in 
Recognition of Bacteria and Viruses  
3.44E-03 3/115 (0.026) IFIH1, OAS2, 
OAS3  
10 G-Protein Coupled Receptor Signalling  4.31E-03 4/252 (0.016)  ADORA2A, 
NFKBIE, PYRY12, 
PTGER3 
11 April-Mediated Signalling  4.50E-03 2/38 (0.053)  NFKBIE, TRAF1  
12 Role of PKR in Interferon Induction and 
Antiviral Response  
4.73E-03 2/39 (0.051) NFKBIE, STAT1  
13 B Cell Activating Factor Signalling  4.97E-03 2/40 (0.05) NFKBIE, TRAF1  
14 iNOS Signalling  5.73E-03 2/43 (0.047) NFKBIE, STAT1  
15 Retinoic Acid Mediated Apoptosis 
Signalling  
5.99E-03 2/44 (0.045) PARP9, PARP12 
16 Dendritic Cell Maturation  6.69E-03 3/146 (0.021) NFKBIE, STAT1, 
STAT4  
17 CNTF Signalling  6.81E-03 2/47 (0.043)  LIFR, STAT1  
18 PPARα/RXRα Activation  9.35E-03 3/165 (0.018) HELZ2, MEF2C, 
NFKBIE  
19 Acetate Conversion to Acetyl-CoA 1.05E-02 1/4 (0.25) ACSL1 
20 Induction of Apoptosis by HIV1 1.06E-02 2/59 (0.034) NFKBIE, TRAF1  
21 T Helper Cell Differentiation  1.16E-02 2/62 (0.032) STAT1, STAT4  
22 CD40 Signalling  1.20E-02 2/63 (0.032) NFKBIE, TRAF1  
23 FLT3 Signalling in Hematopoietic 
Progenitor Cells  
1.50E-02 2/71 (0.028) STAT1, STAT4  
24 Small Cell Lung Cancer Signalling  1.50E-02 2/71 (0.028) NFKBIE, TRAF1  
25 JAK/STAT Signalling  1.55E-02 2/72 (0.028) STAT1, STAT4  
26 cAMP-mediated signalling  1.83E-02 3/212 (0.014) ADORA2A, 
P2RY12, PTGER3 
27 Type I Diabetes Mellitus Signalling  2.70E-02 2/97 (0.021) NFKBIE, STAT1 
28 Fatty Acid Activation  3.12E-02 1/12 (0.083)  ACSL1 
29 p38 MAPK Signalling  3.40E-02 2/110 (0.018)  MEF2C, STAT1  
30 Type II Diabetes Mellitus Signalling  3.57E-02 2/113 (0.018)  ACSL1, NFKBIE  
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Table 5.14 Top 30 IPA canonical pathways exclusive to the WT strain of B. pseudomallei at 
12hpi. The table ranks the pathways from the lowest to the highest p-value based on Fisher’s exact test. 
The ratio is calculated as the number of DEGs in the given pathway (listed as associated molecules) 
divided by the total number of genes annotated in each canonical pathway in IPA. 
 
  Canonical Pathways from IPA p-value Ratio Associated molecules 
1 Role of RIG1-like receptors in 
Antiviral Innate Immunity  
1.70E-04 3/30 (0.1)  IRF7, NFKBIE, 
TRIM25  
2 Activation of IRF by Cytosolic Pattern 
Recognition Receptors  
7.79E-04 3/50(0.06) IRF7, NFKBIE, TNF 
3 Dendritic Cell Maturation  1.91E-03 4/146 (0.027) HLA-A, LY75, 
NFKBIA, TNF  
4 Cyclins and Cell Cycle Regulation  2.52E-03 3/75 (0.04) CCNA2, CCND1, 
CDKN2C  
5 Estrogen-mediated S-phase Entry  3.36E-03 2/24 (0.083) CCNA2, CCND1 
6 PPAR Signalling  4.08E-03 3/89 (0.034) NFKBIA, PDGFC, 
TNF  
7 Antigen Presentation Pathway  4.25E-03 2/27 (0.074) HLA-A, NLRC5  
8 TNFR2 Signalling  4.89E-03 2/29 (0.069) NFKBIA, TNF  
9 Type I Diabetes Mellitus Signalling  5.19E-03 3/97 (0.031) HLA-A, NFKBIA, 
TNF 
10 Glioma Signalling  5.19E-03 3/97 (0.031) CCND1, CDKN2C, 
PDGFC  
11 Graft-versus-host disease Signalling  6.68E-03 2/34 (0.059) HLA-A, TNF  
12 Neuroprotective Role of THOP1 in 
Alzheimer's Disease  
7.07E-03 2/35 (0.057) HLA-A, MME 
13 Role of PKR in Interferon Induction 
and Antiviral Response  
8.27E-03 2/39 (0.051) NFKBIA, TNF  
14 Allograft Rejection Signalling  8.72E-03 2/39 (0.051) HLA-A, TNF  
15 Aryl Hydrocarbon Receptor Signalling  1.13E-02 3/129 (0.023) CCNA2, CCND1, TNF  
16 TNFR1 Signalling  1.25E-02 2/47 (0.043) NFKBIA, TNF  
17 eNOS Signalling  1.28E-02 3/135 (0.022) CCNA2, KDR, PDGFC  
18 OX40 Signalling  1.41E-02 2/50 (0.04) HLA-A, NFKBIA 
19 Airway Inflammation in Asthma 1.44E-02 1/4 (0.25) TNF  
20 Regulation of Cellular Mechanics by 
Calpain Protease  
1.63E-02 2/54 (0.037) CCNA2, CCND1  
21 PXR/RXR Activation  1.80E-02 2/57 (0.035) CYP2C9, TNF  
22 Role of Macrophages, Fibroblasts, and 
Endothelial Cells in Rheumatoid 
Arthritis  
1.91E-02 4/283 (0.014) CCND1, NFKBIA, 
PDGFC, TNF  
23 Acute Phase Response Signalling  1.91E-02 3/157 (0.019) CP, NFKBIA, TNF  
24 Induction of Apoptosis by HIV1  1.92E-02 2/59 (0.034) NFKBIA, TNF  
25 NF-kB Signalling  2.01E-02 3/160 (0.019) KDR, NFKBIA, TNF  
26 Cell Cycle: G1/5 Checkpoint 
Regulation  
2.05E-02 2/61 (0.033) CCND1, CDKN2C  
27 Airway Pathology in Chronic 
Obstructive Pulmonary Disease  
2.15E-02 1/6 (0.167)  TNF  
28 Communication between Innate and 
Adaptive Immune Cells  
2.17E-02 2/63 (0.032) HLA-A, TNF  
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29 Hypoxia Signalling in the 
Cardiovascular System  
2.17E-02 2/63 (0.032) NFKBIA, UBE2L6  
30 IL-10 Signalling  2.31E-02 2/65 (0.031) NFKBIA, TNF  
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Table 5.15 IPA canonical pathways exclusive to the ΔbimA strain of B. pseudomallei at 8hpi. The 
table ranks the pathways from the lowest to the highest p-value based on Fisher’s exact test. The ratio 
is calculated as the number of DEGs in the given pathway (listed as associated molecules) divided by 
the total number of genes annotated in each canonical pathway in IPA. 
Canonical Pathways from IPA p-value Ratio Associated 
molecules 
Role of IL-17A in Psoriasis  1.71E-02 1/7 (0.143) CXCL6  
Role of Pattern Recognition Receptors of 






Table 5.16 IPA canonical pathways exclusive to the ΔbimA strain of B. pseudomallei at 12hpi. The 
table ranks the pathways from the lowest to the highest p-value based on Fisher’s exact test. The ratio 
is calculated as the number of DEGs in the given pathway (listed as associated molecules) divided by 
the total number of genes annotated in each canonical pathway in IPA. 
Canonical pathways from IPA p-value  Ratio  Associated 
molecules  
p53 signalling  5.19E-03 3/94 (0.032) CHEK1, DRAM1, 
FAS 
Type I Diabetes Mellitus Signalling  5.67E-03 3/97 (0.031) FAS, NOS2, 
SOCS1 
Allograft Rejection Signalling  9.56E-03 2/39 (0.051) FAS, H2-M2 
Aryl Hydrocarbon Receptor Signalling  1.29E-03 3/129 (0.023) CHEK1, FAS, 
MCM7  
Citrulline-Nitric Oxide Cycle  1.48E-03 1/4 (0.25) NOS2 
Role of Macrophages, Fibroblasts and 
Endothelial Cells in Rheumatoid Arthritis  
2.12E-02 4/283 (0.014) LEF1, NOS2, 
SOCS1, VCAM1 
ILK signalling  2.67E-02 3/173 (0.017) ITGB7, LEF1, 
NOS2 
Role of BRCA1 in DNA damage response  3.34E-02 2/77 (0.026) CHEK1, MSH2  
Superpathway of Citrulline Metabolism  4.81E-02 1/13 (0.077) NOS2 
Cholesterol Biosynthesis  4.81E-02 1/13 (0.077) DHCR7 
Cholesterol Biosynthesis II (via 24,25-
dihyrolanosterol) 
4.81E-02 1/13 (0.077) DHCR7  
Cholesterol Biosynthesis III (via 
Desmosterol) 
4.81E-02 1/13 (0.077) DHCR7 
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5.2.7 Validating Differentially Expressed Genes by SYBR-Green Real-Time PCR  
5.2.7.1 Reverse transcription of total RNAs into complementary DNA (cDNA)  
       
        Microarray results are influenced by several factors at different steps starting from array 
production, RNA extraction, probe labelling, hybridisation of targets on the probes and image 
analysis, which may lead to false positive expression differences (Tusher et al, 2001; Rajeevan 
et al, 2001). Therefore, DEGs need to be validated with another method such as conventional 
reverse transcription-polymerase chain reaction (RT-PCR) or, the current state-of-the-art for 
gene quantification, real-time PCR (qPCR). In this thesis, qPCR was used to validate several 
DEGs from three independent experiments. The qPCR that was performed here was two-step 
qPCR as the total RNA was first reverse transcribed into cDNA by Reverse Transcriptase (RT) 
separately from the PCR reaction itself. 
        qPCR was performed on cDNA generated from the same RNA samples that were prepared 
primarily for microarray analysis. Total RNA (100ng) was reversed transcribed using random 
oligo (dT) primer with GoScript Reverse Transcriptase that were provided in the GoScript 
Reverse Transcription System (Promega).  The oligo(dT) primers are about 15-20 bases and 
are comprised of thymine bases which anneal to the poly(A) tail at the 3’ end of mRNA 
transcripts and initiates cDNA synthesis. Reverse transcriptase catalyses the addition of dNTPs 
to generate a complementary strand of DNA. The cDNA molecules were then aliquoted into 
small single-use volumes and frozen at -80oC to prevent the need for multiple freeze-thaw 
cycles which can cause cDNA degradation. For each sample, a non-enzyme control (no RT) 
was generated as a negative control, where samples were tested by PCR to check for gDNA 
contamination of the template RNA. Figure 5.10 shows PCR amplification of a 350bp fragment 
of beta-actin (β-actin) after reverse transcription with- or without RT enzyme. The β-actin 
primers were designed spanning an exon-exon boundary. If there was contamination of 
genomic DNA in the RNA samples, a slightly higher band of about ~440bp should appear in 
the no-RT control lane. All 18 samples were free from genomic DNA contamination as none 






Figure 5.10 Agarose gel electrophoresis of cDNA template. There were 18 samples in total of RNA 
isolated from three independent experiments. All 18 samples were reverse transcribed into cDNA with- 
or without RT (reverse transcriptase) enzyme, followed by PCR amplification specific for β-actin. PCR 
products were then visualised using 2.5% agarose gel electrophoresis. Amplification of β-actin from 
cDNA gives a band product at approximately 350bp. 
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5.2.7.2 Primer design and optimisation for qPCR   
        
        In qPCR reactions, two different fluorescent reporter molecules can be used; a sequence 
specific probe containing a fluorescent reporter dye at the 5’ end and a quencher dye at the 3’ 
end, such as a TaqMan probe, or a non-specific DNA binding dye such as SYBR Green which 
binds to double-stranded DNA to produce fluorescence. SYBR Green I reporter molecule was 
used in the qPCR assays presented in this thesis. SYBR green dye binds to double-stranded 
DNA, as more double-stranded amplicons are produced, the intensity of the fluorescence 
increases.  SYBR Green I dye gives substantial sensitivity for target quantification, it is easy 
to use, reproducible and cost effective.  
         One of the limitations in DNA-binding dye chemistry assay is the inherent non-specificity. 
The dye can bind to any double-stranded DNA including primer-dimers, hence, the efficiency 
of the qRT-PCR is highly dependent on the primers used. The primers were carefully self-
designed and analysed using Beacon Designer software (PREMIER Biosoft International) to 
check if the primer sets (forward and reverse primer of the target) could form any secondary 
DNA structures namely a primer-dimer (self-dimer, or cross-dimer) or hairpin structure. The 
primers were designed to span exon-exon boundaries, thus avoiding the detection of target from 
residual genomic DNA in the initial RNA sample. The primers were also checked with the 
NCBI BLAST database search tool to ensure that they did not anneal to any non-specific DNA 
targets. Nine different concentrations of reverse and forward primers were tested (two-by-two 
combinations of 100, 200 or 300nM) to obtain the optimum concentration for each pair where 
it gave the lowest threshold cycle (Ct) but maximum amplification with minimum non-specific 
amplification. The criteria that were taken into account when designing the primers are 
described in more detail in the Materials and Methods 2.18. 
        A non-specific signal cannot always be prevented, but the specificity can be determined 
easily by melt-curve analysis (known as the dissociation curve) on the PCR products from 
every experiment. As the temperature increases, the double-stranded PCR products with the 
incorporated dye begin to dissociate, resulting in decreasing fluorescence intensity. The 
temperature at which the DNA dissociates is dependent on the length and sequence of the PCR 
products generated. Therefore, a single unique peak represents the PCR products with 
homogenous length and sequence (the amplicons), while multiple peaks indicate non-specific 
amplification where more than one population of PCR products have been generated including 
179 
 
primer-dimer artifacts. Figure 5.11 shows an example of a dissociation curve of Interleukin-1α 
gene from 18 samples. Dissociation curve analysis was performed in every qPCR experiment 
to confirm that only a single-peak was generated every time, hence increasing the reliability of 








Figure 5.11 Melt curves from qPCR of IL-1α gene from 18 samples over the entire temperature 
range. The x-axis is temperature and y-axis is the fluorescence intensity. Total RNA was isolated from 
uninfected and infected BMDMs with B. pseudomallei WT or ∆bimA at 8 hpi and 12 hpi, with three 
replicates to give a total of 18 samples. The total RNA was then reverse transcribed into cDNA followed 
by qPCR as described in Materials and Methods 2.19. Melt-curve anlaysis was carried out in every 
PCR run to assess the dissociation-characteristics of double-stranded DNA during heating, hence the 
specificity of the PCR products. SYBR green fluorophore was used to quantify the double-stranded 
DNA. As the temperature increases, the double stranded DNA begins to dissociate and the fluorescence 
intensity starts to decrease. As the melt curves from all the samples produce a single-peak, indicating a 






5.2.7.3 Evaluation of Reference Gene Expression Stability  
    
       Normalisation is crucial for a reliable qPCR assay as it helps to correct for variations in the 
amount of starting material, reverse-transcription yield, and amplification efficiency, thus 
enabling comparisons of mRNA concentrations across different samples. Samples can be 
normalised to sample size, or total RNA, but the use of endogenous reference genes (often 
referred as housekeeping genes) is commonly accepted as the most appropriate normalisation 
strategy (Bustin et al, 2009). Normalisation involves reporting the ratios of the mRNA 
concentrations of the GOI (genes of interest) to those of the reference genes. Hence, the main 
criteria for reference genes is that they must be stably expressed, and should not vary widely 
in different species, tissues or in response to experimental conditions. Their abundances should 
be representative of the total amounts of mRNA present in the samples.  Traditionally, many 
studies presumed the constitutively expressed housekeeping genes such as β-actin (ACTB)  and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were stably expressed and were 
therefore used as normalising controls. However, many publications have demonstrated that 
these endogenous housekeeping genes can quantitatively vary, depending on the experimental 
conditions (Kozera & Rapacz, 2013; Thellin et al, 1999). Therefore, there is a need for 
systematic validation of internal reference genes for each specific experimental design. 
Furthermore, validation of the reference genes are important criteria required in MIQE 
(Minimum Information for Publication of Quantitative Real-Time PCR Experiments). MIQE 
is a guideline that describes minimum information necessary for evaluating qPCR experiments, 
hence ensures its relevance, accuracy and reproducibility (Bustin et al, 2009). 
      The stability of candidate internal reference genes may be assessed using a variety of 
different algorithms namely geNorm, NormFinder and BestKeeper (De Spiegelaere et al, 2015; 
Vandesompele et al, 2002). In this study, we implemented GeNorm using qBase+ software 
from BioGazelle to evaluate a set of reference genes to use in the qPCR experiments. GeNorm 
(Primer Design Ltd), developed in 2002, calculates the gene expression stability (M) for each 
reference gene based on the average pairwise variation (V) between all studied reference genes 
across all samples. Following calculation of the M value, the programme then ranks the genes 
from the most stable gene characterised by the lowest M value, to the least stable with the 
highest M value. In addition, geNorm can determine the optimal number of reference genes for 
qPCR normalisation by finding the smallest needed to minimise mean variation as presented 
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by geNormV chart. This optimal number of reference genes (n) is found when the pairwise 
variation V(n/n+1) drops below 0.15 (Vandesompele et al, 2002). Six different reference gene/ 
primer sets were purchased commercially from PrimerDesign Ltd for use with SYBR green, 
known as the Mouse geNormPLUS 6 gene kit. The reference genes provided in this kit are 
stated in the Materials and Methods 2.18. 
         All 18 samples were assayed in duplicate with each reference gene at the recommended 
optimal concentration of 300nM. The Ct values were then exported into qBase+ software and 
geNorm program was selected for the analysis. From the geNorm M graph (Figure 5.12), the 
software identified that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and casein 
kinase 2 (Csnk2a2) were the most stable reference genes. From data presented in the geNormV 
bar chart (Figure 5.13), the optimal number of reference targets in this experimental situation 
is two (geNormV <0.15) when comparing a normalisation factor based on the 2 or 3 most stable 
targets. As such, the optimal normalisation factor can be calculated as the geometric mean of 





Figure 5.12 Average expression stability values of reference genes. The geNorm programme ranks 
the reference genes from the least stable (highest M value on the left) to the most stable gene (lowest 
M value on the right). The program identified GAPDH and Csnk2a2 as the most stable genes to be used 








Figure 5.13 geNorm V bar chart shows the optimal number of reference targets. The lower the 
variable V is (on y-axis), the less variation. Vandesompele et al (2002) proposed a cut off at 0.15. X-
axis indicates the the variation in normalisation factor. V2/3 indicates the variation in normalisation 







5.2.7.4 Quantification of Real-Time PCR (qPCR)        
        
        After determining the optimal concentration of primers to use in each reaction, it is 
important to test the performance of the qPCR reaction in terms of amplification efficiency. 
The amplification efficiency (E) can be determined from the slope of a standard curve of the 
GOI (gene of interest) and the reference genes. A standard curve was produced from the PCR-
generated product (10-1 to 10-5 ng). An acceptable range for percentage of efficiency is between 
90-100%. This E-value was taken into account for more accurate gene quantification as 
explained below.  
       Relative quantification strategy was chosen for qPCR data presented here. Relative 
quantification (also known as comparative quantification) calculates the relative quantities of 
targets to the calibrator (which is the uninfected BMDM cells at the respective time point). 
There are two different mathematical models established to calculate the expression of the 
target gene in relation to reference genes; Delta-delta Ct (∆∆Ct) and Pfaffl methods. ∆∆Ct 
method assumes the amplification efficiency of both GOI and reference gene is 100% and the 
amplification factor = 2. In contrast, the Pfaffl method is an efficiency-corrected comparative 
quantification, which permits the incorporation of different amplification efficiency/factor into 
the mathematical model. In this study, standard curves have been determined for each target 
and reference gene (they ranged from 90-100% efficiency). Since the standard curves did not 
meet 100% amplification efficiency, it is more appropriate to use the Pfaffl method for 
quantification. A slight modification on Pfaffl modelling has been proposed by Vandesompele 
et al (2002), which permits the normalisation with multiple reference genes. The denominator 
of the Pfaffl method is replaced with the geometric mean of the normalisation factor of two or 
more reference genes (GAPDH and CSNK2A2 in this study). This modified Pfaffl method 





          A panel of ten immune-related genes were selected for validation by real-time qPCR 
(table 5.17). 5/10 are pro-inflammatory cytokine genes (IL-6, IL-1β, IL-1α, CD40, and IL-12β), 
2/10 are members of the interferon signalling pathway (ISG15 and IFIH1) and the remaining 
three genes were shown to be upregulated specifically in response to the ∆bimA mutant at 12hpi 
(NOS2, FNBP1L, and FAS). All the genes selected were indicated to be upregulated by the 
microarray analysis. In terms of direction of fold change, all the genes validated by qPCR 
displayed directionally concordant gene expression profiles between both methods. None of 
the genes tested showed a down-regulation, consistent with the fact that DEGs with negative 
fold change were not validated by qPCR in this study. In most cases, the magnitude of fold 
change by qPCR is much higher compared to fold change obtained from microarray analysis, 
in agreement with the higher sensitivity of qPCR in gene quantification (Bustin et al, 2005). 
However, some of the genes that were not represented on the microarray as significantly 
expressed showed a substantial increase in expression. For examples, NOS2, FNBP1L, and 
FAS genes that were thought to be specifically increased in response to the ∆bimA mutant at 
12hpi, were also significantly increased in fold change expression in response to the WT strain. 
This is possible as both microarrays and qPCR are influenced by several factors which affect 
the correlation of gene expression between the two methods. One of the fundamental 
differences is the method of normalisation with microarray requiring global normalisation 
while qPCR calibrates the gene expression against reference genes (Morey et al, 2006; Etienne 
et al, 2004; Irrisarry et al, 2003; Vandesompele et al, 2002). Besides, the data reported for 
microarray and qPCR were averaged in different manners. The value obtained from microarray 
was derived from the composite array in which each feature of the replicate arrays underwent 
a weighted averaging based on feature quality analysed by the software. On the other hand, 
qPCR data were unweighted averages from replicates.  In addition, each method has individual 
inherent pitfalls. Microarray is easily prone to errors such as cross hybridisation of labelled 
target to the probes, while amplification biases and the formation of primer-dimers are errors 
that are inherent to qPCR. Differences in reverse transcriptase and priming methods also 
contribute to the low correlation between microarray and qPCR. Nevertheless, good laboratory 
technique and proper controls can reduce these errors to obtain as high a correlation as possible.  
          The 32 sets of paired-data highlighted in bold in table 5.17 were then subjected to 
statistical analyses to determine the correlation between the microarray and qPCR results. 
Statistical analysis was performed using Spearman’s Rho non-parametric test using Minitab 17 
Statistical Software. Overall, a significant correlation was observed between microarray and 
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qPCR with a correlation coefficient (r) of 0.734 (Spearman’s Rho, p<0.0001, n=32). This 
highly significant correlation indicates acceptable validation of the microarray results as 
determined in Morey et al, 2006. 
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Table 5.17 Genes selected for validation of the microarray data by qPCR 
  
Infected with WT 8hpi 
(fold change)   
Infected with ΔbimA 
8hpi (fold change)   
Infected with WT 12hpi 
(fold change)   
Infected with ΔbimA 
12hpi (fold change) 
  Microarray  qPCR    Microarray qPCR    Microarray  qPCR    Microarray qPCR  
IL-6  10.74 39.3 ± 13.5   4.47 32.1 ± 10.5   11.66 35.2 ± 2.4   10.2 41.2 ± 8.8 
IL-1β 6.33 8.85 ± 2.57   3.66 8.38 ± 2.62   5.75 6.61 ± 0.83   5.11 6.34 ± 1.73 
IL-1α 4.13 6.61 ± 2.27   2.64 5.04 ± 1.66   4.77 15.3 ± 11.4   4.23 13.66 ± 10.2 
CD40  1.71 3.99 ± 0.99   1.5 4.3 ± 1.07   2.15 6.99 ± 4.51   2.01 6.72 ± 4.09 
ISG15  2.17 4.72 ± 1.17   1.87 4.03 ± 1.14   4.27 12.5 ± 7.2   4.21 12.0 ± 5.6 
IFIH1/MDA-5 1.81 1.08 ± 0.40   not DE 1.05 ± 0.35   2.42 2.55 ± 1.08   2.89 2.41 ± 0.96 
IL-12β 4.4 22.5 ± 10.9   2.89 20.8 ± 7.9   not DE  12.6 ± 1.7   not DE  15.3 ± 0.01 
                        
Nos2  2.6 10.7 ± 6.4   2.34 7.22 ± 5.49   not DE 3.62 ± 0.53   2.83 2.99 ± 1.05 
Fnbp1L  1.61 4.47 ± 1.97   2.05 6.20 ± 1.98   not DE 3.66 ± 1.52   2.56 4.04 ± 2.36 
Fas not DE  1.82 ± 0.23   not DE  2.02 ± 0.65   not DE 1.55 ± 0.60   1.52 1.46 ± 0.48 
  Quantification of qPCR was given as an average fold change based on three independent experiments ± Standard Error 





5.2.8 Investigating the role of FNBP1L in limiting the intracellular survival of ΔbimA 
in BMDMs 
 
        One of the key reasons the microarray experiment was carried out was to identify potential 
mechanism/s involved in the detection and elimination of the B. pseudomallei ∆bimA mutant 
in BALB/C BMDMs. As explained previously, not many genes in this category were mapped 
to IPA canonical pathways, and very few pathways were identified from the analysis. 
Microarray analysis found that FNBP1L (Formin-binding protein 1-like) (also known as Toca-
1) was among those upregulated genes specific to infection of cells with the ∆bimA mutant 
strain. Although qPCR analysis showed that there was no significant difference in FNBP1L 
gene expression between cells infected with either the WT or ∆bimA strain, there was a slightly 
higher expression in cells infected with the ∆bimA mutant compared to the WT strain. With the 
recent findings of a novel role of FNBP1L in anti-Salmonella autophagy (Huett et al, 2009), 
we then selected FNBP1L for functional validation to investigate if the protein is involved in 
limiting the intracellular survival of B. pseudomallei ∆bimA specifically.  
       FNBP1L protein, a transducer of Cdc42-dependent actin assembly, has been identified as 
a novel component of the autophagic apparatus in mammalian cells through a yeast-human 
network analysis performed by Huett et al (2009). FNBP1L has been shown to interact with 
Atg3 (autophagy-related protein 3) via its functional domain protein-kinase C-related kinase 
HR1 (homology domain 1) in a similar fashion to the characterised FNBP1L ligand Cdc42. 
ATG3 acts as an ubiquitin-carrier protein (E2) enzyme that catalyses the lipidation of LC3-I 
into LC3-II, an essential molecule in  autophagosome formation. Interestingly, this FNBP1L-
mediated autophagy targeting Salmonella enterica Typhimurium (S. Typhimurium) is 
independent from ubiquitination signals required for canonical autophagy as described 
previously in Chapter 3. Detailed microscopic examination identified significant colocalisation 
of S. Typhimurium with LC3 molecules. However, the colocalisation was largely absent 
following FNBP1L siRNA knockdown and could be fully rescued by restoration of FNBP1L 
expression (Huett et al, 2009). This observation is paralleled with their gentamycin intracellular 
survival assay in HeLa cells where the bacteria were shown to replicate more in the FNBP1L-
deficient cells compared to the control-treated cells. These data together demonstrate the novel 
role of FNBP1L in restricting the intracellular survival of S. Typhimurium via an autophagy-
dependent mechanism (Huett et al, 2009). Therefore, we investigated if FNBP1L plays a 
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similar role in clearing the ∆bimA mutant in BALB/C BMDMs at 16 hpi by confocal 
microscopy.   
        BALB/C BMDMs were infected with B. pseudomallei WT or the ∆bimA mutant at an 
MOI of 2 for 8 hpi and 16 hpi in a kanamycin-protection manner as described previously. The 
infected BMDMs on the coverslip were then stained with B. pseudomallei antibody (red) and 
anti-FNBP1L (green). Analysis of confocal images revealed no significant colocalisation of 
FNBP1L with either intracellular WT or ∆bimA bacteria at either 8 hpi or 16 hpi (Figure 5.14). 
Similarly, the ∆bimA mutant did not colocalise with LC3 molecules as demonstrated in Chapter 
3, adding more evidence that autophagy via FNBP1L/LC3 is unlikely to be  responsible for the 







Figure 5.14 Representative z-stack confocal microscopy images of BMDMs infected with B. 
pseudomallei WT and ΔbimA mutant bacteria for FNBP1L co-localisation. BMDMs infected with 
WT and ΔbimA mutant bacteria were incubated for the indicated times before fixing and staining for 
confocal microscopy. Bacteria were stained red with mouse anti-B. pseudomallei LPS and anti-mouse 
Ig-Alexa 568 antibodies. FNBP1L was stained green with rabbit anti-FNBP1L and anti-rabbit Ig-Alexa 




5.3 DISCUSSION  
         
        The responses of host cells to pathogens are often accompanied by marked reprogramming 
of their transcriptome. The advent of DNA microarray technology allows us to investigate 
transcriptional profiling of BALB/C BMDMs when infected with B. pseudomallei WT and 
∆bimA mutant strains. The microarray analysis was carried out at two different time points (8 
and 12hpi) chosen based on the intracellular CFU counts, where the number of WT bacteria 
and ∆bimA mutant were not different (at 8hpi) and started to differ significantly (at 12hpi) 
respectively. Using this approach, we have presented in this chapter a global overview of the 
changes in transcript abundance in response to the B. pseudomallei 10276 strain as well as 
specific response to the ∆bimA mutant that resulted in significantly decreased intracellular 
survival.  
        Analysis of global gene expression in response to B. pseudomallei (both WT and ∆bimA 
mutant strains) at the earlier time point of 8hpi identified that among the top ranking DEGs are 
those encoding pro-inflammatory cytokines. These include IL-6, IL-1α, IL-1β, CD40, TNF, 
and IL-12β which were also found to be elevated at 12hpi following B. pseudomallei infection. 
Many of these genes, together with several other genes, were selected for validation at the 
transcriptional level using quantitative real-time PCR (qPCR). With 10 genes being tested, we 
have obtained significant correlation between microarray and qPCR (Spearman’s Rho 
coefficient of 0.734), indicating acceptable validation of the microarray analysis. In addition, 
there are also other inflammatory chemokines that were induced in infected host cells, to name 
several; CXCL3 (also termed as Macrophage Inflammatory Protein 2β (MIP2β)), CXCL2 
(MIP2α), CCL5 (RANTES), CCR7, CCL20 (MIP3α).  These chemokines and cytokines 
together form a cluster of inflammatory mediators that could be designated as a ‘common host 
immune response’, representing a general ‘alarm signal’ for inflammatory infections. This set 
of genes is also found to be upregulated in different cell types upon infection with several 
different pathogens such as Mycobacterium tuberculosis (Magee et al, 2012), Listeria 
monocytogenes (Cohen et al, 2000), Brucella abortus (Eskra et al, 2003), and Staphylococcus 
aureus (Matussek et al, 2005). IPA Functional analysis of this cluster of inflammatory-
associated genes suggests that they are involved in communication between innate and adaptive 
immune cells. For example, IL-6 is a pleiotropic inflammatory cytokine which has been 
reported to be important in the resolution of innate immunity and also as a key immunological 
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switch to orchestrate transition from innate to acquired immune processes (Jones, 2005). The 
chemokines listed above are required for chemotactic activity to recruit more inflammatory 
and immune effector cells such as neutrophils and natural killer (NK) cells.      
        The interferon (IFN)-mediated response was reported as the most prominent pathway 
identified at 12hpi in response to infection with both B. pseudomallei WT and the ∆bimA 
mutant strains. In IPA analysis, several pathways are mentioned related to the interferon-
mediated response which include ‘Activation of IRF by Cytosolic Pattern Recognition 
Receptors’ (1st rank), ‘Interferon Signalling’ (2nd rank) and ‘Role of RIG1-like Receptors in 
Antiviral Innate Immunity’(3rd rank). Type I and Type II IFN are the main classes of the IFN 
family, which separately bind to their respective receptors. Expression of some genes are 
regulated by both Type I and II IFNs such as IFITM1, whereas others are selectively regulated 
by distinct IFNs. For example, only Type I IFNs drive the expression of 2’,5’-oligoadenylate 
synthetase 1 (OAS1) gene while expression of the IFN-regulatory factor 1 (IRF1) gene is 
preferentially induced by Type II IFNγ (Horiuchi et al, 2011). All the genes mentioned here 
were found to be upregulated in BMDMs infected with both WT and ΔbimA strains, suggesting 
that both Type I and Type II IFN signalling pathways are crucial for host responses against B. 
pseudomallei.  
        In melioidosis studies, it is well-known that IFNγ plays an important immunoregulatory 
role in melioidosis. IFNγ is a potent macrophage activator which is essential in mediating 
antibacterial host defence. In vivo studies using a mouse model show that depleting IFNγ with 
neutralising antibody significantly increases host susceptibility to melioidosis (Santanirand et 
al, 1999).  In human studies, plasma IFN-γ concentration, which is usually undetectable in 
plasma of normal controls, was greatly increased in melioidosis patients (Lauw et al, 1999). A 
similar report on elevated levels of circulating IFNγ in melioidosis patients is described by 
Brown et al (1991). In addition, one of the IFNγ-inducing cytokines IL-12p40 was found to be 
significantly higher in melioidosis patients (Lauw et al, 1999). Our microarray analysis also 
found upregulation of the gene encoding IL-12p40 in this category. Our in vitro system does 
not include IFN-γ as a macrophage activator, hence, the upregulation of gene transcription in 
IFN-γ signalling indicates a distinct host response to infection.  
        Whilst IFN-γ plays an important role in the pathogenesis of melioidosis, the role for Type 
I IFN is not well described.  IFNα4 was upregulated specifically in our microarray dataset as a 
global response to infection with B. pseudomallei. Besides, our microarray analysis has shown 
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upregulation of the cytosolic RNA sensor RIG-1 (RNA helicase retinoic acid inducible gene 1 
protein, also known as Ddx58) and RIG-1-like (RLR) protein MDA-5 (melanoma 
differentiation-associated gene 5, also known as Ifih1) upon B. pseudomallei infection of 
BMDM cells. RIG-1 and MDA-5 both contain a DExD/H box RNA helicase domain that 
recognises dsRNA, and two caspase recruiting domain (CARD)-like domains to relay the 
signal. Bacterial mRNA is distinct from eukaryotic RNA as bacterial mRNA is not capped and 
contains triphosphates at the 5’ end, rendering it a perfect ligand for the RIG-1 receptor 
(Hagmann et al, 2013). Upon RNA recognition, RIG-1 and MDA-5 are recruited to the outer 
membrane of mitochondria, where they encounter adaptor protein IPS-1 (also known as MAVS, 
CARDIF or VISA) that regulates downstream Type I IFN signalling. Although these sensors 
are typically thought to detect viruses, it is increasingly evident that they are also involved in 
the innate immune response to intracellular bacterial pathogens. It has been reported that 
Legionella pneumophila (Monroe et al, 2009) and Listeria monocytogenes (Hagmann et al, 
2013) can secrete RNA and translocate it into the host cell cytoplasm, where it triggers the 
immunosurveillance RIG-1/MDA-5 pathway. In L. pneumophila, the translocation of bacterial 
RNA was shown to be mediated by a Type IV Secretion system, whereas L. monocytogenes 
secretes the RNA via a SecA2 secretion system (Hagmann et al, 2013; Monroe et al, 2009). To 
our knowledge, this cytosolic RNA-sensing pathway has not been reported previously to be 
associated with melioidosis. It will be interesting to examine in future studies how B. 
pseudomallei induces a Type I interferon response via the RIG-1/MDA5 pathway. The 
activation mechanism could result from direct recognition of bacterial RNA or an indirect host 
response due to secretion of other bacterial effectors.  
       In addition to interferon signalling, our microarray analysis also observed higher 
transcription of several genes encoding poly(ADP-ribose)-polymerase (PARP) proteins that 
are associated with three different IPA canonical pathways; ‘Retinoic Acid Mediated Apoptosis 
Signalling ‘, ‘Death Receptor Signalling’ and ‘UVA-Induced MAPK Signalling’. These include 
PARP9, PARP10, PARP12 and PARP14. These genes and their associated pathways are 
observed most profoundly at 12hpi as a global response to both B. pseudomallei WT and the 
∆bimA mutant. PARP enzymes comprise a catalytic domain ADP-ribosyl transferase which 
transfer negatively charged ADP-ribose moieties from donor NAD+ molecules onto the 
acceptor protein, a mechanism known as poly(ADP-ribosylation) (PARylation). This post-
translational modification is essential in controlling a wide array of cellular processes; DNA 
repair, chromatin modulation and transcriptional regulation, cell division and roles in cellular 
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stress response and inflammation (Gibson & Kraus, 2012; Schreiber et al, 2006). PARPs are 
categorised largely on the basis of their domain architecture and their functional motifs. Some 
PARPs namely PARP1, PARP2 and PARP3 are localised in the nucleus where their primary 
function is to sense DNA breaks and transmit signals for DNA repair. However, in a situation 
of genotoxic stress, PARP-1 can be activated excessively which leads to cell death (David et 
al, 2009;D’Amours et al, 2001). PARP9 and PARP14 are examples of macroPARPs, 
containing a macrodomain fold which are high-affinity ADP-ribose-binding modules that can 
assist the migration of these PARPs to sites of poly- and possibly mono(ADP-ribosyl)ation 
(Karras et al, 2005). PARP 9 localisation is not known, but PARP 14 is present in stress 
granules in the cytosol. Interestingly, very recent findings by Iwata et al (2016) identified 
PARP9 and PARP14 as key regulators of macrophage activation, both in humans and mouse. 
PARP 9 was shown to promote IFN-γ induced responses, but PARP 14 suppressed the IFN-γ 
response. This cross-regulation of macrophage activation is important for a balance of pro-
inflammatory and anti-inflammatory processes in host cells (Iwata et al, 2016). PARP 12 is an 
example of a CCCH PARP which have a Cys-Cys-Cys-His zinc finger that bind to RNA, as 
well as Trp-Trp-Glu domains for PAR binding activity. PARP10 is not categorised in any 
subfamily but found to be a partner protein of proto-oncoprotein c-Myc which inhibits cell 
proliferation and transformation (Yu et al, 2005). These together show the importance of 
PARPs in which their activity is a key component of cellular stress responses that lead to 
physiological or pathological outcomes. Like other post-translational modifications such as 
ubiquitination, phosphorylation, acetylation, and SUMOylation, ADP-ribosylation has 
profound effects on cellular functions.  
       To identify potential mechanism/s involved in clearing the B. pseudomallei ∆bimA mutant 
in infected BALB/C BMDMs, we selected one candidate for functional validation known as 
FNBP1L (Formin-binding protein-1 like, also known as TOCA-1) by confocal microscopy to 
assess the colocalisation of FNBP1L with the bacteria. From the literature, FNBP1L protein is 
required to limit replication of Salmonella enterica serovar Typhimurium (S. Typhimurium) in 
epithelial cells through an autophagy-dependent mechanism (Huett et al, 2009). However, this 
anti-Salmonella autophagy mechanism is independent from ubiquitin signalling as described 
previously in Chapter 3. FNBP1L was shown to interact with ATG3 (autophagy-related protein 
3), which plays a role as an ubiquitin carrier enzyme mediating lipidation of LC3-I molecules 
to form LC3-II molecules during autophagosomes biogenesis (Huett et al, 2009).   
Interestingly, this FNBP1L molecule is non-essential for classical autophagic induction by 
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rapamycin or serum-starvation. However, our preliminary confocal images analysis do not 
show that the ∆bimA mutant colocalises with FNBP1L protein. As shown previously in Chapter 
3 the ∆bimA mutant also does not significantly colocalise with LC3 molecules, which further 
confirms that autophagy via FNBP1L protein and LC3 molecules is not involved in restricting 
the intracellular survival of the ∆bimA mutant in BMDM cells. Furthermore, the studies 
performed by Huett and colleagues were conducted in non-phagocytic immortalised HEK293T 
and HeLa cells (Huett et al, 2009). It is possible that the pro-autophagy activity of FNBP1L 
observed during infection with S. Typhimurium is cell type-dependent. It would be interesting 
in future to study the role of this protein against B. pseudomallei in those cell lines.  Although 
in other studies, FNBP1L has been described as a protein required for Shigella flexneri actin 
polymerisation (Leung et al, 2008), here we did not investigate if the protein was recruited to 
the actin tails of B. pseudomallei.  
        In relation to the autophagy pathway as described in Chapter 3, Klionsky et al (2015) 
demonstrate that the induction of autophagy in certain circumstances is accompanied by an 
increase in the mRNA levels of certain autophagy-related genes (ATG), such as ATG5 (beclin 
1, a protein crucial for autophagy initiation), ATG7 (the activating enzyme for Atg8 
conjugation), ATG8/LC3, ATG9 (involves in autophagosomes formation), ATG12 (ubiquitin-
like modifier that conjugate with Atg5) and ATG14 (recruits other ATG proteins at the early 
stages of autophagasome formation)  (Klionsky et al, 2015). However, the global 
transcriptomic microarray analysis here found that none of these genes is differentially 
expressed in infected BMDMs cells with either WT B. pseudomallei or ∆bimA. This finding 
adds further evidence demonstrating that autophagy is not important in controlling the 
intracellular survival of B. pseudomallei in BALB/C BMDMs. If any of the genes listed above 
had been shown to be upregulated upon infection, it would have been desirable to knock down 
the gene/s by siRNA transfection, followed by subsequent investigation of the effect of 
knockdown on bacterial intracellular survival. 
        Microarray analysis suggested that NOS2 and FAS were among those genes specifically 
upregulated in response to infection with the ∆bimA mutant strain. NOS2 encodes for inducible, 
nitric oxide synthase enzyme (iNOS) which is responsible for the production of nitric oxide, 
an antimicrobial compound. Whereas FAS (also known as APO-1/CD95) is a member of the 
TNF receptor family where its interaction with the ligand FasL results in the transduction of 
cell signalling leading to apoptosis (Nagata, 1997). However, validation by qPCR identified 
that the NOS gene was significantly elevated in cells infected with both WT and ∆bimA mutant 
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strains, at 8hpi and 12hpi, with the fold change ranging from 7.22 to 20.2.  Although the fold-
change amplitude of the gene expression is considerably high, we were not able to detect nitrite 
in the supernatants of infected cells by Griess assay, presumably because the nitrite produced 
is below the limit of detection of the assay (as mentioned in Chapter 4).  B. pseudomallei was 
found previously to suppress the production of nitric oxide, unlike other Gram-negative 
bacteria such as E. coli and Salmonella Typhi (Utaisincharoen et al, 2001). Besides, the 
production of nitric oxide requires macrophage priming by IFN-γ and LPS, which were not 
included in our assay (Utaisincharoen et al, 2001;Lowry & Goldberg, 1998). On the other hand, 
qPCR validation of the FAS gene found the gene was expressed slightly higher (amplitude less 
than 2-fold), not just in cells infected with the ∆bimA mutant strain, but also with the WT strain.  
        Up to 40% of the genes that were classified as DEGs specifically upregulated in response 
to the ∆bimA mutant were not characterised, and those characterised were mapped to very few 
canonical pathways in the IPA analysis. This suggests that the innate mechanism/s involved in 
the cellular response to the ∆bimA mutant could be novel or mediated by host post-translational 
modification, which is beyond the capability of the DNA microarray used in this chapter. 
Another important point to note is that in our microarray analysis, the RNA that was analysed 
was a mixture of RNA from both infected and uninfected macrophages. Approximately only 
0.5% of the BMDMs were infected based on the CFU counts in the kanamycin protection assay. 
This consequently limits the experimental power to identify innate mechanism/s activated upon 
infection. The increase in signals detected between uninfected and infected groups could reflect 
a ‘bystander effect’ where the signals emanating from infected cells may be perturbing gene 
expression in uninfected cells to make them more anti-microbial. Therefore, the altered gene 
expression identified in the infected group is either due to a direct effect upon infection, or an 
indirect bystander effect.  It would be better if the infected BMDMs were sorted out from the 
uninfected ones by FACS before isolating the RNA. However, this is not possible as working 
with a hazard group 3 pathogen does not allow us to bring the pathogen out from the 
Containment Level 3 (CL3) facility and contaminate the in-house FACS machine. Hence, 
although quite a number of DEGs were identified between groups, it should be noted that these 
signals may be confounded by the small proportion of infected cells in the samples, as well as 
bystander effects.  
        In addition, analysis from the PCA plot suggests the variations between replicates are 
more profound than the variations observed between groups of uninfected and BMDMs  
infected with either B. pseudomallei WT or the ΔbimA strain at respective time points. We 
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would think that differentiating bone-marrow cells into mature macrophages (BMDMs) in the 
presence of GM-CSF and foetal-calf serum (FCS) on different days for independent biological 
repeats results in true day-to-day biological variations of the primary cultures. This could 
account for the primary source of such variability rather than the microarray methodology itself 
such as RNA isolation or array hybridisation. To overcome such variation, Depke et al (2014) 
suggested using a standardised culture system to differentiate BMDMs in which they 
successfully produced highly reproducible biological replicates. This could be implemented in 
future for studying global expression analysis in BMDMs. While subtle gene-expression 
responses were highly sensitive to changes in primary BMDMs, remarkably we found no 
convincing evidence of induction of a specific gene expression response in cells infected with 




6 CHAPTER 6: GENERAL DISCUSSION  
       
        Melioidosis, an infectious disease that affects both humans and animals is caused by the 
bacterium Burkholderia pseudomallei. Current treatment for melioidosis is limited by the 
intrinsic antibiotic resistance of B. pseudomallei and there is no effective and safe vaccine 
available for human use.  Effective innate immune responses are critical for controlling the 
early phase of infection. Diabetic patients who have defective innate immune responses are 
more susceptible to melioidosis (Currie et al, 2010; Chanchamroen et al, 2009). The innate 
immune system is designed to detect invading pathogens, and send endogenous alarm signals 
from the infected cells to trigger recruitment of more immune cells to the site of infection for 
pathogen clearance. When this innate immune system fails to clear the infection, the adaptive 
immune system comes into play as a second line of defence to continue the unresolved host-
pathogen battle. Macrophages are important host innate immunity cells, yet B. pseudomallei 
can survive within such cells, particularly those of diabetic patients. The main aim of this thesis 
is to provide more understanding of the macrophage: bacterium interaction. The thesis also 
aimed to understand how actin-based motility mediated by the bacterial factor BimA could 
help the bacteria to evade the macrophage’s protective cell-autonomous immunity pathways. 
Discovering such an evasion mechanism would facilitate the development of immune-based 
host-directed therapies, which in turn could benefit the treatment of a range of intracellular 
bacteria refractory to antibiotic treatment including B. pseudomallei. Throughout studies in this 
thesis, bone-marrow derived macrophages (BMDMs) differentiated from the bone marrow 
cells of BALB/C mice, which represent an acute murine melioidosis model, were used for the 
investigations.  
      In Chapter 3, we consistently observe BimA-dependent actin tail formation (Figure 3.5) 
and survival of B. pseudomallei in BALB/C BMDMs (Figure 3.3). No actin structures were 
associated with cytoplasmic ∆bimA mutant (Figure 3.5) and the ∆bimA mutant is impaired in 
intracellular survival at 16 hpi (hours of post infection) (Figure 3.3), making this a robust 
system to address the objectives to identify the BimA-dependent evasion mechanisms of B. 
pseudomallei. This phenotype however, can be restored upon inducible expression of BimA in 
trans, consistent with a role for the BimA protein in actin-based motility (Figure 3.5). We 
observed that the defect in the intracellular survival of the ∆bimA strain is not due to 
phagosomal killing as determined by kanamycin and chloroquine protection assay (Figure 3.6) 
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but rather, an unknown cell-autonomous innate mechanism is thought to be involved in 
detection and elimination of the ∆bimA mutant. 
 
6.1 Autophagy and future directions  
       Whilst there are numerous strategies to evade different cell-autonomous defence pathways, 
cytosol-adapted Listeria monocytogenes and Shigella flexneri use actin-based motility to avoid 
host autophagy recognition and elimination (Yoshikawa et al, 2009; Ogawa et al, 2005). Whilst 
autophagy has previously been implicated in targeting phagosomal B. pseudomallei in an LC3-
associated phagocytosis (LAP) -dependent manner, cytoplasmic B. pseudomallei has been 
shown to be capable of escaping canonical autophagy (Gong et al, 2011; Cullinane et al, 2008). 
With a traditional ‘hypothesis-driven’ approach, we speculated that autophagy evasion could 
be dependent on the BimA-mediated actin-based motility. Whilst autophagy has been shown 
to target mutants of L. monocytogenes and S. flexneri incapable of actin-based motility for 
degradation, the present studies have clearly demonstrated that autophagy does not play a role 
in the clearance of the B. pseudomallei ∆bimA mutant from infected BMDMs. The studies 
presented in this thesis included LC3-conversion assay by Western blot (Figure 3.9) and 
confocal imaging for colocalisation of LC3 with bacteria (Figure 3.10) as well as the 
autophagic adaptor protein p62 with bacteria (Figure 3.12). Prior to autophagy-mediated 
degradation of the actin-based motility deficient L. monocytogenes mutant, the mutant is 
extensively ubiquitinated when compared to the WT strain.  However, such selective 
ubiquitination is not observed for the B. pseudomallei ∆bimA mutant as the majority of both B. 
pseudomallei WT and the ∆bimA mutant are similarly ubiquitinated (Figure 3.10). Besides 
marking cytosolic bacteria with ubiquitin as a signal to initiate autophagy, bacterial glycans in 
the cytoplasm can be recognised by galectin molecules, in which galectin-8 has been 
demonstrated to link into the autophagy pathway (Thurston et al, 2012). Some other adaptor 
proteins namely, NDP52 and optineurin, are also worth investigation in the future (Kraft et al, 
2010). The importance of autophagy in innate sensing mechanisms highlights the emerging 
link between cytoskeletal elements and the host defence mechanism. Interestingly, septin 
proteins have also been identified to be recruited to intracytoplasmic Shigella flexneri, which 
cage the non-motile bacteria and promote autophagy (Mostowy et al, 2010). This phenomenon 
is known as septin-caging and therefore warrants further investigations in relation to its role in 
control of B. pseudomallei in future.  
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6.2 Cellular signalling pathways and future directions 
        Host cell-autonomous immunity begins when the receptor (PRR) senses microbial 
components (PAMPs) or danger molecules (DAMPs) which then mediate downstream 
intracellular signalling networks for bacterial elimination. In Chapter 4, the aim was to 
investigate the role of Toll-like Receptors (TLR) in recognition and elimination of the B. 
pseudomallei ∆bimA mutant. Instead of investigating individual TLRs, the studies focused on 
the contribution of the TLR adaptor proteins; MyD88 and TRIF. A gene silencing technique 
using short interfering RNAs (siRNAs) (Figure 4.4) was used to knockdown MyD88 gene 
expression, and in a separate experiment MyD88- or TRIF-blocking peptide were used to 
inhibit the respective signalling pathway (Figure 4.7 and Figure 4.10 respectively). In addition 
to the role of the TLRs, the investigation included the involvement of canonical and non-
canonical inflammasome pathways which result in pyroptotic cell death. Instead of 
investigating the individual inflammasome-associated receptors (NLRs), the studies in this 
thesis only focused on the associated caspase maturation and also the end products of specific 
cytokine secretion (Figure 4.14 and figure 4.15). However, none of these pathways were shown 
to be promising candidate pathways involved in clearance of the ∆bimA mutant from infected 
BMDMs. The TRIF-IFNβ-non-canonical inflammasome pathway may be required for 
controlling B. pseudomallei intracellular fate, this cell-autonomous response is unlikely to be 
specific to the ∆bimA mutant. 
      We also propose that the host innate mechanism that targets the ∆bimA mutant may require 
post-translational modifications (PTM) which is beyond the capability of experiments carried 
out in this thesis.  Host genes translated into proteins are often subject to PTMs, which exert 
an additional layer of regulation. Therefore, a proteomic approach for global profiling of host 
protein modification during infection would be a superior tool to understand host-pathogen 
interactions. As such, mass spectrometry (MS)-based proteomics serves as a high sensitivity 
high-throughput approach for global protein profiling as well as identification of relevant 
PTMs (Angel et al, 2012). In terms of PTMs, phosphorylation is the most recognised 
modification and a central regulator of various cellular signalling pathways (Angel et al, 2012). 
Protein phosphorylation is a reversible PTM, regulated by kinases and phosphatases. Protein 
phosphorylation is known to be involved in transcriptional and translational regulation, cellular 
signalling and communication as well as many other cellular processes including energy 
metabolism, apoptosis, cell cycle progression, cell differentiation and cytoskeleton regulation 
(Hunter, 2000). MS-based phosphoproteomics is an excellent tool for revealing such global 
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changes in cellular phosphoproteomes. Bacterial pathogens evolve mechanisms through toxins, 
effector molecules or virulence factors to modulate and hijack signalling pathways for their 
own benefits and survival. In the innate immune system, recognition of microbial associated 
PAMPs or DAMPs by specific PRRs triggers the phosphorylation-based signalling cascades 
which result in the production of cytokines and chemokines, inflammasome activation, 
apoptosis or other forms of cell death to restrict the survival of the invading pathogen. For 
example, activation of TLRs results in the activation of many kinases including interleukin-1 
receptor-associated kinases (IRAK), mitogen-activated protein kinases (MAPKs), 
extracellular-signal regulated kinases (ERK, also known as classical MAPKs) and IκB kinase 
(IKK), followed by subsequent phosphorylation of the master transcriptional regulators AP-1 
and NFκB. Some pathogens such as Yersinia spp have been shown to attenuate the immune 
response by irreversible inactivation of MAPKs and IKK (Mukherjee et al, 2006).  Shigella 
flexneri has been shown to dephosphorylate p38 MAPK and ERK via its T3SS effector protein 
OspF in infected epithelial cells. Such dephosphorylation results in attenuation of pro-
inflammatory cytokine IL-8 (Schmutz et al, 2013). Similarly, Salmonella Typhimurium 
prevents apoptosis by targeting kinases Akt and RSK1 (protein downstream of ERK 
phosphorylation) through its T3SS effector protein SopB, as determined by global 
phosphoproteomics analysis (Rogers et al, 2011). Therefore, we propose a large-scale 
phosphoproteomics approach to provide insight into the regulation of the host-pathogen 
interactions and the cell signalling pathways, specifically in response to the ΔbimA mutant. 
MS-based phosphoproteomics is also capable of discovery of novel cell signalling circuits. The 
findings from the phosphoproteomics data could then be confirmed with functional studies 
involving small interfering RNAs (siRNAs) and relevant kinase inhibitors.  
 
6.3 Host transcriptomic studies and future directions  
        From the traditional ‘hypothesis-driven’ approaches described above, we moved to an 
unbiased high-throughput method using microarray (Chapter 5). The technology provides an 
overview of the expression pattern of thousands of differentially expressed genes during 
infection, which in turn offers more insight into pathways and networks for host-pathogen 
interactions.  Global transcriptional profiling by microarray revealed that the BALB/C 
BMDMs mount innate immune responses to infection with both B. pseudomallei WT and the 
∆bimA mutant when compared to uninfected control cells during the experimental time points 
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of 8 and 12 hpi. A microarray dataset presented by table 5.10 and 5.11, found a similar cohort 
of core inflammatory ‘alarm signal’ molecules comprised of various pro-inflammatory 
cytokines and chemokines, as a similar suite of genes induced in THP-1 human monocytic-like 
cells (Perumal Samy et al, 2015), as well as in murine tissues infected with a B. pseudomallei 
WT strain (Chin et al, 2010). These inflammatory signals also serve as a means for 
communication between innate and adaptive immune response (Table 5.10). At later time 
points of infection, the predominant response has pervasive similarities to the transcriptional 
programme mediated by interferon-related signalling (Table 5.11). The involvement of 
interferon-mediated signalling in infected BALB/C BMDMs in our in vitro assays is mirrored 
with the in vivo host transcriptomic changes in the acute melioidosis BALB/C mouse model 
(Chin et al, 2010). IFNγ has been shown to be essential for resistance to B. pseudomallei both 
in vitro and in vivo (Utaisincharoen et al, 2004; Santanirand et al, 1999).  In fact, IFNγ and its 
inducing cytokines IL-12β were found to be significantly higher in melioidosis patients  (Lauw 
et al, 1999; Brown et al, 1991). Whilst there are extensive investigations on the role of IFNγ 
in the pathogenesis of melioidosis, the role of Type I IFN is not well described. Very few 
studies reported on the importance of IFNβ in suppressing the intracellular growth of B. 
pseudomallei when added exogenously (Utaisincharoen et al, 2003), however, it is believed 
that B. pseudomallei infection is unlikely to induce host TLR/TRIF-dependent pathways to 
produce Type I IFN (Tangsudjai et al, 2010; Wiersinga et al, 2008; Utaisincharoen et al, 2003). 
The identification of upregulated genes encoding RNA sensors of the RLR family (RIG-1 and 
MDA-5) in the present microarray dataset is an interesting finding. As far as we are aware no 
literature has been published regarding the role of any of these cytosolic RNA sensors in 
detecting the presence of B. pseudomallei to produce Type I IFN, which we postulate to be a 
specific response by BALB/C BMDMs upon B. pseudomallei infection. Therefore, this thesis 
is the first report identifying the possible involvement of RIG-1 and MDA-5 receptors in 
sensing cytosolic RNA as well as related interferon signalling in melioidosis. Recently, it has 
been demonstrated that RIG-1/MDA5 signalling pathways can also result in a programmed cell 
death known as apoptosis (Chattopadhyay & Sen, 2017) which has not being investigated in 
this thesis. Nevertheless, we would wish to pursue future validation and functional 
characterisation for the candidate receptors and interferon mediators.  
       The second goal of the microarray experiment was to identify an innate immune response 
that specifically targets the ∆bimA mutant, however, we found no conclusive evidence at the 
transcriptional level. To our surprise, very few functional pathways were identified for this 
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category, with very few molecules associated with each pathway (Table 5.14 and Table 5.15). 
We were unable to identify clusters that could be considered specific to the presence of 
cytoplasmic bacteria that are unable to form actin tails. Many of the differentially expressed 
genes identified as being specific to the ∆bimA mutant have no previously known role. This 
suggests that the host mechanisms targeting the ∆bimA mutant are likely to be novel. Besides, 
it could be possible that the specific genes involved are not present on microarrays or the 
transcript abundance is too low to be detected, representing some of the pitfalls of the 
microarray technology. Therefore the more expensive next generation sequencing technologies 
such as RNA-seq could be used in future to overcome such limitations. Additionally, future 
experiments would be more powerful if RNA from the infected cells could be isolated from 
the uninfected as discussed in Chapter 5. As microarray technology detects the known 
transcripts with existing genomic sequencing information, RNA-seq on the other hand, is ideal 
for exploring novel transcripts. Besides, RNA-seq delivers much lower background signal as 
compared to microarray, therefore capable of overcoming common hybridisation issues seen 
with microarrays.  
 
6.4 Final conclusions 
        In conclusion, the present studies provide evidence that B. pseudomallei bimA-dependent 
elimination in BALB/C BMDMs is unlikely to involve autophagy, TLR-dependent signalling, 
canonical inflammasome nor non-canonical inflammasome pathways.  Although studies of 
global transcriptome profiling by microarray have proven powerful tools in the study of host-
pathogen interactions, they cannot fruitfully assist discovery of novel genes as well as 
mechanisms that rely on protein post-translational modification. Besides, there are other 
possible cell-autonomous immunity pathways that may be involved in targeting bimA-deficient 
bacteria such as galectins and septin caging. The future also requires more combinations of 
various ‘omics’ techniques such as MS-proteomics and RNA-seq technologies. These 
strategies together will provide valuable information about host-pathogen interactions, which 
can be utilised in the development of immune-based host-directed therapies as viable 
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